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Abstract 
 
The realm of natural product synthesis constitutes a major part of the interactions 
between chemistry and the living world. By designing and developing new synthetic 
routes to natural products, a better insight is gained in terms of new methodology, 
biological activity and structural novelty. As the field of natural products chemistry 
advances, ideal syntheses must be strived towards with the investigation of new 
methodology with high efficiency. Outlined herein are efforts towards the synthesis of 
four natural products of varying synthetic interests. Although many factors drive 
interest in their synthesis, they are united by a common goal of pursuing good 
synthesis. 
(±)-Angelmarin (43) has potential a therapeutic agent in the treatment of pancreatic 
cancer and was synthesised in only 7 linear steps without the use of protecting 
groups. This was enabled by the recently developed gold(I) catalysed intramolecular 
hydroarylation chemistry which allowed synthesis of the key coumarin heterocycle in 
(±)-columbianetin (44) under mild conditions from the propiolate ester. 
 
Investigations were made into the synthesis of the ochrosamines A (117) and B 
(118), isolated from the endangered rainforest tree Ochrosia moorei, exploring the 
scope and limitations of novel chemistry such as the vinyl aziridine rearrangement 
and interrupted Fischer indole synthesis. A number of interesting results were 
obtained from which much was learnt about the polycyclic system. 
  ix 
 
 
The hasubanan framework (204) was of synthetic interest as the unnatural 
enantiomer has potential as a new opiate analogue. The research hoped to expand 
on recently developed methodology for an intramolecular Alder-ene reaction and its 
application in a high value context. 
 
Lastly, significant progress was made towards the synthesis of bicuculline (228) with 
the successful synthesis of the advanced intermediate (326) utilising an innovative 
osmium catalysed intramolecular amidohydroxylation reaction. This carries the 
possibility of developing an enantioselective synthesis. It is hoped that the natural 
product can ultimately be synthesised from this late stage material. 
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Chapter 1 - Introduction 
1.1 Towards the syntheses of biologically relevant secondary metabolites. 
 
To its broadest extent natural products encompass all of the molecules of life; 
featuring extremely diverse classes of chemical compounds, from large scale 
polymers and organometallic complexes to steroid hormones and complex alkaloids1 
(Figure 1.1). As such natural products are inexorably intertwined with the field of 
organic chemistry. Friederich Wöhler’s 1828 synthesis of the natural product, urea, 
fundamentally changed how the world was seen from a chemical perspective.2 The 
molecules of life were no longer seen as the exclusive domain of living organisms. In 
essence this momentous discovery opened the door to the development of organic 
chemistry as a discipline in its own right.3 Sitting at the interface of chemistry and the 
natural world, total synthesis pushes the boundaries of what is achievable whilst 
furthering our understanding of inherent chemical reactivity.4 
 
One of the more fascinating aspects of natural products are the secondary 
metabolites. They are as their name suggests, molecules produced by an organism 
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that are not essential to its structure or metabolism.5 Within various species these 
secondary metabolites have been shown to possess diverse roles from insecticides 
and pheremones, to antibiotics and venomous toxins.6 This broad range of activities 
allows further understanding and manipulation of the biological systems in which 
they are found.7 
One of the keenest examples of this is in drug design and development.8 In the 
twenty-five years spanning 1981-2006, over 60% of new chemical entities registered 
for use as drugs have been either natural products or of naturally inspired origin.9 
Upon isolation, secondary metabolites are commonly assayed for potential 
bioactivity, thereby identifying possible lead compounds for drug development. It has 
been proposed that one of the key reasons for the relatively high success rate of 
naturally inspired drugs is that their biosynthesis has evolved alongside key 
biological targets.10 If a secondary metabolite interacts with a biological target to 
benefit the producing organism, the genes controlling the synthesis and expression 
of that metabolite are more likely to be passed on. This constitutes a significant 
evolutionary selection pressure at the molecular level for the production of structures 
that interact strongly with biological systems.11 In this fashion the field of natural 
products aids in the provision of relevant structural novelty in drug design and the 
discovery of potential biological targets for the treatment of disease. 
 
1.2 Why do we synthesise Natural Products? 
 
Given the inherent natural availability of these compounds, a salient question is 
raised; why make them? Indeed many such natural products are used or produced 
commercially in their natural form.9 However a broad range of reasons from the 
practical to the intellectual, sit as the driving forces of synthesis. Isolation of material 
is often laborious, requiring multiple procedures at high expense with poor 
reproducibility.1b From an economic perspective, synthesis may be the only choice. 
When the yield from natural sources is a mere fraction of a percent it becomes 
commercially untenable to isolate compounds on any reasonable scale. At the 
moment of discovery, world supplies of such isolated products are often in the range 
of only a few milligrams of material.  
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Natural sources may also be ecologically sensitive, where obtaining large quantities 
of the source organism may significantly endanger the species population.12 In order 
to commence further research as a potential drug target, synthetic methods are 
commonly required in order to provide the required quantities. A recent and notable 
example of this has been in the development of an anticancer compound taxol (1), 
derived from the bark of the pacific yew tree.13 Having demonstrated significant 
pharmaceutical potential, the demand for material became a threat to the relatively 
uncommon species. One of the early solutions to this problem was establishing a 
semi-synthetic procedure14 as part of an effort towards a total synthesis, from 10-
deacetylbaccatin III (2) which could be obtained in larger quantities from the 
european yew,15 which can be sustainably forested (Figure 1.2). 
 
As a secondary consideration, the synthesis of natural products can also be seen as 
a worthwhile intellectual pursuit; often there is a race to be the first to achieve a 
synthesis of a novel structure.4 This competitive element provides a strong impetus 
for the discovery of new processes and further development of the field. Due to the 
often complex and multifunctional nature of the intermediates, total synthesis also 
acts as a robust proving ground for the demonstration and validation of new 
methodology.16 
The realm of natural product synthesis thereby serves as a theatre for the exposition 
of skill in the field of organic chemistry. Some of the greatest organic chemists have 
showcased their mastery in meeting the challenge provided by a complex natural 
product.17 Some of these syntheses represent a marathon of time and effort to 
achieve a total synthesis of monumental status such as the selective total synthesis 
of palytoxin (3) by Kishi et al.18 Palytoxin itself is one of the largest molecules of its 
kind ever synthesised; It possesses a molar mass of over 2600, with 64 stereogenic 
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centres. It was accomplished over several years in a longest linear sequence of 39 
steps from 7 different building blocks with as many as 140 steps overall.16, 19 (Figure 
1.3). 
 
In contrast to this other syntheses are a sophisticated work of art and strategy. R.B. 
Woodward's landmark synthesis of strychnine (4) in 1954 remains a testament to his 
genius, achieved before the invention of many reactions and techniques that would 
now be seen as essential.20 However with the advancement of the field there has 
been a distillation of simplicity with Vanderwal’s total synthesis of strychnine in 2011 
requiring one fifth the number of steps.21 (Figure 1.4). 
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1.3 What constitutes a good synthesis? 
 
As the field of organic chemistry has progressed and matured, it has been 
established that given enough time and effort almost any natural product can be 
synthesised. It is no longer enough to merely synthesise a target molecule, instead 
the ideal synthesis must be strived toward.16 One of the most obvious measures of 
an ideal synthesis is the overall yield of a synthetic sequence. Even with quite high 
individual yields, the overall yield decreases exponentially with the number of linear 
steps (Figure 1.5). At later stages setbacks becomes extremely costly in terms of 
resources as large quantities must be advanced through the synthesis to provide 
enough material for experimentation.17 It therefore becomes imperative to 
strategically minimise the number of steps in the sequence. One of the simpler ways 
of achieving this is to develop a convergent synthesis, where two or more separate 
fragments are synthesised and then combined at a later stage to give a substantially 
more complicated product. By telescoping the synthetic scheme in this fashion, the 
number of linear steps can be dramatically reduced.4 
 
In a more nuanced fashion one can also consider the efficiency of a synthesis in 
terms of its atom economy. Originally coined by Trost,22 atom economy is a measure 
of what proportion of the mass used in reagents becomes incorporated into the 
0
10
20
30
40
50
60
70
80
90
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
P
e
rc
e
n
ta
g
e
 O
v
e
ra
ll 
Y
ie
ld
Number of Linear Steps at 80% yield
Exponential Losses with Increasing Linear Steps
Figure 1.5: Linear inefficiency
 Chapter 1 
  6 
 
desired product. Atom economic syntheses generate minimal additional waste and 
are a hallmark of a well-designed synthesis. As such they tend to feature catalytic 
reactions with high levels of selectivity, exploiting the natural reactivity of the 
system.23 Typically poor atom economy reactions feature stoichiometric reagents of 
high molecular weight that effect minimal change, such as the use of protecting 
groups or extensive changes in oxidation states.22 
 
1.4 Exemplary syntheses 
 
To demonstrate the importance of strategy, one can compare the aforementioned 
syntheses of strychnine by Woodward24 and Vanderwal21. As an overview of the key 
steps, Woodward initially utilised a Fischer indole synthesis on a readily available 
ketone (5) to build a core framework (6) around which, the rest of the molecule was 
artfully constructed. The inherent reactivity of the indole towards electrophilic 
substitution was exploited via initial formation of the gramine (7) which was further 
elaborated to an imine (8) which underwent a second electrophilic substitution to 
generate a key spirocycle (9). After some functional group manipulation, an inspired 
ozonolytic opening of the aromatic ring reveals a diester (10) one of which then 
cyclises form a pyridone (11) under acidic conditions. After an exchange of 
protecting groups an intramolecular Dieckmann condensation establishes the central 
six-membered ring (12).25 (Scheme 1.1). 
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After a lengthy reductive procedure the methyl ester is converted into an acyl group 
and the amine deprotected to give intermediate (13). Oxidative cyclisation with 
selenium dioxide then effects an additional ring closure to give the alpha ketoamide 
(14). Nucleophilic addition of sodium acetylide introduces the remaining two carbon 
fragment to give compound (15) which, after some manipulation generates the allylic 
alcohol (16) that subsequently undergoes cyclisation under basic conditions to give 
strychnine (4).25 (Scheme 1.2). 
 
Comparatively the synthesis by Vanderwal starts with a readily obtained allyl 
tryptamine (17) which is condensed with an N-aryl pyridinium salt (18) to give the 
Zincke aldehyde (19). Under basic conditions this then undergoes a formal Diels-
Alder reaction to rapidly assemble an advanced tetracyclic system (20). This was 
then deprotected and alkylated with a silyl substituted allylic bromide (21) to give a 
tethered allylic alcohol (22). A copper mediated Brook rearrangement then generates 
an organocopper species in situ that undergoes Michael addition to the conjugated 
aldehyde to give the known Wieland-Gumlich aldehyde (23), albeit in 5-10% yield. 
This was then converted under literature conditions to give strychnine (4) in just 6 
linear steps.21 (Scheme 1.3). 
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Woodward’s synthesis is a thoughtful and robust implementation of the limited 
chemistry known at that time; building upon the inherent reactivity of the system to 
generate complex motifs. However it is limited by its lengthy manipulations in 
protecting groups and oxidations states. When we compare this to the more recent 
synthesis by Vanderwal, the steps therein are highly productive, resulting in complex 
transformations with minimal accessory manipulation. 
Two further examples of brilliant and concise synthesis can be found in the 
Paquette26 synthesis of ceratopicanol (24), and the Wender27 synthesis of α-cedrene 
(25). These approaches are characterised by the employment of powerful 
methodology to generate high levels of chemical complexity from relatively simple 
starting materials. 
Demonstrating robust methodology developed around squarate esters, Paquette 
undertook a one pot nucleophilic addition of two vinyl nucleophiles (26) and (27) to 
isopropyl squarate (28). After initial addition, the two resulting diastereomers (29) 
and (30) converge respectively via a dianionic oxy-Cope rearrangement, or by strain 
assisted 4π electrocyclic ring opening and 8π electrocyclic ring closing; to give an 8-
membered dienolate (31). The presence of an ether in the beta position of one the 
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nascent enolates results in elimination to give a ketone enolate (32) that allows for a 
regioselective transannular aldol reaction to yield the product (33). In practice this 
occurs in a single reaction, resulting in the isolation of the triquinane core of the 
natural product after a single step in 44% yield. The trade-off of the methodology is 
that an additional 6 steps were required to introduce the remaining methyl group and 
reduce the system to the desired oxidation state in ceratopicanol (24).26 (Scheme 
1.4). 
 
In comparison, the Wender synthesis of α-cedrene (25) is extremely concise. A 
reductive coupling of keto alkene (34) with chloroarene (35) generates a simple 
aromatic system with a tethered alkene (36). This system was then irradiated under 
UV light to generate excited state meta-diradical intermediates (37) and (38) in the 
aromatic system that undergo cycloaddition to the tethered alkene. The system was 
designed so that between the steric limitations of the tether and the electronics of the 
aromatic ring, out of the 36 possible products only two were observed (39) and (40) 
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in a combined yield of 65%. These were converted by treatment with bromine to a 
pair of epimeric bromides (41) which were reduced directly with tributyltin hydride to 
the ketone (42) in a single reaction. Wolff-Kishner reduction thus afforded α-cedrene 
(25) in only 4 steps.27 (Scheme 1.5). 
 
An overarching theme of these works is that they employ sophisticated chemistry to 
achieve highly specific results generating a high degree of complexity. The products 
of these powerful reactions are then tailored towards the final target. It is this pursuit 
of novelty and the use of such sophisticated chemistry that is a hallmark of great 
synthesis, these classic works of total synthesis stand out primarily for the chemistry 
upon which they are based. 
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1.5 Foreword 
 
This body of work shall elaborate on efforts made to produce a range of quite 
different natural products each of which has its own motivations for synthesis. 
However, within this body of work are a number of overarching themes with respect 
to pursuing good synthesis, investigating chemical novelty, and demonstrating robust 
methodology in a high value context. 
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Chapter 2 - Angelmarin and Columbianetin 
 
2.1 Introduction 
 
Over the last twenty years the pharmaceutical sector has seen a proliferation in new 
treatments for cancer. Much of this has been driven at an academic level by the 
isolation of novel cytotoxic natural products such as taxol.13 In the treatment of 
cancer one of the most difficult problems to address is in establishing selective 
toxicity for tumour cells over otherwise healthy cells.7 One of the distinct 
physiological properties of solid cancerous tumours is that, as a result of rampant 
cellular growth, the associated vasculature is often deficient.28 (Figure 2.1). The 
expanding cellular masses often occlude any existing blood vessels and result in 
areas that are starved of oxygen and nutrients. Cancer cells respond to this in 
developing a considerable tolerance to these conditions by reversible modulation of 
their metabolism.29 Furthermore, such tolerance has been shown to be a key factor 
in resistance to standard chemotherapy, general malignancy and poor clinical 
prognosis.30 
 
Figure 2.1: Comparative vasculature of normal and tumour tissues; adapted from 
Brown and Giaccia.31 
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In order to address this notable deficiency in medical treatment Kadota et al. sought 
compounds that could counter this metabolic tolerance as a potential new method in 
the treatment of cancer.32 In this regard they developed a new screening 
methodology whereby a variety of resistant cancer cell lines were screened for 
selective cytotoxicity under nutrient deprived conditions compared to a control of 
non-cancerous cells with adequate nutrition. Based on this “anti-austerity” strategy 
over 500 plant extracts were screened from a library of those used in traditional 
Japanese Kampo medicine. In doing so they discovered that extracts of one of these 
plants; Angelica pubescens, was particularly active in eliminating resistance of 
cancer cells to nutrient starved conditions;32 exhibiting preferential cytotoxicity at 
concentrations of 50 µg/mL. Following further bio-assay guided fractionation and 
purification, they isolated a new compound named (+)-angelmarin (43), whose 
structure was determined to be that shown below in Scheme 2.1; an ester derived 
from the known natural products (+)-columbianetin (44) and p-coumaric acid (45).33  
 
Angelmarin (43) was then further tested against the pancreatic cancer cell line 
PANC-1 to determine the extent of its cytotoxicity. It was found to dose dependently 
inhibit tolerance to nutrient starved conditions, displaying 100% cell death at 
concentrations as little as 0.01µg/ml within 24 hours. The effect was more 
pronounced at a concentration of 10 µg/ml, at which 100% cell death was effected in 
only 6 hours.32 Intriguingly neither p-coumaric acid (45) nor (+)-columbianetin (44) 
showed any activity in the essay, implying that the bioactivity of angelmarin (43) 
relies on the complete structure. Although exact information regarding the mode of 
action of angelmarin (43) has not yet been established; a number of other potential 
drug candidates have been found through the same anti-austerity methodology.34 
Two notable examples are (-)-arctigenin35 (46)  and (+)-grandifloracin36 (47) (Figure 
2.2). 
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Although distinct molecular targets have not been identified, it has been 
demonstrated that both grandifloracin (47) and arctigenin (46) both inhibit the activity 
of Akt, a cytosolic protein kinase that is upregulated under nutrient deprived 
conditions.37 Grandifloracin (47) has also been shown to additionally suppress the 
phosphorylation state of mTOR, another protein kinase in the same signalling 
pathway. It has been suggested that grandifloracin (47) mediates cell death by 
activating autophagy,36 a process that recycles cellular proteins and redundant 
organelles38. Arctigenin (46) has also shown potent in vivo activity using mouse 
xenografts and has since progressed into clinical trials for the treatment of pancreatic 
cancer.39 Pancreatic cancer remains one of the most severe forms of cancer with the 
lowest known five year survival rate. It is resistant to most forms of modern 
chemotherapy with surgery representing the only major treatment option.28 As a 
potential lead candidate in drug development, (+)-angelmarin (43) was seen as an 
excellent target for total synthesis. 
 
2.2 Previous syntheses 
 
The related natural product (+)-columbianetin (44) has been known for some forty 
years,33 and multiple syntheses have been carried out.40 However, the somewhat 
recently isolated (+)-angelmarin (43) has only been synthesised twice, the first time 
by Coster41 and the second by Hamada.42 These syntheses are both somewhat 
semisynthetic, starting from the commercially available coumarin natural product, 
umbelliferone (48) and can be viewed as modifications of the 1971 synthesis of 
racemic columbianetin (44) by Bohlmann and Franke.40b In the synthesis of 
columbianetin (44) by Franke, umbelliferone (48) was O-alkylated under Finkelstein 
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conditions using 2-chloro-2-methyl-3-butyne then subjected to a Lindlar reduction to 
form the required O-isoprenyl umbelliferone (49). This alkene was then heated to 
effect a surprisingly regioselective Claisen rearrangement, generating the natural 
product osthenol (50), as an intermediate. The common osthenol intermediate was 
converted by Franke to racemic columbianetin (44) via peracid epoxidation and 5-
exo-tet cyclisation under basic conditions.40b (Scheme 2.2). 
 
Similarly, in the synthesis by Coster, umbelliferone (48) is alkylated with the 
considerably cheaper allyl bromide to form compound (51). Following regioselective 
claisen rearrangement under thermal conditions, allyl derivative (52) is then 
converted into osthenol (50) by olefin metathesis with isobutene (53) using Grubb's 
second generation catalyst. Coster then protected the free phenol of osthenol (50) 
with a TBS group to form silyl ether (54) prior to subjection to Shi epoxidation 
conditions with the classic fructose derived organocatalyst (55).43 The crude epoxide 
product was then deprotected using tetrabutylammonium fluoride which was 
accompanied by a 5 exo-tet cyclisation to yield (+)-columbianetin (44).41 (Scheme 
2.3). 
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Coster’s approach was to functionalise the hindered tertiary alcohol with Meldrum’s 
acid (56), which undergoes cycloreversion to generate an active ketene 
intermediate, forming a malonate ester (57) under neutral conditions. The crude 
malonate ester (57) was then directly subjected to a Doebner Knoevenagel 
condensation with p-hydroxybenzaldehyde (58) generating (+)-angelmarin (43) in 
good yield over two steps.41 (Scheme 2.4). 
 
In the synthesis by Hamada, the isoprenylated derivative (49) was accessed directly 
via a Tsuji-Trost allylation of umbelliferone (48) with the carbonate derivative (59) 
followed by regioselective Claisen rearrangement under conditions identical to those 
described by Franke. Like Coster, Hamada protected the free phenol of osthenole 
(50) with a TBS group prior to subjection to Shi epoxidation conditions, however 
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Hamada was able to obtain substantially better enantiomeric excesses and yields by 
utilising the diacetate catalyst (60). The crude epoxide product was then deprotected 
using tetrabutylammonium fluoride which was accompanied by a 5 exo-tet 
cyclisation to yield (+)-columbianetin (44).42 (Scheme 2.5). 
 
In contrast to the approach by Coster, Hamada subjected columbianetin (44) directly 
to a copper cyanide mediated esterification with the TBS protected acid chloride (61) 
derived from p-coumaric acid (45), followed by deprotection with TBAF to form the 
natural product (+)-angelmarin (43). The acid chloride derivative was prepared 
somewhat inefficiently in three steps, involving bis TBS protection to form compound 
(62), selective cleavage to regenerate the carboxylic acid functionality in compound 
(63) followed by conversion to the acid chloride (61) using thionyl chloride.42 
(Scheme 2.6). 
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2.3 Initial strategy and retrosynthetic analysis 
 
In order to set ourselves aside from the two known synthetic approaches it was 
decided that we would undertake a de novo synthesis of angelmarin (43) and form 
the often difficult to synthesise coumarin functionality by a gold(I) catalysed 
intramolecular hydroarylation reaction, which had been previously developed in the 
group.44 Although originally considered to be an inert metal, gold has since 
encountered a renewed level of interest in its catalytic activity.45 The high relativistic 
effects at the gold(I) centre enable it to act as a highly efficient pi acid.46 In this 
system the gold(I) centre activates the tethered alkyne (64) to act as an electrophile 
for the nucleophilic aromatic ring resulting in an alkenyl gold species (65). 
Protodeauration then regenerates the Au(I) catalyst (Scheme 2.7) and furnishes the 
coumarin (66). Gold catalysis is capable of activating alkenes, allenes and alkynes to 
a wide variety of nucleophilic species and has seen diverse use in synthesis.45 
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Key disconnections similar to the syntheses reported by Coster41 and Hamada42 
were employed, including the formation of the ester linkage from p-coumaric acid 
(45) and columbianetin (44). Disconnection of the coumarin ring via the propiolate 
(67), required a synthesis of the dihydrobenzofuran derivative (68). In a similar 
fashion to the known literature,40b, 41-42 this was disconnected to the epoxide which 
could be available from prenyl resorcinol (69) which we envisioned could be 
available via a directed ortho-metalation47 of appropriately protected resorcinol and 
alkylation with prenyl bromide (70). Use of an appropriate enantioselective 
epoxidation method would allow access to either enantiomer of the natural product 
(Scheme 2.8). 
 
This approach offers a number of key advantages over the ones that were reported 
by Coster and Hamada; most notably is that there is no requirement to start from 
umbelliferone (48) in an arguably semi-synthetic fashion. By use of appropriate 
methodology one could envision modification of the structural framework of 
angelmarin (43) at almost every position by variation of the resorcinol structure used 
in the ortho directed metalation, or by variation of the prenyl bromide electrophile. 
Additionally it has been demonstrated that through use of the intramolecular 
hydroarylation methodology that substitution is possible at both the 3 and 4 positions 
of the coumarin ring system by addition of an electrophilic source of iodine and 
varying the alkyne terminal functionality respectively.48 
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2.4 Results and Discussion 
 
In the initial strategy to form the key aryl-prenyl bond, it was envisioned that this 
could be achieved via the directed ortho-metallation of bis MOM-protected resorcinol 
(71). As such, resorcinol (72) was subjected to MOM protection with sodium hydride 
and MOMCl in DMF, this proceeded smoothly to afford the bis MOM protected 
resorcinol (71) in good yield.49 In order to deprotonate at the desired position, 
protected resorcinol (71) was dissolved in anhydrous, degassed THF and cooled 
to -78 °C, BuLi was then added dropwise and the solution heated 0 °C and stirred for 
1 hour in order to accelerate the rate of deprotonation. This was then cooled to -78 
°C and the electrophile, prenyl bromide (70) added, which was allowed to return to 
room temperature overnight, furnishing the desired prenylated resorcinol derivative50 
(73) in 68% yield (Scheme 2.9). 
 
However when attention was turned to the deprotection of the MOM groups under 
acid catalysed conditions51 (dilute aqueous acid in tetrahydrofuran) this primarily 
resulted in decomposition, presumably due to the formation of stabilised tertiary 
carbocation intermediates. This was supported by the isolation of the known52 
dihydrochromene (74) which featured a desymmetrisation of the aromatic ring 
protons in the 1H NMR spectrum and two characteristic triplet signals at 2.68 and 
1.83 ppm; indicating an intramolecular cyclisation and loss of the alkene 
functionality. Attempts to use milder conditions such as pyridinium p-
toluenesulfonate in methanol resulted in incomplete deprotection and no isolation of 
the desired product.53 In an attempt to avoid this problem, the prenyl group was 
epoxidised with m-CPBA to yield the protected epoxide derivative (75), in the hope 
that cyclisation may occur in situ to afford the desired dihydrobenzofuran derivative 
(68). However when the epoxidised derivative was subjected to similar and even 
quite mild conditions such as NaHSO4 on silica in methanol,51 only solvent attack at 
the more hindered site was observed (76) with some isolation of chromene (77).54 
The isolated material (77) possessed a pair of signals at 5.58 and 6.61 ppm with a 
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coupling constant of 10 Hz, indicative of the cyclised system. This occurred 
presumably by a 6-endo-tet cyclisation and elimination (Scheme 2.10). 
 
Continuing on from this, it was decided that an alternative approach featuring a 
phenolic dianion (78) derived from deprotonation and lithium halogen exchange of a 
monoprotected, halogenated resorcinol derivative could furnish the desired product 
(69) by selective C alkylation with prenyl bromide (70).53 As such the halogenated, 
monoprotected resorcinol derivatives were synthesized by sequential regioselective 
halogenation and mono protection. In the case of the bromide derivative (79), 
regioselectivity was accomplished by perbromination of resorcinol (72) followed by 
selective reduction of the more sterically available 4 and 6 ring positions.55 The 
iodinated derivative (80) was more readily available, by a direct base catalysed 
process which increases the electron density at the 2 position of resorcinol (72).56 
Mono protection was then achieved using MOMCl as a limiting reagent in the 
presence of an excess of base57 to give modest yields of the requisite ethers (81) 
and (82) in spite of the inherent statistical effects, presumably due to the enhanced 
nucleophilicity of the resorcinol dianion (Scheme 2.11). 
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Treatment of the halogenated, monoprotected resorcinol derivatives (81) and (82), 
with 3 equivalents of t-BuLi followed by addition of either prenyl bromide (70) or 
prenyl iodide (83) did not furnish the desired product, giving only the rearranged and 
formally oxidised product as a single stereoisomer (84) in moderate yield along with 
dehalogenated starting material (85) (Scheme 2.12). 
 
This result was fairly consistent with both halogenated resorcinol derivatives (81) and 
(82) and with either prenyl bromide (70) or prenyl iodide (83) as the electrophile. It 
seemed that dianion formation was more efficient with the aryl iodide (82), as the 
reactions involving aryl bromide (81) resulted in the recovery of minor quantities of 
starting material (81). Attempts to use a mixed anion approach with NaH or KH 
followed by t-BuLi yielded only a small quantity of dehalogenated material with most 
of the starting material unchanged. The structure of the product (84) was 
unequivocally confirmed by X-ray crystallography as the E-stereoisomer, consistent 
with the NMR of the bulk material, and a positive NOE effect between the adjacent 
methyl groups on the alkene (Figure 2.3). 
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Figure 2.3: ORTEP derived from the single-crystal X-ray analysis of compound (84) 
with labelling of non-hydrogen atoms. Anisotropic ellipsoids display 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. 
The absence of halide from any of the major products and the similarities between 
the aryl halides is consistent with the notion that initial formation of the MOM-
stabilised dianion (78) does successfully occur. Illustrated for the iodide (82) in 
scheme 2.13, three full equivalents of t-butyl lithium are required, the first 
deprotonates the acidic phenol functionality generating the lithium oxide salt (86) and 
isobutane. The second equivalent is involved in lithium halogen exchange which 
occurs via the hypervalent ate complex (87), generating t-butyl iodide and the 
dianion (78). The third equivalent is required to effect E2 elimination of the t-butyl 
iodide which drives the lithium halogen exchange to completion, liberating lithium 
iodide, isobutane and isobutene as unreactive side products.58 
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From the dianion (78), formation of the observed product is non-trivial. Low 
temperature conditions significantly limit the relative energy of most intermediates 
required for rearrangement. The following explanation is somewhat speculative but 
fits the available information (Scheme 2.14). The high energy dianion would be 
expected to be extremely basic in character, thus upon addition of prenyl bromide 
(70) it is assumed that rapid vinylogous E2 elimination occurs to generate isoprene 
(88) and the observed dehalogenated starting material (85) after quenching. 
Isoprene (88) itself is extremely reactive and is known to polymerise via 
carbolithiation in the presence of catalytic quantities of highly anionic organometallic 
species such as butyl lithium.59 Using this as precedence it is assumed that any 
formed isoprene (88) is immediately consumed in carbolithiation by a second 
equivalent of dianion (78). Addition to the 4 position of isoprene (88) explains the 
observed skeletal rearrangement of the electrophile resulting in a transient allyl 
lithium species (89). 
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Thus far the mechanism is yet to explain the stereoselectivity of the olefin or the 
observed oxidation. Speculatively, the allyl anion system could then undergo an 
intramolecular proton transfer60 via a localised anion (90) to give the conjugated 
anion (91). Theoretically this could be driven by the higher acidity of the benzylic 
position and the resulting delocalisation with the aromatic ring.61 As allyl lithiums are 
configurationally unstable62 a rotation of the terminal methyl group may occur due to 
an unfavourable interaction with the chelating MOM group. This would establish the 
observed alkene regioselectivity and functionalise the benzylic position as the anion 
(92) for oxidation (Scheme 2.15). 
 
Introduction of the oxygen atom to this anionic system was not established, and 
could be from oxygen or from the aqueous quench. The simplest explanation is the 
reaction with adventitious oxygen at the least hindered benzylic site of the allylic 
anion to give the observed product (84) upon quenching. Alternatively subsequent 
lithium halogen exchange would yield and intermediary bromide that could hydrolyse 
in the aqueous conditions used in isolation. Any true explanation in the mechanism 
of the observed product would warrant significant further research, ideally backed by 
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calculations; as such that was determined to be beyond the scope of this body of 
work. 
Although fascinating in its own right, the observed product was not a productive 
intermediate in the potential synthesis of (+)-angelmarin (43). Consequently, in order 
to avoid the problem of using cumbersome protecting groups in the presence of 
demonstrably acid sensitive functionalities41 it was decided that that the desired 
alkene (69) could instead be formed by a Stille cross coupling63 of a halogenated 
resorcinol derivative (79) or (80), and the corresponding organotin species (93).  As 
such the prenyl stannane derivative (93) was synthesised by a Barbier reaction of 
prenyl bromide (70) with tributyltin chloride using magnesium metal; the magnesium 
required activation with 1,2-dibromoethane to initiate the reaction.64 Owing to its 
relative cost, prenyl bromide (70) was synthesised on a larger scale using the 
method reported by Kara et al., from the isoprenyl alcohol (94) and acetyl bromide 
via an SN' reaction.65 (Scheme 2.16). 
 
A large range of conditions common to the Stille cross coupling were screened in an 
attempt to effect the desired transformation. This included variations in the source of 
palladium, different ligands, the use of LiCl to stabilise the transmetallation transition 
state,66 use of catalytic copper(I) salts to decrease the energy requirement for 
transmetallation,67 and addition of caesium fluoride to encourage elimination of 
tributyltin species.68 However in spite of these efforts, this approach was abandoned 
without any of the prenyl resorcinol (69) being isolated. The major product of these 
reactions was the formation or resorcinol (72), presumably due to the acidity of the 
phenolic groups. Under more forcing conditions using triphenylarsine as a ligand the 
butyl resorcinol derivative (95) was observed by 1H NMR (not further characterised) 
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indicating a potential steric limitation of the prenyl group. In addition to the resorcinol 
peaks the compound bore the characteristic shifts of the butyl group with a triplet at 
2.63 ppm corresponding to the two benzylic hydrogens, two multiplets at 1.53 and 
1.40 ppm, corresponding to the aliphatic methylene protons and a triplet at 0.94 ppm 
integrating to three protons (Scheme 2.17). 
 
In order to get around this problem, it was decided that this key bond could be 
selectively formed by starting with 1,3-cyclohexanedione (96), utilizing the specific 
activity of the doubly activated methylene position to introduce the prenyl substituent 
with complete regioselectivity. The known prenylated cyclohexanedione (97)69 could 
then be oxidatively aromatized to give 2-prenyl resorcinol (69) (Scheme 2.18). 
 
The prenylated cyclohexanedione (97) was therefore synthesised according to the 
procedure described by Marazano et al.,69 proceeding in good yield. Disappointingly, 
subjection of prenylated cyclohexanedione (97) to common oxidative aromatisation 
and dehydrogenation protocols70 such as manganese dioxide or DDQ did not result 
in formation of the desired prenyl resorcinol derivative (69), it seemed that 
dehydrogenation was occurring across the activated methine and allylic sites to form 
compound (98) which then undergoes electrocyclic ring closure to form the known54 
pyran (99) which was isolated in modest yield and confirmed by comparison to the 
literature data (Scheme 2.19). 
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Interestingly when the aromatisation was attempted utilising molecular iodine in 
methanol, as described by Mphalele,71 the iodinated dihydrofuran (100) was formed 
via a 5-exo-tet cyclisation of the iodonium intermediate (101) as the major product 
along with the dihydropyran (102). Hoping to capitalise on this, the prenyl 
cyclohexane derivative (97) was subjected to epoxidation with m-chloroperbenzoic 
acid in the presence of potassium carbonate which was gratifyingly accompanied by 
ring opening of the epoxide (103) in situ exclusively via the analogous 5-exo-tet 
cyclisation to give the desired tetrahydrobenzofuran derivative (104) which was 
confirmed by X-ray crystallography (Scheme 2.20, Figure 2.4). 
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Figure 2.4: ORTEP derived from the single-crystal X-ray analysis of compound 
(104) with labelling of non-hydrogen atoms. Anisotropic ellipsoids display 30% 
probability levels. Hydrogen atoms are drawn as circles with small radii. 
Intriguingly treatment of the dihydrofuran (104) with manganese dioxide gave the 
furan derivative (105) in 44% yield, however when DDQ was used as an oxidizing 
agent the selectivity of the aromatization was reversed, forming the desired 
benzannulated compound (68) in good yield.72 This can be rationalised by the fact 
that manganese dioxide is known to act via sequential single electron transfer which 
would be selective for the allylic position,73 DDQ however is known to react via 
sequential deprotonation and hydride abstraction which would be selective for the 
acidic protons alpha to the ketone.74 (Scheme 2.21). 
 
The free phenol (68) was then regioselectively functionalized with propiolic acid 
under neutral conditions using DCC, affording the corresponding phenylpropiolate 
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(67) in moderate to good yields.44 It is important to note that it must be done in the 
absence of a nucleophilic catalyst to prevent base promoted Michael type addition to 
the propiolate ester. Exposure to Echavarren’s Au(I) catalyst (106)75 resulted in 
smooth conversion of  to form (±)-columbianetin (44) via an intramolecular 
hydroarylation, the result of which was confirmed by X-ray crystallography (Figure 
2.5, Scheme 2.22). 
 
Figure 2.5: ORTEP derived from the single-crystal X-ray analysis of (±)-
columbianetin (44) with labelling of non-hydrogen atoms. Anisotropic ellipsoids 
display 30% probability levels. Hydrogen atoms are drawn as circles with small radii. 
Attachment of the remaining p-coumaric acid residue was then accomplished 
according to the method reported by Coster.41 As such columbianetin (44) was 
heated under reflux in toluene in the presence of Meldrum’s acid (56) to form the 
crude malonate ester, which was in turn subjected to Doebner Knoevenagel 
condensation with p-hydroxybenzaldehyde (58) to form the racemic natural product 
(±)-angelmarin (43) in 76% yield over two steps (Scheme 2.22). 
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With a workable synthesis of the racemic natural product in hand, attention was then 
turned towards an asymmetric modification. In order to determine the success of any 
enantioselective steps, conditions were sought for separation of the enantiomeric 
tetrahydrobenzofurans (104) by chiral HPLC. This was achieved by the use of a 
DAICEL chiralcel OJ-H column which features a tris p-toluate cellulose stationary 
phase; with a flow rate of 0.5 mL/min using a 5% solution of isopropanol and hexane. 
Following on from the success encountered by Coster41 and Hamada,42 initial 
attempts at introducing chirality were focused around the use of a Shi epoxidation. 
The Shi epoxidation utilises a ketone organo catalyst which is readily derived from 
fructose (107). The fructose catalyst (55) reacts with OXONE® to generate a 
dioxirane intermediate in situ. The dioxirane is the active species that carries out the 
epoxidation; it is thought to proceed via a spiro transition state with the two three 
membered rings being at right angles to one another.76 (Figure 2.6). 
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Figure 2.6: Proposed transition state for in situ epoxidation 
Accordingly, the Shi catalyst (55) was synthesised following literature precedent by 
kinetic protection of fructose (107) in sulfuric acid and acetone to form the bis 
acetonide (108); followed by oxidation to the ketone (55) using pyridinium 
chlorochromate.77 (Scheme 2.23). 
 
The prenylated cyclohexanedione derivative (97) was then subjected to a range of 
known Shi epoxidation conditions78 featuring different oxidants,79 solvent 
combinations41 and addition rates. Attempts were even made at generating the TBS 
enol ether in situ. However, ultimately this was not particularly successful in forming 
the desired tetrahydrobenzofuran adduct (104), with a best yield of 18% and a 
negligible 15% enantiomeric excess by chiral HPLC analysis. This is thought to be 
due to competing formation of a dioxirane intermediate (109) which would result in 
racemic epoxidation, additionally it would seem that the dioxirane forming conditions 
also effected formation of the previously observed pyran (99), detectable by proton 
NMR; most likely by oxidation of the enolate. A representative selection of the 
conditions used is presented below (Scheme 2.24, Table 2.1). 
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Table 2.1: Conditions representative of those used in the attempted Shi epoxidation 
Conditions R S M yield e.e.  
30% loading, Na2EDTA, buffer, BTAC, K2CO3, Oxone, 
MeCN:DMM (1:1) 30% 5% 0% 
30% loading, buffer, BTAC, K2CO3, Oxone, MeCN:DMM 
(1:1) 30% trace - 
30% loading, Na2EDTA, buffer, BTAC, K2CO3, Oxone, 
MeCN,  10% trace - 
100% loading, Na2EDTA, buffer, BTAC, K2CO3, Oxone, 
MeCN:DMM (1:1) 0% trace - 
30% loading, H2O2, MeCN 80% trace - 
100% loading, H2O2, MeCN 100% 0 - 
30% loading, sodium percarbonate, MeCN, H2O 80% 0 - 
TBSCl, K2CO3, MeCN, then 30% loading, Oxone, buffer, 
then TBAF 80% 15% 8% 
30% loading, KOH, H2O, MeCN, Oxone 0 18% 15% 
buffer = 0.05 M Na2B4O7.10H2O, 1.5 eq. oxidant, 2.5 eq. K2CO3 
It was then considered that chirality could perhaps be established prior to the 
alkylation step by using the known chiral epoxide species80 (110) which could then 
annulate onto the doubly activated methylene compound by sequential alkylation 
and epoxide ring opening. This epoxide could be accessed according to literature 
precedent via a Katsuki-Sharpless asymmetric epoxidation of prenyl alcohol (111) 
and subsequent transformation of the epoxy alcohol (112) into the primary halide.81 
As this was a change over the existing procedure it was decided to optimize the 
annulation step with the racemic material (113), which was readily available from 
alcohol (94) on a large scale by the procedure described by Shimizu et al.82 (Scheme 
2.25). 
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Initial attempts to obtain the tetrahydrobenzofuran (104) in a similar fashion to the 
formation of prenylated cyclohexanedione (97) were unsuccessful, featuring 
decomposition of the starting material, presumably through an aldol like mechanism, 
in addition to some O-alkylated product (114) which was confirmed by X-ray 
crystallography (Figure 2.7).  
 
Figure 2.7 : ORTEP derived from the single-crystal X-ray analysis of (114) with 
labelling of non-hydrogen atoms. Anisotropic ellipsoids display 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. 
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As the hypothesised annulation chemistry lacked literature precedent, a systematic 
approach was taken to establish favourable conditions. Quenching of the reaction 
with saturated aqueous sodium carbonate and subsequent extraction and 
evaporation of the extracts under reduced pressure removes any starting materials 
or acidic side products, allowing the crude residues to be rapidly analysed directly by 
1H NMR via integration of the key oxymethine proton of the desired product (104) 
and the enol proton of the O-alkylated side product (114). As such, some fifty 
reaction conditions were rapidly screened, including standard variations in reaction 
time and temperature, solvent, and base. The major observation was that the 
product distribution varied between O-alkylation (114) and the desired 
tetrahydrobenzofuran (104). A collection of the more salient results is presented in 
Table 2.2, (Scheme 2.26). 
 
Table 2.2 : Conditions representative of those used in the attempted annulation 
Base Solvent Comment Yield 
Ratio 
(114:104) 
DIPEA DIPEA/H2O Decomposition 8 1:0 
K2CO3 DMF Trace 104 detected 81 80:1 
Ag2O DCM Electrophile hydrolysis  - 
Pyridine neat Minimal reactivity 10 1:0 
NEt3 neat No reaction observed  - 
TBAOH CHCl3 H2O Slow 22 1:0 
LiOH DMSO, 50 °C Isolated yields 81 8:1 
i-PrMgBr Dioxane Decomposition 34 9:1 
NaH DMF Trace 104 detected 83 80:1 
i-PrMgBr THF No recovery  - 
Neat µwave, 100 °C ~15% pyran 74  - 
Al(Oi-Pr)3 i-PrOH Complex mixture 38 0:1 
NaOEt EtOH Poor conversion 49 9:1 
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Na2CO3 MeCN NaI catalyst 96 7:1 
Na2CO3 Acetone NaI catalyst 95 9:2 
K2CO3 Acetone KI catalyst 92 8:1 
Li2CO3 Acetone LiI catalyst 86 5:2 
Li2CO3 MeCN LiI catalyst, isolated  93 2:1 
 
In order to fully assess the chemistry at hand a broad range of potential bases were 
explored; a variation of reversible, irreversible, organic and inorganic. In addition to 
this, these bases were employed across a broad range of various solvents capable 
of dissolving the starting material, including phase transfer conditions, microwave 
irradiation and sonication. Invariably the major product was O-alkylation (114) 
accompanied at times by small to trace quantities of the desired product (104). 
Attempts to activate the halide leaving group with a silver oxide presumably resulted 
in hydrolysis of the electrophile, a characteristic cream white precipitate of AgBr 
formed but no alkylation products were isolated. The use of organic bases was 
generally unsuccessful. Fascinatingly, when using i-PrMgBr, it was decided to exploit 
the Schlenk equilibrium83 by the use of dioxane as a solvent, this results in 
precipitation of MgBr2 and the formation of Mg(i-Pr)2 which had a dramatic effect on 
the observed results, either by enhancing the activity of the base or by altering the 
local structure of the formed enolate. Some success was encountered late in the 
project by employing in situ Finkelstein alkylation conditions;84 by varying the group 1 
counterion and solvent, the maximum isolated yield of the desired product (104) was 
31%. Minimal attempts were made to utilise the corresponding iodo epoxide,80 
isolated crudely from Finkelstein halogen exchange however it proved to be 
modestly unstable. Given the relative success of the in situ Finkelstein conditions, it 
may warrant further investigation, along with other potential leaving groups. 
 
In addition to this approach it was envisioned that it may be possible to effect chiral 
epoxidation using a Katsuki-Sharpless asymmetric epoxidation.85 Although in the 
literature this is usually carried out on allylic alcohols, the limited number of degrees 
of freedom inherent to the prenylated cyclohexanedione (97) could potentially allow 
for a stable 7 membered transition state (115). Unfortunately preliminary work into 
this approach was negative and it was not further pursued. Similarly attempts in 
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carrying out a Sharpless asymmetric dihydroxylation86 and forming the desired 
structure (104) by acetalisation and elimination of the diol (116) resulted only in 
decomposition upon dihydroxylation, presumably due to an incompatibility of the 
electron rich enol to the osmium reagent (Scheme 2.27). 
 
2.5 Summary 
 
The work described above represents a novel synthetic approach to angelmarin (43) 
and columbianetin (44), utilising the highly versatile intramolecular hydroarylation44 
reaction under mild conditions and in the presence of a notably fragile tertiary 
alcohol.41 The synthesis is only 7 linear steps, a number of which can be carried out 
without chromatographic separation, and in the complete absence of any protecting 
groups. In addition to this, some progress has been made in the annulation of a 
potentially chiral electrophile80 which could be used in the synthesis of many 
dihydrofuran derivatives and to develop a synthesis of either enantiomer of the 
natural products, angelmarin (43) and columbianetin (44) (Scheme 2.28). 
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Chapter 3 - Ochrosamines 
 
3.1. Introduction 
 
In a search for potential new anti-inflammatory drug therapies, Quinn et al. embarked 
on a high throughput library screen of locally obtained plant and marine invertebrate 
extracts. Over the course of this study they identified a stem and leaf extract of the 
endangered Australian rainforest tree, Ochrosia moorei, as being bioactive in the 
down regulation of pro-inflammatory gene expression. An assay guided isolation 
protocol resulted in the discovery of two novel natural products, the ochrosamines A 
(117) and B (118).87 (Figure 3.1) 
 
Although they were determined to be inactive components in the assay, the 
ochrosamines (117,118), are part of the large strychnos family of alkaloids, the most 
iconic of which, strychnine (4) shares a similar scaffold.88 The ochrosamines 
themselves are structurally quite intriguing; in particular the endocyclic enamine 
functionality present in the D ring is quite rare, with only a few examples occurring in 
the literature such as strychnozairine (119)89 and the dimeric (+)-panganensine 
epimers X and Y (120).90 All of which have been of interest as potential lead 
compounds for the development of novel antimalarials.91 (Figure 3.1). This suggests 
that the enamine functionality may play a role in bioactivity; however similar to the 
ochrosamines, the limited natural availability has limited further studies. As the 
Ochrosia rainforest tree is endangered,87 this makes the ochrosamines prime 
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synthetic targets, allowing for the investigation of any bioactivity specific to the novel 
structural functionality whilst safeguarding environmental biodiversity. 
 
Figure 3.2: structural features of (+)-ochrosamine B together with a ball-and-stick 
model generated in Chem3D 
The structural elements of the ochrosamines are quite complex (Figure 3.2), 
possessing a cage like ABCDE pentacyclic framework with three contiguous 
stereocentres including a quaternary carbon stereocentre. Coupled with the 
interesting vinylogous amide functionality and the isolated exocyclic alkene, these 
factors make the ochrosamines an excellent synthetic challenge, further driven by a 
lack of any existing total syntheses. 
 
3.2. Biosynthetic origins 
 
 
Biosynthetically it is presumed that the ochrosamines are ultimately derived from the 
amino acid tryptamine (121) and the simple monoterpenoid geraniol (122), in a 
fashion common to the strychnos class (Scheme 3.1). The following brief description 
highlights the key bond forming events, for further information see O’Connor and 
Maresh.92 Initially geraniol (122) is enzymatically oxidised to the dialdehyde followed 
by an enantioselective 1,4-hydride reduction. This yields an intermediate (123), 
depicted as the enol, which is believed to undergo an intramolecular Michael addition 
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and acetalisation to form nepetalactol (124).93 This system is further oxidised, 
glycosylated, and esterified over numerous steps resulting in loganin (125).92 The 
glycosylation of the hemiacetal is quite interesting and consitutes a biosynthetic 
example of the use of a protecting group for a highly reactive functional group.94 
Loganin (125) then undergoes an oxidative cleavage to generate secologanin (126) 
which is a common intermediate in the formation of many natural products (Scheme 
3.2). 
 
An enzymatically controlled Pictet-Spengler reaction between tryptamine (121) and 
secologanin (126) generates strictosidine (127) as an intermediate. This occurs via 
initial Schiff base condensation followed by an electrophilic aromatic substitution of 
the indole. Glycoside hydrolysis then reveals a dialdehyde (128) which undergoes 
reductive amination with the secondary amine, accompanied by a tautomeric alkene 
shift to yield geissoschizine (129).92 (Scheme 3.3). 
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The exact mechanism of the rearrangement of geissoschizine (129) to form the 
strychnos alkaloid carboskeleton has not been conclusively established; however 
Scott et al.95 have proposed an acid catalysed retro Pictet-Spengler, which reoccurs 
at the 3 position of the indole. The spirocyclic iminium intermediate (130) then 
undergoes nucleophilic attack from the pendent enol thus generating the strychnos 
scaffold (131).95. Any particular order of events from the generalised strychnos 
intermediate to the ochrosamines has yet to be established. Based on speculative 
analogy with similar natural products,92 reductive decarboxylation via a beta lactone 
(132) reasonably establishes the isolated exocyclic alkene; which, accompanied by 
methylation and oxidation events, would yield the ochrosamines (117,118) (Scheme 
3.4). 
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3.3. Relevant previous work 
 
Synthesising such a complex framework presents a significant synthetic challenge. 
Prior work within the research group resulted in the successful synthesis of the 
structurally and biosynthetically related alkaloid, aspidospermidine (132).96 The 
similarities between the two molecules are quite striking, both bearing a pentacyclic 
ABCDE ring system and a characteristic quaternary carbon at the three position of 
the indoline with aspidospermidine bearing an additional quaternary carbon. The 
ochrosamines possess a greater degree of functionalisation and differ in the 
connectivity of the D ring (Figure 3.3). 
 
Retrosynthetically aspidospermidine (132) was disconnected to the known97 
intermediate (133); aiming to exploit in house chemistry for the synthesis of indoles 
based on an Ullman coupling and reductive cyclisation.98 Disconnection of the D and 
B rings reveals a complex A-E scaffold onto which the remaining rings are 
annulated. This system in turn would be synthesised via an Ullman type coupling 
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between the commercially available o-iodonitrobenzene (134) and an appropriately 
functionalised enone (Scheme 3.5.). 
 
Synthesis of the key iodoenone building block was achieved by Wittig homologation 
the known aldehyde99 (135) with the methoxy substituted phosphorous ylid (136), 
producing the corresponding enol ether as a mixture of diastereomers (137). Acid 
mediated hydrolysis revealed the homologated aldehyde which was immediately 
reduced with sodium borohydride to give the corresponding alcohol (138). The free 
alcohol was protected as the acetate and subjected to a chromium mediated allylic 
oxidation developed by Pearson et al.100 resulting in the enone (139). The enone 
underwent facile alpha iodination under the Johnson conditions101 to give desired 
coupling partner (140) in essentially quantitative yield (Scheme 3.6). 
 
The pivotal Pd catalysed Ullman coupling with o-iodonitrobenzene (134) proceeded 
smoothly, affording the required A-E ring scaffold (141) in good yield. The protected 
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alcohol was converted via its mesylate to the corresponding azide (142). Upon 
heating, the azide underwent an intramolecular Huisgen 1,3-dipolar cycloaddition, 
interestingly this was accompanied by the immediate expulsion of dinitrogen from the 
triazole intermediate (143), giving aziridine (144) as the only isolated product.96 
(Scheme 3.7). 
 
Sequential acid mediated opening of the aziridine ring and titanium (III) mediated 
reductive cyclisation of the nitro group resulted in isolation of indole (133); a known 
precursor to aspidospermidine. This was then elaborated according to the method 
published by Toczko and Heathcock,102 featuring amidation with chloroacetyl 
chloride to give the amide (145). Finkelstein iodination and a silver promoted 
intramolecular alkylation of the indole gave the lactam (146) which was then reduced 
to give the natural product aspidospermidine (132) (Scheme 3.8). 
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3.4. Retrosynthetic analysis 
 
Seeking to replicate the success of the aspidospermidine work, it was again decided 
to generate a key A-E ring system onto which the remainder of rings could be 
annulated. Early introduction of the alpha aryl quaternary centre would allow it to be 
used as a cornerstone upon which synthesis could be constructed. Owing to the 
structural similarities it was again sought to exploit the powerful Ullman cross 
coupling/reductive strategy98 to introduce the B ring. As such the simple nitro aryl 
enone (147) was chosen as an ideal starting material, which could be accessed 
through the known Ullman cross coupling.98 
 
Synthetically, two novel annulation strategies were envisioned to annulate the 
desired C and D rings. Following some modest precedence, an iodide catalysed 
aziridine annulation strategy was proposed to introduce the C ring and the 
quaternary carbon centre. Th rearrangement of aziridines has been previously 
employed in a successful synthesis of the natural products crinine103 (148) and 
horsfiline104 (149) (Scheme 3.10). 
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As an intermolecular variant, conjugate addition of the free aziridine (150) would 
result in an activated zwitterionic intermediate (151) that can undergo ring opening in 
the presence of iodide which would act as a nucleophilic catalyst. The thus 
generated primary iodide could then act as a tethered alkylating agent allowing 
nucleophilic annulation onto the nascent enolate functionality. This would allow 
relatively rapid assembly of a complex intermediate (152) from relatively simple 
starting materials, leveraging the thermodynamic driving force of the aziridine ring 
strain. The lower oxidation state of this variant would also prevent the need for 
subsequent imine reduction (Scheme 3.11). 
 
Once the quaternary centre and C ring are established, an appropriate 
dehydrogenation protocol would then reveal a second Michael acceptor system 
(153) that would allow for an annulation of the D ring system using diketene (154). 
Under relatively neutral conditions the nitrogen centre could undergo nucleophilic 
ring opening of the highly electrophilic diketene, once again driven by ring strain. 
Tautomerisation of the ring opened product creates a beta-keto amide (155) which is 
a strong Michael donor. It was envisioned that this would then be able to undergo an 
intramolecular conjugate addition potentially as a one pot reaction that would then 
establish the D ring and give rise to the advanced tricyclic intermediate (156) 
(Scheme 3.12). 
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Protection of the more enolisable ketone as the enol ether (157) would allow an exo 
methylenation using the conditions established by Eschenmoser105 to establish the 
last of the carbon-carbon bonds. A late stage reduction of the aromatic nitro group in 
compound (158), in a fashion similar to the aspidospermidine work, followed by 
reductive amination would thus afford the desired pentacyclic framework (159). N-
Methylation and semireduction of the amide followed by an acidic workup would thus 
furnish the natural product ochrosamine B (118) which may be able to be converted 
via a Rubottom like oxidation106 to give ochrosamine A (117) (Scheme 3.13). 
The proposed synthetic scheme would allow for extremely rapid assembly of 
ochrosamine skeleton with the development of some novel and powerful annulation 
chemistry. This would be built around a solid foundation of the established Ullman 
chemistry for generating substituted indolines.98  
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3.5 Results and Discussion 
 
In order to investigate the proposed aziridine chemistry, the known AE ring system 
(147) was synthesised. Following the in house protocol cyclohexenone (160) was 
first converted to the alpha iodoenone (161) via a Johnson iodination.101 The 
iodoenone was then subjected to an Ullman coupling with o-iodonitrobenzene (134) 
to generate significant quantities of the initial AE ring scaffold98 (147). Commercially 
available ethanolamine (162) was treated with chlorosulfonic acid in ether to 
quantitatively yield the sulfonate zwitterion (163) which rapidly precipitates.107 
Treatment of the zwitterion with concentrated sodium hydroxide allows for the 
distillation of free aziridine (150) albeit in poor yield.108 In its isolated form, the 
aziridine proved to be quite unstable with a relatively short half-life that necessitated 
fresh preparation from the zwitterion (Scheme 3.14). 
 
With the required materials in hand, the aziridine annulation chemistry was 
investigated. Given the proposed mechanism and precedence for the aziridine 
annulation,103-104, 109 initial conditions focused on the use of tetrabutylammonium 
iodide (TBAI) as an organosoluble source of iodide under the assumption that the 
best conditions would be relatively anhydrous and require a strong, “naked”, 
nucleophile. Initial results were not encouraging and the major observations were the 
return of starting material and polymerisation of the relatively unstable aziridine, 
(150) this was consistent across a range of different solvents (CHCl3, DMSO, THF, 
Toluene) and temperatures. Use of TBAI was abandoned as its removal additionally 
complicated both extraction and analysis of the reaction mixture. Capitalising on the 
high solubility of potassium iodide,110 the solvent was changed to acetone however 
this proved to be too reactive, showing some crude spectroscopic evidence of 
solvent condensation with the aziridine without isolation of any distinct products. 
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Given that the proposed annulation requires a relatively long lived zwitterion, the 
solvent was changed to acetonitrile to take advantage of the relatively high dielectric 
constant.111 This had the added advantage of maintaining a relatively high solubility 
of potassium iodide,112 with a lower inherent solvent reactivity as the nitrile 
functionality is substantially less electrophilic than the ketone of acetone. 
Disappointingly this failed to result in the isolation of any of the desired product 
(152). Attempts at further promoting the reaction by addition of an oxophilic Lewis 
acid (SnCl4, TMSCl) to promote Michael addition hastened aziridine decomposition. 
Varying the rate of addition and dilution of aziridine did not affect results in any 
noticeable fashion (Scheme 3.15). 
 
In addition to difficulties arising from the polymerisation of aziridine, it was presumed 
that the enone system being worked upon was not sufficiently electrophilic to result 
in significant generation of the required zwitterionic intermediate (151). A potential 
reason for this is the relatively high steric strain of the resulting aryl substituted Z-
enolate which would promote retro Michael addition. Faced with a lack of results and 
the inherent difficulties of working with aziridine, which is toxic, volatile, and prone to 
polymerisation; it was ultimately decided to revise the synthetic strategy. 
Given the previous experience in the use of activated methylene systems (see 
chapter 2), the earlier proposed A, C, E ring system intermediate (152) was instead 
disconnected to 1,3-cyclohexanedione (96). Following previously established results 
within the group regarding chemoselective reductive cyclisations of nitriles with 
Raney cobalt,113 it was decided that the nitrogen atom of the C ring would be 
introduced as a nitrile functional group. The activated methylene could be arylated 
via nucleophilic aromatic substitution114 and further alkylated with chloroacetonitrile 
(164) to yield an appropriately functionalised symmetric intermediate (165). 
Chemoselective reduction of the nitrile or nitro functionality, followed by imine 
condensation with one of the ketones would desymmetrise the system and would 
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then direct regioselectivity in constructing the rest of the molecule. Further 
elaboration of A, C, E ring system (152) would be achieved via the earlier proposed 
ketene methodology, to access the natural product. Condensation of remaining 
ketone with a chiral amine could potentially be used to allow resolution of a single 
enantiomer. 
 
Utilising the experiences developed in the previous chapter, commercially available 
1,3-cyclohexanedione (96) was subjected to the previously more successful 
conditions to establish the best method of alkylation. A familiar pattern thus emerged 
in that the major observed product was typically O-alkylation (166) which was 
variably obtained in 35-95% yield, with results tending to be poorly reproducible on 
scale. Although the use of iodoacetonitrile gave a better ratio of the C-alkylated 
product (167), the overall yields were significantly lower, therefore it was sought to 
generate the iodoacetonitrile in situ using Finkelstein type conditions.84 Consistent 
with previous observations the in situ Finkelstein conditions resulted in the most 
favourable distribution of products. Results were similar regardless of which halide 
was used as a starting material, leading to use of the cheaper chloroacetonitrile 
reagent (164) (Table 3.1, Scheme 3.17). 
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Conditions X Yield (C)* Yield (O) 
DMSO, TBAI, K2CO3, rt, 16 h Cl 3 95 
DMSO, TBAI, K2CO3, rt, 16 h Br 15 82 
DMSO, K2CO3, rt, 16 h I 13 22 
MeCN, KI, K2CO3, 82 °C, 16 h Cl 24 62 
MeCN, KI, K2CO3, 82 °C, 16 h Br 28 67 
Acetone, KI, K2CO3, 56 °C, 16 h Cl 28 53 
Acetone, NaI, Na2CO3, 56 °C, 16 h Cl 72 17 
Acetone, NaI, Na2CO3, 56 °C, 16 h (5g scale) Cl 32 40 
 Table 3.1. (* yields are a crude estimate of the C-alkylated fraction: see 
experimental) 
Although the O-alkylated product (166) was easily obtained, frustratingly the C-
alkylated system (167) could not be well characterised or purified. Evidence 
suggests that it exists as a tautomeric mixture with the enol (168) that may be slowly 
and reversibly interconverting with the cyclic form (169) which is also tautomeric with 
the aminofuran (170), identified by certain characteristic peaks in the 1H NMR 
spectrum. A key aromatic singlet appears at 5.95 ppm, corresponding to the furan 
form, in addition to peaks at approximately 3.0-3.5 ppm corresponding to tautomeric 
forms of the acetonitrile derived methylene and a pair of broad singlets at 5.5 and 6.5 
ppm identified as the NH protons of the aromatic form. All of these peaks 
disappeared on addition of D2O indicating the protons were readily exchangeable 
(Figure 3.4). 
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This was supported by significant cross peaks and streaking in the two dimensional 
TLC analysis, poor reproducibility and reversible solvent dependent changes in 
relative NMR peak intensities. The material obtained was used directly in 
subsequent steps in the hope that the equilibrium mixture would be funnelled 
through the most reactive individual species consistent with the Curtin-Hammett 
principle.115 
Installation of the quaternary centre was initially proposed via a nucleophilic aromatic 
substitution process with 2-fluoronitrobenzene (171). This proceeds by addition of an 
appropriate nucleophile to an aromatic ring bearing an electron withdrawing group 
and leaving group. Addition occurs ipso to the leaving group resulting in a formal 
build of negative charge and a loss of aromaticity, forming a Meisenheimer 
complex114 (172). This system is mesomerically stabilised by the electron 
withdrawing groups and the use of a fluorine as the leaving group results in an 
additional stabilisation through inductive effects.114 (Scheme 3.18). 
 
Disappointingly subsequent exposure of the nitrile dione mixture to the typical 
conditions used to facilitate nucleophilic aromatic substitution with fluoro 
nitrobenzene (171) (DMSO or DMF, K2CO3, 80-150 °C, etc.)114 failed to yield any 
usable material as decomposition of the starting material seemed to predominate at 
the higher temperatures employed, with recovery of the nitroarene. Additional 
attempts at a transition metal catalysed process with 2-iodonitrobenzene (134) (CuI, 
Pd(PPh3)4) were likewise unsuccessful. It is theorised that at higher temperatures the 
nitrile moiety may be lost as cyanide in an E1cB elimination, resulting in a transient 2-
exomethylene intermediate (173); such an intermediate would be extremely reactive 
and is presumed to be the cause of the very large number of observed side products 
(Scheme 3.19). The additional tautomerism of the dione starting material (see Figure 
3.4) with multiple electrophilic and nucleophilic positions further complicates the 
situation. 
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To investigate the alternative order of events whereby the dione (96) is arylated then 
alkylated, the known116 aryl dione (174) was synthesised. Use of the literature 
conditions with fluoronitrobenzene (171) resulted in an unsatisfactory yield of less 
than 20% involving laborious separations. Utilising the conditions developed by 
Bonjoch et al.117 iodonitrobenzene (134) was subjected to essentially similar 
nucleophilic aromatic substitution conditions with the strict exclusion of light, resulting 
in a much improved yield of 81%. The isolated nitroenone (174) exists solely as the 
enol form by 1H NMR and the diketo proton is not observed.  
Without the fluoro group the electronics of the substitution process make an SNAr 
process untenable. When using the iodide it is proposed that the reaction instead 
occurs via a non-chain radical nucleophilic substitution.118 Initial association of the 
nucleophile to the aromatic system, potentially through the iodine atom results in a 
single electron transfer event to form a radical anion, concomitant loss of iodide 
results in a radical pair which recombine to give the product after tautomerisation. 
This is favoured by high viscosity DMSO which prevents diffusion of the reactive 
intermediates out of the solvent cage119 (Scheme 3.20). 
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With the nitroarylenone tautomer (174) in hand, conditions for formation of the 
quaternary centre were sought. As the best results of previous alkylation efforts were 
observed upon exposure to Finkelstein like conditions,84 this was the first resort. In 
performing the reaction, two products were observed by crude NMR, of which one 
could be cleanly separated. This was tentatively identified as the desired symmetric 
product (165) based on a desymmetrisation of the aliphatic ring protons in 1H NMR 
including clearly identifiable ddd signals, with high coupling constants (18 Hz) 
consistent with geminal coupling that had not been observed in the enol starting 
material. This was further supported by the presence of a nitrile group in the IR 
spectra. The other major product was identified as the O-alkylated product (175) due 
to a characteristic AB system present at 4.6 ppm in the 1H NMR, corresponding to 
the methylene directly attached to oxygen. This AB system seemed to indicate that 
the o-nitro group was preventing free rotation about the aryl-cyclohexenone bond. In 
varying the metal counter-ion used in the Finkelstein alkylation the proportion of O-
alkylated product was higher going down the group 1 metals. This was assessed by 
crude NMR analysis, comparing two distinct aromatic protons. When the lithium 
counter ion was used with an excess of LiI (2.2 equivalents), what was thought to be 
the C alkylated product (165) predominated (Table 3.2, Scheme 3.21). 
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Conditions %Yield % (165) % (175) 
Acetone, LiI (cat), Li2CO3, 56 °C, 16 h 63 48 52 
Acetone, NaI (cat), Na2CO3, 56 °C, 16 h 83 35 65 
Acetone, KI (cat), K2CO3, 56 °C, 16 h 81 29 71 
Acetone, LiI (2.2 eq.), Li2CO3, 56 °C, 16 h 72 81* 19 
Table 3.2 % O or C product calculated from discrete aromatic proton NMR integrals 
after quench and extraction, * 58% isolated yield. 
After laborious purification it was possible to isolate and then crystallise some of 
what was assumed to be the C-alkylated product (165), however the O-alkylated 
product could not be cleanly isolated. Surprisingly an X-ray crystal analysis revealed 
what was assumed to be the C alkylated product of the Finkelstein reaction not to be 
the desired symmetric system but an unexpected atropisomeric compound (176) 
resulting from overall substitution of the enol hydroxyl group by cyanide (Figure 3.5). 
The crystal structure shows a significant dihedral angle of 63° between the planes of 
the two ring systems and a 33° out of plane deformation of the nitro group with 
respect to the aromatic ring. 
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Figure 3.5 Left: Ball and stick model derived from the X-ray crystal structure of (176) 
with selected dihedral angles (modelled using Mercury 3.7). Right: Structure of 
C13H10N2O3 (176) with labelling of selected atoms.  Anisotropic displacement 
ellipsoids display 30% probability levels.  Hydrogen atoms are drawn as circles with 
small radii. 
Presumably the high nucleophilicity of the iodide anion115 and the Lewis acidity of the 
lithium counter-ion facilitate a conjugate addition of iodide to the O-alkylated product 
(175). This intermediate (177) could then eliminate glyconitrile to give the highly 
electrophilic iodoenone (178). Glyconitrile decomposes under basic conditions120 into 
formaldehyde and lithium cyanide, in a process which may be concerted with the 
elimination from the intermediate (177) as shown in scheme 3.22. The loss of 
formaldehyde as a gas under the refluxing temperatures would thus drive the 
reaction forward.115 The cyanide anion could in turn undergo Michael addition to the 
highly electrophilic iodoenone (178) which can be seen as a vinylogous acyl iodide. 
This intermediate would then eliminate iodide to yield the observed product (176).. 
As evidence for this mechanism the reaction the impure O-alkylated material (175) 
obtained from using the potassium counter-ion was then resubjected to prolonged 
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heating under the lithium iodide Finkelstein conditions in the absence of electrophile, 
after which almost complete conversion of the O-alkylated material (175) was 
observed and the atropisomeric product (176) was obtained in 88% yield (Scheme 
3.22). In addition to iodide this transformation could also conceivably be catalysed by 
initial hydrolysis of (175) by adventitious water to give (174) and a population of 
cyanide anions. The cyanide anions could then serve as a catalyst to effect the direct 
transformation of (175) to (176) in an analgous fashion without the intermediate 
iodoenone (178). 
 
On the basis of this result it was determined that direct intermolecular alkylation of 
the dione (174) was not feasible. In a return to the previously explored chemistry, it 
was theorised that an intramolecular alkylation may be possible either through 
addition of aziridine (150) in a fashion similar to that attempted previously (see 
Scheme 3.15) or via an ethylamine bearing an appropriate leaving group. 
Unfortunately attempts to condense the dione (174) directly with aziridine (150), 
chloroethylamine (179), bromoethylamine (180), zwitterion (163), or even 
ethanolamine (162) were unsuccessful and no vinylogous amides (181) or (182) 
were observed despite their reported ease of synthesis.117 A range of conditions 
were attempted featuring various acids (AcOH, TMSCl, Ti(OEt)4), dehydrating agents 
(4 Å sieves, TMOF, etc.), solvents and temperatures. 
Hoping to take advantage of the previous discovery it was decided to synthesise 
iodoenone (178); the proposed intermediate in the formation of the side product 
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(176). Exposure of the dione (176) to Appel-like conditions,121 afforded the 
moderately unstable iodoenone (178) in relatively good yield. The system showed 
similar evidence of atropisomerism in the 1H NMR spectra with discrete 
diastereotopic splitting of the protons in the aliphatic ring. The iodoenone (178) 
proved somewhat capricious resulting in either decomposition or complete recovery 
of starting material when attempts were made introduce aziridine (150), 
bromoethylamine (179), chloroethylamine (180), ethanolamine (162) or zwitterion 
(163) (Scheme 3.23). 
 
Disillusioned by the observed results, the overall synthetic strategy was reassessed 
and a less conventional approach was taken based on some related organolead 
chemistry developed by Pinhey. The Pinhey reaction exploits the high oxidation 
potential of an aryl substituted Pb(IV) compound to effect electrophilic arylation of 
activated carbon acids or electrophilic dearomatisation of substituted phenols, 
creating a quaternary carbon centre alpha to an aromatic ring122 (Scheme 3.24). 
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The required aryl organolead compounds can be accessed in situ by a mercury 
catalysed transmetallation of the organoboron or organotin compounds.122 Although 
less well established in the realm of natural product synthesis; this approach features 
a powerful transformation with a demonstrated capacity to establish highly 
functionalised and sterically demanding quaternary centres, from fairly easily 
accessible starting materials. The literature suggests a fairly broad substrate scope, 
with electron donating and withdrawing functionalities tolerated123 on the aromatic 
ring of the aryl lead species and varying substitution patterns.124 It has even been 
used recently in a total synthesis of maeocrystal V (183) utilising a sterically hindered 
ortho-MOM protected aryl lead species125 (Figure 3.6). 
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Applying this transformation in the context of the ochrosamine system yielded some 
distinct possibilities for variation, tying into the original A,C,E ring system (see 
Scheme 3.11) in the hope of still using the earlier proposed diketene chemistry. 
Disconnection by electrophilic arylation, results in the previously synthesised nitrile 
dione (167); and by dearomatisation, results in the known phenol126 (184). The nitrile 
functionality was seen as a relatively good candidate to introduce the nitrogen of the 
C ring, as it is resistant to oxidative conditions and has particularly low steric 
demand. These options would then be complemented by an appropriate nitrogen 
bearing, aryl lead system derived from the corresponding stannane or boronic acid. 
The nitrostannane (185) was known127 and the nitroboronate (186) was commercially 
available, however identifying that the sterically demanding and highly electron 
withdrawing nitro group as potentially problematic;128 a protected methylaniline (187) 
was also investigated (Scheme 3.25). 
 
N-methylaniline (188) was protected with a t-butoxycarbonyl group129 to give the 
carbamate (189) which was then deprotonated in a directed ortho-metallation with n-
butyl lithium. Quenching of the anion with trimethoxyborane130 resulted in the 
formation of the crude boronic acid (187) in low yet sufficient yield which was used 
without purification. Following literature conditions salicylaldehyde (190) was 
reduced via a crossed Cannizaro reduction131 to the alcohol (191) which was 
subjected to sodium cyanide in hot dimethylformamide.126 This results in the 
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transient formation of a quinone methide which acts as a strong Michael acceptor to 
form the desired 2-(cyanomethyl)phenol (184).132 Stille coupling of iodonitrobenzene 
(134) with hexabutylditin afforded the corresponding nitrophenylstannane (185)127 
(Scheme 3.26). 
 
With the required materials in hand, attempts were made to effect the desired Pinhey 
coupling. In order to assess the feasibility of the reaction, the nitrostannane (185) 
was subjected to transmetallation with Pb(OAc)4 and catalytic Hg(TFA)2 using 
standard conditions used to isolate aryl lead triacetates.122 Although some material 
did crystallise during the course of the reaction, indicating successful 
transmetallation, it decomposed upon attempts to isolate and characterise it. 
Encouraged by this result, each combination of the Pinhey chemistry was attempted 
in situ. Unfortunately despite an exhaustive analysis of each of the possible 
combinations of starting materials, no Pinhey reaction product could be isolated 
(Scheme 3.27). 
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Although both moderately electron poor substrates123 and ortho substituted aromatic 
systems133 have been used in the Pinhey arylation it is possible that the combination 
of both may inhibit either, substitution of the phenol (184) or dione (167) at the lead 
centre, or the ensuing reductive elimination through steric crowding. The reaction is 
likely further complicated by the complex nature of the nitrile dione (167) which might 
not be reacting through the desired enol form; recall Figure 3.4. 
It was therefore required to re-evaluate the overall synthetic strategy. One of the 
common ways of overcoming problems encountered with O-alkylation of enolate 
systems is to employ an appropriate 3,3-sigmatropic rearrangement.115 This 
approach has been used successfully in the same nitrodione system by Bonjoch et 
al. via an allylation;117 therefore a more original approach was sought. Due to 
ongoing problems with the ortho nitro group it was alternatively decided to attempt 
an interrupted Fischer indole synthesis to establish the quaternary carbon centre. 
Traditionally the Fischer indole synthesis occurs via 3,3-sigmatropic rearrangement 
of a tautomerised phenylhydrazone (192), subsequent ring closure and elimination of 
ammonia then results in the formation of an indole (193).134 In the interrupted version 
of the same reaction, the enamine position of the phenylhydrazone (192) is 
disubstituted so that the sigmatropic rearrangement results in the formation of a 
quaternary centre preventing aromatisation to the indole135 (Figure 3.7). 
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The challenge then becomes in selectively forming the desired enamine, as 
illustrated below in a synthesis of aspidospermidine (132) by Zard et al.136 In this 
case regioselectivity was achieved via the formation of the more stable substituted 
enamine (194) under thermodynamic conditions with only the desired product (195) 
reported in 62% yield (Scheme 3.28).  
 
More generally, the selectivity of this process is known to be quite low and highly 
substrate dependent.135 Often this has been overcome by controlling the substrate in 
way that only one single enamine form is possible such as with aldehydes137 or 
those with bridgehead carbons in the alpha position.138 As a more versatile approach 
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to constructing the desired alpha aryl quaternary centre, it was suggested that the 
regioselectivity of the enamine formation could be controlled through electronic 
effects using a 1,3-dione. In this case any formed hydrazone should easily 
tautomerise to the stabilised vinylogous amide which could then undergo the 
interrupted Fischer cyclisation. This is supported by the literature in that the Fischer 
indole synthesis with 1,3-cyclohexanedione (96) is known and regioselectively 
cyclises onto the 2 position139 to give the indole (196) (Figure 3.8). 
 
This strategy removes the effectively removes the troublesome nitro group and 
establishes the B-ring at a much earlier stage of the synthesis, however the 
remaining diketene chemistry should still be feasible. Disconnection in this case 
follows a similar pattern to that proposed earlier, now via the imine (197). In applying 
this particular strategy to the system at hand requires an appropriately substituted 
1,3-dione to create the intermediate vinylogous amide. The ideal substitution at the 2 
position was a relatively inert two carbon fragment containing nitrogen. In addition to 
the previously synthesised nitriledione (167), a phthalyl protected ethylamine (198) 
was suggested.140 The idea being that treatment with phenylhydrazine would cause 
both the desired 3,3-sigmatropic rearrangement and simultaneously deprotect the 
nitrogen moiety (Scheme 3.29). 
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Potassium phthalimide (199) was therefore alkylated with 1,2-dibromoethane under 
literature conditions141 to yield the required two carbon electrophilic fragment (200). 
Alkylation of 1,3-cyclohexanedione (96) once again proved troublesome, with 
significant O-alkylated product (201) isolated and an inability to cleanly isolate the 
desired tautomeric mixture corresponding to dione (198) which as a result, remains 
poorly characterised (see experimental). Incorporation of the phthalyl ethyl amine 
was clearly evident in the 1H NMR by the presence of two distinct apparent doublets 
at 7.79 ppm and 7.68 ppm corresponding to the aromatic ring in addition to the 
aliphatic signals. However between the mixture of tautomers and impurities from 
self-condensation of the starting material, the 13C NMR could not be adequately 
resolved from the multitude of signals. Unfortunately exposure of this material to 
various conditions135 featuring phenylhydrazine resulted only in complex or 
intractable mixtures, with only limited NMR evidence of the 3,3-sigmatropic reaction 
having taken place from minor signals corresponding to desymmetrisation of the 
aliphatic ring protons and a lack of clear signals corresponding to the cyclised 
aromatic ring. Similarly treatment of nitriledione (167) with phenylhydrazine resulted 
only in decomposition (Scheme 3.30). 
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Further revision suggested elaboration of a preformed ABE indole core (196) which 
could be further elaborated to tie in to the existing plan for synthesis. From the oxo 
indole (196) reductive amination would install the required nitrogen allowing for an 
internal alkylation onto the indole which has good literature precedence96, 142. 
Following the literature procedure for the Fischer indole synthesis, 1,3-
cyclohexanedione (96) was converted into the corresponding known139 indole (196). 
Unfortunately all attempts at reductive amination or imine formation143 with 
substituted aminoethyl systems failed. It is assumed that the indole nitrogen 
significantly deactivates the ketone, acting as a vinylogous amide and preventing 
imine condensation. This is further evidenced by the overreduction observed using 
hydridic reagents such sodium cyanoborohydride, a phenomena previously observed 
in the literature144 (Scheme 3.31). 
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3.6. Future Work 
 
At this point the project was placed on hiatus to pursue more rewarding endeavours, 
as potential future work it may be worth utilising some of the existing synthetic 
methods to access advanced intermediates in order to attempt the proposed 
diketene chemistry. One such recently developed method by Vanderwal et al.145 
would allow very direct access to the required ABCE core (20) in just three steps 
(see Chapter 1 for overview). From such a system it would only require a few minor 
functional group interconversions to attempt the key diketene chemistry and thus 
further elaborate the system to form the natural product (Scheme 3.32). 
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Chapter 4 - Hasubanans 
 
4.1 Introduction 
 
The hasubanan class of alkaloids; named after the originally isolated hasubanonine, 
are a complex class of alkaloids that have been thoroughly investigated with respect 
to their biological significance.146 When the first alkaloid of the family was isolated in 
1951 by Kondo et al. it was originally misidentified as being part of the well-known 
morphinan class (202) due to limited spectroscopic data. Further analysis147 
established that hasubanonine (203) was a novel linkage isomer of the morphinan 
system with antipodal stereochemistry,148 comprising an independent class of 
alkaloids found to be widespread amongst the genus Stephania (Figure 4.1). 
 
Over the course of the following 60 years the hasubanan class of alkaloids has 
become well populated with more than 40 different alkaloids all bearing the 
characteristic benzo fused aza[4.4.3]propellane core in the depicted absolute 
configuration (204). This is complemented by a wide range of differing oxygenation 
patterns and formation of accessory rings, resulting in a high degree of both diversity 
and complexity within the class of alkaloids149 (Figure 4.2). Many of the plants in the 
Stephania genus have been used in traditional folk medicine for centuries. The 
flowers, berries, leaves or roots have been used to treat a broad range of ailments 
from diarrhoea to asthma and even leprosy.150 In traditional Chinese medicine alone, 
analgesic properties have been attributed to more than 25 different species in the 
Stephania genus.151 This is of particular interest given the salient similarities 
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between the hasubanan framework and that found in morphine, a common opiate 
pain-killer.28 
 
Although hasubanan alkaloids have been tested for activity upon various opioid 
receptors,152 they have relatively modest activity.153 The relative orientation of the 
heterocycle is thought to a significant factor in determining biological activity which 
led to a hypothesis by Schultz and Wang154 that the unnatural enantiomers of the 
hasubanan alkaloid framework may possess powerful opiate like activity. This is 
further supported by the distinct structural similarities between the unnatural 
enantiomer of the hasubanan framework (205) and that of the naturally occurring 
morphinans (206). As can be seen in Figure 4.3 the two systems each bear a core 
tetracyclic ring system bearing a characteristic T-shape that directs the amine 
functionality perpendicular to the generalised plane of the ABC ring system shared 
by both systems. 
 
 
4.2 Biogenesis.  
 
Although the complete biogenesis of the hasubanan alkaloids has yet to be fully 
elucidated, the best known member is hasubanonine (203) itself which can be seen 
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as representative of the class.155 The core structures of hasubanan alkaloids are 
thought to be ultimately derived from two molecules of the amino acid, tyrosine (207) 
that diverge early in the biosynthesis.156 One molecule of tyrosine undergoes 
enzymatic decarboxylation to yield the intermediate tyramine which undergoes 
further oxidation and methylation to the identified intermediate (208) which was 
confirmed by isotopic feeding studies.157 The other molecule of tyrosine is oxidatively 
deaminated to give 4-hydroxyphenylpyruvate (209). Decarboxylative condensation 
results in the imine (210) followed by the enzymatic equivalent of an intramolecular 
Pictet-Spengler reaction.158 This generates a key benzylisoquinoline (211) which is 
further oxidised and methylated to yield a bis-phenol (212) (Scheme 4.1). 
 
This benzylisoquinoline system is then well set up to undergo oxidative coupling to 
form the enantiomorphic morphinan alkaloid system. Structural differences between 
ortho-para (213) and para-para (214) coupling products most likely generates some 
of the diversity found in the ring oxygenation patterns.147 The intermediacy of the 
morphinan (215) has been conclusively proved by isotopic feeding studies,157 
although the mechanism of the rearrangement of the morphinan system to that of the 
hasubanans has yet to be conclusively established. It has been proposed that the 
enone in the now dearomatised C ring acts as an electrophile for the nucleophilic 
tertiary amine.157 The resulting aziridinium intermediate159 (216) would then eliminate 
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or be reduced enzymatically,160 followed by further functional group transformation to 
yield hasubanonine (203). Changes in the oxidation and methylation states at 
various points in the biosynthesis in turn generate the observed diversity in 
oxygenation patterns found throughout the hasubanan class of alkaloids156 (Scheme 
4.2). 
 
4.3 Applicable syntheses 
 
Interest in this particular class of alkaloids was piqued in part due to the prior 
research and successful synthesis of the structurally similar natural product, 
hamayne.161 The three A, C and D rings of the tetracyclic core system in hamayne 
are found in the hasubanans with the structural difference coming from the 
connectivity of the B ring. Hamayne attaches via a single methylene between the 
aromatic ring and the nitrogen atom, whereas the hasubanans attach via an ethyl 
linkage between the aromatic ring and one of the carbons alpha to the nitrogen 
atom. As the hamayne synthesis introduces the B ring at a late stage161 it was 
envisioned that a similar approach could be taken that would intersect with much of 
the chemistry used in the hamayne project (Figure 4.4). 
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The synthesis of hamayne begins from the known162 TBS protected alcohol (218) 
which is subjected to a ring closing metathesis to generate the cyclopentene 
derivative (219). Subjection of this system to bromoform and base in the presence of 
a phase transfer catalyst results in the isolation of the dibromocyclopropane (220) 
resulting from addition of dibromocarbene. Thermally induced electrocyclic ring 
opening and direct functionalization of the resulting dibromide (221) with sodium 
azide affords the highly functionalised cyclohexane ring (222). Staudinger reduction 
of the azide followed by protection with nosyl chloride affords the corresponding 
derivative (223).161 This strategy rapidly introduces the amine found in the natural 
product replete with a bromo alkene that allows easy access to cross coupling 
chemistry (Scheme 4.3). 
 
As such the compound (223) was subjected to Suzuki conditions with boronic acid 
(224) smoothly resulting in the cross coupled product (225). The protected amine 
was then alkylated with 1-bromo-2-butyne (226) to give an appropriate substrate 
(227) for a palladium catalysed Alder-ene reaction. Indeed, exposure of this 
compound to Pd(OAc)2 and the BBEDA ligand (228) under microwave irradiation163 
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yielded the desired product (229),161 forming the key quaternary carbon centre 
(Scheme 4.4). 
 
Chemoselective oxidative cleavage of the more substituted alkene was achieved via 
an Upjohn dihydroxylation followed by a phenyliodonium diacetate mediated 
cleavage of the resulting diol to give ketone (230). The protecting nosyl group was 
removed via E1cB elimination to give the ketoimine (231) which was reduced with 
sodium triacetoxyborohydride to give the free amine (232) with the C11 alcohol in the 
desired configuration. Under the Pictet-Spengler conditions using paraformaldehyde 
and formic acid, the final desired ring was formed and this was accompanied by 
deprotection of the TBS group, resulting in the formate diester which was then 
deprotected with methanolic ammonia to afford the racemic natural product (±)-
hamayne (217).161 
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Essentially the most important step in the synthetic sequence as it applies to the 
hasubanan skeleton is the Pd mediated Alder-ene reaction164 as it is used to form 
the pivotal quaternary carbon centre. The Pd mediated Alder-ene reaction actually 
proceeds through a significantly different mechanism than that of its non-catalysed 
namesake and renders them truly distinct at a mechanistic level.165 The original 
Alder-ene reaction166 is pericyclic; proceeding via a concerted 6-membered transition 
state in what is essentially a sigmatropic shift involving the carbon hydrogen bond of 
the ene. This often requires harsh conditions in the absence of strongly activating 
steric or electronic effects.167 The concerted process conserves stereochemical 
information and can be highly selective.168  
 
Comparatively the Pd catalysed version originally developed by Trost proceeds at 
much lower temperatures.164 The Pd catalyst coordinates to both the alkene and 
alkyne, thereby facilitating the formation of an intermediary palladacycle in an 
oxidative process. This palladacycle then undergoes beta hydride elimination to give 
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the alkenyl palladium hydride species which undergoes reductive elimination to yield 
the product.165 The key difference is that the beta hydride elimination is not 
concerted and occurs in a syn-fashion with the most readily available hydrogen. This 
can ultimately lead to mixtures of alkene diastereomers (Scheme 4.7). In the 
hamayne synthesis, the use of a cyclic alkene substrate and the small ring tether 
conserves stereochemistry and prevents the formation of side products as the 
intermediate palladacycle can only eliminate in one direction.161 
 
4.4 Retrosynthesis 
 
As such an analogous retrosynthetic analysis of the hasubanan skeleton featuring 
the Pd-mediated Alder-ene reaction as a key step was devised for a project originally 
researched by Jeremy Nugent in the pursuit of his honours dissertation.169 
The hasubanan framework (204) was first disconnected via a late stage Friedel 
Crafts acylation to the corresponding arylindoline system (233) which would be 
favoured by the relatively electron rich aromatic ring systems common in the 
hasubanans.170 This arylindoline bears striking resemblance to intermediate (229) in 
the hamayne synthesis. It was hoped that this intermediate could then be reached by 
the key Pd catalysed Alder-ene chemistry that had been so successful in 
synthesising the key features of the hamayne skeleton.161 It was envisioned that the 
accessory functionality in (234) resulting from these disconnections could then be 
either removed in a fashion similar to the hamayne synthesis or used as handle to 
introduce further diversity in exploring the hasubanan system (Scheme 4.8). 
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The required propargylic amine (235) could then be accessed by alkylation and 
protection of the alpha aryl amine (236) which would be available through an 
Overman rearrangement171 of the trichloroacetimidate derived from the 
corresponding allylic alcohol (237). Disconnection of the aryl carbon-carbon bond 
through Suzuki cross coupling chemistry similar to that used in the hamayne 
synthesis thus reveals simple starting materials. Enantioselective reduction of the 
enone (238) would then allow selective access to the unnatural enantiomeric series 
of the hasubanan system; thereby allowing the investigation of its biological 
potential154 (Scheme 4.9). 
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4.5 Prior Work 
 
As a generalised summary, the following progress had been achieved by J. Nugent 
in his honours year.169 Following literature precedent the Iodonium ylid (239) of 
cyclohexanedione (96) was subjected to thermal rearrangement to generate the iodo 
substituted phenoxyenone (240). This underwent Suzuki cross coupling with the 
methylenedioxy substituted aryl boronic acid (224) to generate the key aryl linkage 
(241). Transesterification of the phenoxy group to the ethoxy group (242) allowed 
nucleophilic addition of the anion of acetonitrile to generate the desired enone (243). 
The enone was then reduced under Luche172 conditions to give the allylic alcohol 
(244), which could be used as a substrate for trichloroacetimidate formation and 
subsequent Overman rearrangement to give the desired amine (245) (Scheme 4.10). 
Initial experiments regarding the rearrangement chemistry had indicated that it might 
not be a suitable substrate for trichloroacetimidate formation.169 
 
4.6 Results and Discussion 
 
As such the initial objectives were to replicate or improve on the existing synthetic 
scheme and further investigate the trichloroacetimidate formation and subsequent 
Overman chemistry. In an initial attempt to reduce the step count and address some 
minor supply issues, it was decided to disconnect the nitrile (243) via the Suzuki 
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coupling product (246) to the corresponding known bromomethoxyenone173 (247). 
This obviates the need for transesterification of the vinylogous ester at the cost of 
using the somewhat less activated bromo functionality. Some encouragement was 
provided by literature precedence that the bromomethoxyenone (246) was a 
competent coupling partner in the Suzuki-Miyaura reaction174 (Scheme 4.11). 
 
Following the literature protocol, initial bromination of cyclohexanedione (96) under 
comproportionating conditions affords the bromo dione (248) in good yield. 
Subsequent esterification with trimethylorthoformate in MeOH with a solid supported 
acid catalyst then affords the desired bromomethoxyenone173 (247). As a further 
effort to streamline the synthesis, research was conducted into the possibility of 
telescoping the two reactions. Gratifyingly when 1,3-dione (96) was dissolved in 
methanol and treated with a single equivalent of bromine at 0 °C in the absence of 
light, the desired methoxyenone (247) could be isolated in 40% yield. Presumably 
initial electrophilic bromination of the dione moiety generates hydrobromic acid which 
acts as the required acid catalyst for the formation of the methoxyenone (Scheme 
4.12). 
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Table 4.1: Optimisation of tandem bromination, esterification reaction. 
Entry Light Additive T in °C Comment Yield 
1 no none 0 incomplete esterification, aromatisation 40 % 
2 yes none 0 decomposition, multiple products ~5 % 
3 no none 25 complete aromatisation 0 % 
4 no none - 10 less aromatisation 45 % 
5 no none - 40 low aromatisation, poor esterification 52 % 
6 no none - 78 reaction sluggish, poor esterification 23 % 
7 no TMOF - 40 higher aromatisation observed 63 % 
8 no pyridine - 40 poor esterification, no aromatisation 55 % 
9 no 
TMOF + 
Pyridine 
- 40 minimal dibromination also observed 87% 
Isolated yields reported, 1 eq. Br2 
Careful analysis of the reaction mixture revealed partial aromatisation to the 
corresponding resorcinolic systems and incomplete esterification of the bromo dione 
(248). Efforts made in the optimisation of this reaction are summarised in Table 4.1 
Strict exclusion of light was found to be necessary to isolate appreciable quantities of 
product. The observed aromatisation is a transformation that is known to occur upon 
treatment of the same system with iodine71 and showed some temperature 
dependence, with – 40 °C identified as an optimum (entry 5). In the context of this 
reaction, this was thought to be in part due to the high acidity of HBr in methanol 
forming the easily aromatised bis-enolic tautomers (249) of the corresponding diones 
in situ170 (Scheme 4.14). 
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Inclusion of pyridine as a weak base to the reaction mixture attenuated the acidity 
and substantially reduced formation of aromatised byproducts by NMR; however the 
sluggish methoxyenolisation still limited yields. As the methoxyenolisation produces 
water as a side product, it was decided to exploit this under the reaction conditions. 
After addition of bromine, an equivalent of trimethylorthoformate (TMOF) was added; 
this helped drive the esterification to completion but seemed to promote 
aromatisation. By utilising both TMOF and pyridine a respectable yield of 87% was 
achieved (entry 9). 
Exposure of the bromoethoxyenone (247) to the previously developed169 Suzuki 
coupling conditions resulted in a disappointing yield of 31% for the cross coupled 
product (246). Upon inspection it was revealed that there was competing hydrolysis 
of the vinylogous ester to form the enol (250). This can be attributed to the relative 
instability of the methoxy group to the quite basic conditions employed. By changing 
from potassium carbonate to the organic base, triethylamine, the yield improved 
remarkably to a functional 64% isolated yield with minimal hydrolysis (Scheme 4.15). 
 
Gratifyingly, subjection of cross coupled material (246) to modified conditions for 
acetonitrile addition, occurred smoothly and upon addition of aqueous hydrochloric 
acid cleanly afforded the desired nitrile adduct (243) in superior yield. Nucleophilic 
addition occurs at the ketone forming an alcohol enol ether intermediate, which upon 
exposure to mildly acidic conditions hydrolyses the enol ether and eliminates water 
to give the product. Luche reduction again proceeded smoothly in a manner 
consistent to that observed by Nugent.169 With significant quantities of the required 
allylic alcohol (244) in hand attention was then turned toward fully investigating the 
acetimidate formation and subsequent Overman rearrangement175 to give the 
requisite amine (245) (Scheme 4.16). 
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Trichloroacetimidates are invariably formed under basic conditions from 
trichloroacetonitrile.51, 171, 175-176 As the basicity of the acetimidate anion is quite high, 
only catalytic base is generally required. Frustratingly, subjection of the allylic alcohol 
(244) and trichloroacetonitrile to the usual conditions prevalent in the literature (NaH, 
KH, DBU)51 resulted only in recovery of starting material or a variety of complex and 
intractable mixtures without any isolation of the desired imidate product (251). 
Although isolation and characterisation of side products proved futile, analysis of 
mixed chromatographic fractions by 1H NMR revealed the presence of characteristic 
doublets at around 3.4 ppm corresponding to the benzylic position. This was 
interpreted as evidence that acidic protons alpha to the nitrile were being 
deprotonated and the double bond was shifting out of conjugation with the aromatic 
ring, thus resulting in a mixture of diastereomers (252) (Scheme 4.17). 
 
To address this issue, the strong hindered base, Proton-sponge® (253) was used 
which is known for its slow deprotonation.177 It was theorised that this would favour 
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the kinetic deprotonation of the alcohol over the methylene. Intriguingly, treatment of 
the allylic alcohol (244) under these conditions led only to the isolation of the diene 
(254) which could be fully characterised. The E-stereochemistry of which was 
confirmed by NOE spectroscopy showing positive correlations between the nascent 
olefinic singlet and the aromatic system. It was postulated that the 
trichloroacetimidate (251) does form but the basic conditions facilitate vinylogous 
E1cB elimination. The imidate activates the alcohol into becoming a good leaving, 
group driven by exothermic formation of trichloroacetamide (255) upon elimination170 
(Scheme 4.18). 
 
As a way of circumnavigating this difficulty the order of steps for the synthetic 
strategy was altered. In this case the late stage Friedel Crafts reaction, planned to 
close the last ring of the synthesis, was instead brought forward. The hasubanan 
skeleton (256) was disconnected via the Alder-ene and Overman chemistry to the 
tricyclic structure (257). Following literature precedence178 this could be prepared via 
an intramolecular Friedel Crafts reaction from an appropriate diene (258). After 
Luche reduction to form the allylic alcohol (259), it was envisioned that this would be 
an appropriate substrate for the Overman chemistry, abrogating the possibility of 
E1cB elimination. The necessary material could then be easily accessed from the 
previously synthesised vinylogous ester (246) (Scheme 4.19). 
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Indeed, upon subjection of the vinylogous ester (246) to vinylmagnesium bromide in 
a manner similar to the previous acetonitrile addition; the corresponding vinyl enone 
(258) was obtained in good yield. Unfortunately when subjected to the literature 
conditions for cyclisation and after screening a number of other Lewis acids, no 
product was observed. Upon close inspection it became obvious that the 
methylenedioxy group was incompatible with the harsh Lewis acid conditions 
required for the Friedel Crafts chemistry.51 As the methylenedioxy group itself is not 
of vital importance to the hasubanan alkaloids it was substituted for the 
corresponding similar, yet substantially more acid stable dimethoxybenzene 
derivative (Scheme 4.20). 
 
Interestingly, when the corresponding dimethoxyphenylboronic acid (260) was 
substituted in the existing synthetic scheme, the yield of the Suzuki reaction 
plummeted and significant problems were encountered with the solubility and polarity 
of the product; which could not be separated from other impurities. In this case the 
 Chapter 4 
  85 
 
Suzuki coupling reaction mixture was carried through crude and had to be separated 
after the addition of vinylmagnesium bromide, in a combined yield of only 37% 
across two steps for product (261). Subjection of this material to the Friedel Crafts 
conditions resulted in the isolation of the desired tricyclic compound (262) in a 
modest 35% yield, not dissimilar to that reported in the literature.178 Material was 
brought through the synthetic scheme nonetheless and Luche reduction resulted in 
quantitative isolation of the requisite allylic alcohol (263) suitable for 
trichloroacetimidate formation (Scheme 4.21). 
 
Unfortunately, once again despite screening a wide range of conditions common in 
the literature,51 the trichloroacetimidate (264) could not be isolated. It is thought that 
the steric environment directly surrounding the allylic alcohol is too crowded to allow 
for the formation of the bulky trichloroacetimidate functionality (Scheme 4.22). This 
was taken as clear evidence that the Overman rearrangement approach was not 
suitable for this system, requiring a rethink of the original synthetic strategy. 
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Aiming to retain most of the existing synthesis to form (234), it was proposed that the 
requisite amine (265) could be installed via a two-step process from the existing 
enone intermediate (243). First by direct aziridination179 of the cross coupled product 
(243) to form a highly substituted aziridine (266), followed by an aza-Wharton 
rearrangement to generate the allylic amine (265) for which there is some literature 
precedence180 (Scheme 4.23). 
  
The aza-Wharton reaction proceeds via an initial hydrazone condensation which 
then pushes electrons into the system, opening the aziridine ring forming an unstable 
vinyl diazene (267) which fragments with release of dinitrogen to generate the 
product. The reaction itself is driven by the formation of the strong dinitrogen triple 
bond, the release of a gas and the relief of the aziridine ring strain180c (Scheme 
4.24).  
 
By comparison to the oxygen analogue, epoxidation; direct aziridination of olefins is 
far less common.179 A review of the literature revealed three main categories of 
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direct aziridination methods. Either by direct addition of a metal nitrenoid to the 
olefin,179, 181 azide cycloaddition with accompanying loss of nitrogen,182 or by a 
Michael type addition of a nitrogen centre bearing a leaving group.183 In order to 
maximise the potential for success, representative examples from each category 
were attempted however no desired product either with (266) or without (268) the 
tosyl protecting group was ever observed, with the reactions leading variously to 
recovery of starting material (243) or decomposition under more forcing conditions. 
This is in keeping with literature precedent, in that outside of intramolecular cases, 
no examples exist of direct aziridination of tetrasubstituted electron poor olefins96, 179, 
180c, 181d (Scheme 4.25). 
 
Given the previous success with the acetonitrile anion, an alternate pathway was 
envisioned whereby the amine (265) could be formed from a nucleophilic addition to 
an appropriately substituted imine (269). This imine could then in turn be formed 
from the known enone (270). Following the literature protocols, the Johnson 
iodination101 of cyclohexenone (160) proceeds smoothly to give the iodoenone (161), 
followed by Suzuki coupling with the previously featured boronic acid169 (224) 
(Scheme 4.26). 
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Direct condensation of the aryl enone (270) with tosylamine, was remarkably 
unsuccessful under all attempted conditions,143 resisting even the aza-Wittig / 
Staudinger ligation of tosyl azide in the presence of triphenylphosphine.184 The lack 
of success in this endeavour was generally attributed to the high steric strain of the 
alpha aryl group leading to excessive steric strain and therefore easy hydrolysis of 
the resulting imine (269). However, even upon attempted condensation with the 
much smaller and more nucleophilic dimethylhydrazine, the system failed to yield 
stable hydrazone adducts (271) (Scheme 4.27). 
 
In an attempt to synthesise O-methyloxime (272), under more forcing conditions with 
methoxyamine and trifluoroacetic acid, additional aromatic signals were observed in 
the 1H NMR corresponding to what was believed to be a Semmler-Wolff 
aromatisation185 product (273). Although this compound was not characterised, it 
was taken as encouragement that the imine formation is possible, although the 
product was likely unstable (Scheme 4.28). 
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The low boiling point and relative instability of methoxyamine186 limited the scope of 
available reaction conditions. As such it was decided that an appropriately 
substituted nitrone (274) would be synthesised. The known N-PMB hydroxylamine 
(275) was selected as the PMB group could later be orthogonally deprotected under 
oxidative conditions.51 It was viewed that the use of the nitrone offered multiple 
advantages.187 Not only would the Semmler-Wolff aromatisation no longer be 
feasible, as the nitrone would no longer a leaving group on nitrogen; but also the 
electronic features would attenuate the possibility of Michael addition in the 
subsequent step.115, 170 When exposed to most standard conditions (Dean-Stark, 4Å 
sieves, MgSO4, TMOF etc.)143 no evidence could be obtained that condensation was 
successful. Fortuitously subjection of the system to two equivalents of titanium 
ethoxide as a combined Lewis acid and dehydration agent188 resulted in the 
observation of the nitrone adduct (274) through identification of the corresponding 
M+H peak by LCMS and careful 1H NMR analysis of the unpurified product, 
particularly a strong upfield shift in the alkene triplet. Disappointingly the nitrone 
adduct itself could not be chromatographically isolated and the titanium impurities 
were difficult to remove without hydrolysing the nitrone. This was further supported 
by 2D TLC which confirmed decomposition of the product on silica (Scheme 4.29). 
 
Confident that nitrone formation was taking place in the reaction system and in light 
of the isolation difficulties; it was decided to investigate a single pot reaction. It was 
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envisioned that the excess titanium ethoxide could perhaps further facilitate the 
nucleophilic addition process as a Lewis acid.170 After 48 hours at reflux to ensure 
maximal formation of the nitrone (274), lithiated acetonitrile was generated in 4 fold 
excess then added via cannula. This excess is necessary due to the formation of 
ethanol as a reaction side product. Unfortunately no corresponding product (276) 
was observed; even by mass spectroscopy. The major observation was recovery of 
the enone (270) and minor formation of a product corresponding to nucleophilic 
addition to the ketone, which was not further characterised (277). A pair of coupled 
protons at 2.64 ppm and 2.46 ppm with a coupling constant of 16.4 Hz was 
observed, accompanied by transformation of the previously clear aliphatic ring 
protons into complex multiplets without incorporation of the desired nitrogen 
substituents. It was interpreted from this that there was a persistent equilibrium 
present in the reaction system and that addition of the basic nucleophile resulted in 
selective addition to the substantially more electrophilic ketone (Scheme 4.30). 
 
Nitrones are also well known as 1,3-dipoles that are capable of undergoing Huisgen 
dipolar cycloadditions189 with a range of electron rich and electron poor 
dipolarophiles.134 Application of this reactivity to the formed nitrone would result in a 
spirocyclic product and would proceed without the need for basic conditions. It was 
perceived that the resulting spirocyclic system had the potential to offer an additional 
kinetic benefit to the envisioned Alder-ene cyclisation. The rigidity of the spirocyclic 
system orthogonal to the plane of the cyclohexane ring, would force the alkyne to 
occupy a position that would be optimal for the rearrangement to occur (Figure 4.5). 
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As the regioselectivity of the cycloaddition would most likely be controlled by steric 
factors,190 four suitable dipolarophiles were selected that could be converted into the 
desired aldehyde or ester functionality upon eventual cleavage of the isoxazolidine 
ring (278). Ethyl vinyl ether and vinyl acetate provided good examples of electron 
rich dipolarophiles;191 whereas methyl vinyl sulfone and acrylonitrile were selected as 
good electron poor dipolarophiles.190, 191b In all cases, reductive cleavage of the 
isoxazolidine reveals the same aldehyde. Disappointingly and despite numerous 
attempts, this approach proved fruitless, resulting in only complex mixtures from 
which little information could be gleaned. It is inferred that the strong Lewis acidity of 
the titanium ethoxide results in decomposition of the dipolarophiles, potentially 
involving the ethanol side product. It is worth noting that the inability to isolate the 
nitrone (274) makes it difficult to reach strong conclusions regarding reactivity 
(Scheme 4.31). 
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Disaffected by these results, a further reimagining of the synthetic sequence was 
sought. Enthralled by the potential of a spirocyclic intermediate to facilitate the 
desired Alder-ene chemistry, it was incorporated into the overall synthetic strategy. 
Further encouragement was provided in the form of literature precedence as the 
related [6,5]-spirocyclic pyrazolidinone (279) had been synthesised from the 
corresponding exo alkene192 (280). Transposing these ideas onto the chemistry at 
hand results in a simple disconnection to the previously established alpha arylenone 
(270) via an appropriate olefination protocol (Scheme 4.32). 
 
In practice olefination proved to be modestly difficult as 1,4-addition provided a 
competing pathway problematic, resulting in mixtures of products under Doebner-
Knoevenagel or Horner-Wadsworth-Emmons conditions.134 In order to prevent 
conjugate addition, conditions were sought that featured a harder nucleophilic 
species.115 Satisfyingly, utilisation of a Peterson olefination protocol193 resulted in the 
smooth isolation of a single product (281). Interestingly on full characterisation it was 
revealed to possess the higher energy Z-double bond stereochemistry, which was 
confirmed by NOE spectroscopy. It was hoped that the additional steric strain would 
activate the system to Michael addition. In order to fully probe the reaction 
possibilities the alpha bromo cyclohexenone194 (282) was synthesised from 
cyclohexanone (160) and also converted to its diene ester (283), this proceeded 
smoothly under the same conditions again affording only the Z-stereoisomer. 
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It has been established that the enolate formed under these conditions tends to 
feature the lithium oxide trans with respect to the trimethylsilyl group.195 Application 
of the Zimmerman-Traxler model for the addition of the Z-esterenolate, results in two 
possible transition states.170 Upon inspection there is a clear steric interaction 
between the ethyl group of the ester enolate and the alpha aryl system. The resulting 
silyl alkoxide (284) then rapidly eliminates lithium trimethylsiloxide in an exclusively 
syn-fashion, resulting in the observed product (281)195 (Figure 4.6). 
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Disappointingly, when the ester diene was subjected to the literature conditions for 
pyrazolidinone formation;192 multiple products were observed by NMR. The major 
identifiable product retained the ethyl group and featured both an isolated doublet at 
2.8 ppm and a characteristic AB system, which with loss of both of the alkene 
signals, indicated desymmetrisation. Although not isolated, based on this information 
it was believed that a stepwise double Michael addition process was occurring, 
resulting in a bicyclic product (285) which could also be detected by ESI mass 
spectrometry with an m/z mass peak at 319.2 corresponding to the proton adduct. 
Unfortunately due to the high polarity the product was lost on silica, when attempts 
were made to purify it. In the hope of isolating a more tractable product, attempts 
were also made to form the isoxazolidinone with hydroxylamine or PMB 
hydroxylamine but to no avail with primarily return of starting material. When similar 
conditions were trialled on the bromoalkene (283), starting material was returned, 
with the usually unstable haloalkene showing remarkably little reactivity. 
Unfortunately none of the desired products (286, 287) were isolated (Scheme 4.34). 
 
4.7 Future Work 
 
Although a number of avenues were explored, none of them proved to be ultimately 
fruitful. As such, further extensions of the approaches featured herein will be the 
subject of “future work”. Of particular interest could be the reapplication of the 
bromoenone to pre coupling formation of the desired allylic amine system using the 
imine based methodology. Although attempts were made using the iodoenone, these 
were thwarted by the photosensitivity of the resulting products. Given the surprising 
comparative stability of the related bromide derivatives observed late in the project, 
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this may be worth further investigation. As a furtherance to the development of the 
Pd catalysed Alder-ene reaction it may also be worthwhile forming the butynyl ethers 
of the various allyl alcohols synthesised during the project to investigate their activity 
and provide additional structural novelty (Figure 4.7). 
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Chapter 5 – Bicuculline 
 
5.1 Introduction 
 
The phthalide isoquinoline natural product bicuculline (288) was first isolated in 
1932, from Dicentra bicucullaria, commonly known as Dutchman’s breeches.196 It 
has since been detected in a range of different species within the Papaverae 
(Poppy) family of which it is a member.197 It was determined shortly thereafter to be a 
powerful and toxic convulsant198 which can be used to model epilepsy. In 1970 there 
was an explosion of interest in the compound after it was shown to be a relatively 
selective antagonist of gamma aminobutyric acid (GABA) induced inhibition at 
neuronal synapses, providing some of the first evidence of GABA as a 
neurotransmitter.199 In the intervening 45 years, bicuculline (288) has played a key 
role in the investigation of GABA receptors, featuring in hundreds of publications as 
a biological probe200 (Figure 5.1). 
 
It has since been determined that bicuculline has lower selectivity than originally 
thought, with reports stating that it may also have some indirect antagonistic effect 
on other neurotransmitters such as glutamate, glycine and 5-hydroxytryptamine.201 
The major additional activity that has proven to result from administration of 
bicuculline, is antagonism of nicotinic acetylcholine receptors (nAChRs).202 The 
nAChRs are pentameric complexes that form a ligand gated ion pore through the cell 
membrane. These pentameric complexes can consist of multiple different protein 
subtypes that determine the varying physiological roles of the receptors28 (Figure 
5.2). Following an in depth investigation using isolated oocyte receptor expression, 
Demuro et al. determined that the degree of antagonism by bicuculline on nAChRs 
was moderately subtype selective with the order of potency being 
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α7>α2β4>α4β2>αβγδ with IC50s ranging from 6.8 to 34 μM. This led to the 
conclusion that bicuculline has potential as a lead compound in the development of 
selective anticholinergics for possible medical use.203 
 
Figure 5.2 Left: Ligand gated ion channel cross sectional view. Right: Top down 
view of a muscular αβγδ type nicotinic acetylcholine receptor showing the different 
subunits and binding sites.28 
 
5.2 Biosynthesis  
 
As a phthalide isoquinoline alkaloid the biogenesis of bicuculline (288) is remarkably 
similar to that of the initial stages in the biosynthesis of hasubanan (see Chapter 4). 
Here a molecule of dopamine (289) and 4-hydroxyphenyl pyruvate (209) undergo the 
analogous enzymatic Pictet-Spengler type reaction via imine (290), which after 
further oxidation and methylation generates the intermediate reticuline (291).204 
Interestingly, oxidation of the N-methyl group results in an intramolecular 
electrophilic aromatic substitution, forming an additional ring. Oxidation of the O-
methyl groups of the aromatic rings then furnishes the methylenedioxy systems to 
yield the natural product stylopine (292)205 (Scheme 5.1). 
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It is believed that from stylopine (292), further N-methylation results in the quaternary 
ammonium salt which then undergoes oxidation at the methylene group to give an 
aldehyde (293). Further oxidation at the unsubstituted benzyl position gives the 
known hemiacetal egenine (294) which is readily converted into bicuculline (288).206 
This is supported by radiolabelling studies of the related phthalide isoquinoline 
natural product noscapine (295), which determined that the lactone carbonyl 
originated from the N-methyl group of reticuline (291)207 (Scheme 5.2). 
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5.3 Prior Art 
 
Bicuculline (288) has been the subject of multiple syntheses, with the first completed 
by Groenewoud and Robinson in 1936.208 In this approach the two separate ring 
systems were disconnected to give a nitro phthalide (296) and the known 
hydrastinine (297). A three step protocol was then used to remove the aromatic nitro 
group from (298) with later resolution of the natural product by crystallisation as the 
tartrate salts (details unavailable).208 Several variants of this iminium addition 
approach have since been published209 (Scheme 5.3). 
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Another strategy that has been employed in the synthesis of bicuculline (288) follows 
a more biosynthetic approach.210 Here the disconnection was made in the 
isoquinoline ring to give a linear amide (299) which was cyclised under Bischler-
Napieralski conditions to give the enamine hydrochloride salt (300). This can be 
seen as the amide equivalent of the enzymatic Pictet Spengler reaction that forms 
the isoquinoline ring in nature.134 Upon reduction this gave a racemic mixture of 
norbicuculline diastereomers (301) from which bicuculline (288) had to be 
labouriously purified by crystallisation as the tartrate salt followed by methylation210 
(Scheme 5.4). 
 
One of the few enantioselective approaches employed in the synthesis of bicuculline 
(288) and related phthalide isoquinolines has utilised the reversed polarities to that of 
Groenewoud and Robinson with the same disconnection between rings. This 
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strategy instead generated a benzylisoquinoline anion bearing a chiral auxiliary (302) 
which was then added to piperonal (303).211 The most notable of these approaches 
is that by Gawley and Zhang, wherein the desired adduct could be formed with 80% 
diastereoselectivity (other isomers not reported), albeit in 62% yield212. This was 
achieved by using a magnesium counterion in combination with a camphor derived 
chiral auxiliary. The major diastereomer (304) could be isolated chromatographically 
and converted in a further 4 steps to (+)-bicuculline (288) (Scheme 5.5). 
 
The major disadvantage of these approaches is that they invariably result in mixtures 
of diastereomers that have proven difficult to control and require substantial further 
effort to separate and resolve to afford enantiomerically pure bicuculline.210 This is 
particularly incompatible with the synthesis of analogues as each new compound 
would require the development of new conditions. In order to investigate the 
structure activity relationship of bicuculline in the various receptor subtypes, a 
synthetic scheme was desired that could reliably form the desired diastereomer in an 
ideally modular approach that would favour the ready synthesis of derivatives.7 In 
this respect it was envisioned that the carbon skeleton could be formed via 
stereoselective synthesis of the corresponding stilbene, followed by oxidative 
functionalization in a stereocontrolled manner. Initial efforts in this regard focused 
around the ring opening of an epoxide and were the subject of an honours 
dissertation within the research group by Lucy McPherson, which is summarised 
below.213 
Retrosynthetically, bicuculline (288) was disconnected to an appropriately protected 
epoxide (305). A carboxybenzyl (Cbz) group was chosen to protect the nitrogen 
functionality, which could be deprotected under hydrogenative conditions.51 
Conceptually, initial deprotection would reveal the nucleophilic amine which would 
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then undergo ring opening of the epoxide, accompanied by esterification of the 
resulting alcohol to give the natural product (288). As epoxide ring opening proceeds 
with inversion, the trans-epoxide was required give the desired stereochemistry 
(Scheme 5.6). 
 
The highly functionalised epoxide (305) in turn could then be accessed by syn-
selective epoxidation of the corresponding trans-stilbene (306). Using the 
established Shi epoxidation protocol77 it would then be possible to carry this out 
enantioselectively. The stilbene itself could then be synthesised by sequential cross 
coupling chemistry of a corresponding bis-functionalised vinyl equivalent (307) and 
two aromatic iodides (308) and (309) (Scheme 5.7). 
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The first of the required coupling partners was synthesised from the commercially 
available 3,4-methylenedioxyphenylacetic acid (310). Oxalyl chloride mediated 
formation of the acid chloride, followed by quenching with methylamine furnished the 
corresponding methylamide (311) in good yield. Borane mediated reduction of the 
secondary amide followed by acid hydrolysis of the resulting amine-borane complex 
resulted in isolation of the free secondary amine which was protected under standard 
conditions to give protected material (312).51 Subsequent iodination under silver 
trifluoroacetate promoted conditions then gave the requisite coupling partner (308). 
The second coupling partner (309) was known within the group and could be 
accessed via directed orthometallation214 of the commercially available 4-iodo-1,2-
methylenedioxybenzene (313) followed by quenching with methyl chloroformate 
(Scheme 5.8). 
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Owing to their relatively high stability, a methyliminodiacetyl (MIDA) boronate was 
selected as an appropriately functionalised coupling partner, for which there were 
multiple options.215 After some optimisation the stannyl substituted system was 
deemed the most appropriate as the stannane is more reactive to cross coupling 
conditions in the absence of base. Following literature procedures215 
ethynylmagnesium bromide (314) was quenched with trimethylborate to give the 
crude ethynylboronic acid which was immediately condensed with 
methyliminodiacetic acid (315) to give the stable MIDA derivative (316). Radical 
mediated hydrostannylation with tributyltin hydride then afforded the desired 
stannane (317) in moderate yield (Scheme 5.9). 
 
Subjection of the synthesised stannane (317) to Stille coupling conditions with the 
iodo ester (309) allowed isolation of the selectively cross coupled MIDA protected 
product (318) in moderate yield. Subsequent exposure of this material to the second 
cross coupling partner (308) then afforded the desired trans-alkene (306) in an 
unoptimised yield of 28%. Upon treatment of the trans-alkene with m-CPBA to effect 
peracid mediated epoxidation, the product epoxide (305) was found to be somewhat 
chromatographically unstable.213 As such it was subjected directly to deprotection 
conditions in the hope of isolating the natural product (288) directly. Unfortunately 
the stilbene epoxide proved unstable to the hydrogenative conditions and only 
decomposition was observed (Scheme 5.10). 
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The project was then taken over by Luke Pasfield as part of his PhD thesis.216 Key 
yields were optimised however isolation of the desired epoxide proved elusive. 
Limited 1H NMR, and MS evidence was obtained for the formation of the natural 
product under Lewis acid mediated conditions however it could not be cleanly 
isolated. Owing to the difficulties in handling of the stilbene epoxide system, it was 
decided that another approach be taken whereby the functionalisation of the alkene 
could be achieved via an osmium catalysed intramolecular aminohydroxylation 
reaction.217 This was spurred on in part by the recent publication by Donohoe et al. 
which demonstrated that O-benzoylated hydroxamic acids (319, 320) were viable 
substrates for the reaction that can even be used with accompanying esterification218 
(321, 322). Although not known in an intramolecular fashion, enantioselectivity has 
been achieved (323) in the intermolecular variant with benzyl carbamate 
substrates219 (324). With further research this may allow for a potentially 
enantioselective synthesis of bicuculline (288) (Scheme 5.11). 
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In applying this methodology to the synthesis of bicuculline (288) it is apparent that 
the cis-stilbene (325) is required to achieve the desired stereochemical outcome. 
The resulting amide (326) could then be methylated and reduced to afford the 
natural product. The required O-benzoylated hydroxamic acids can be readily 
synthesised in a few steps from the corresponding carboxylic acid,218 revealing the 
mono protected stilbene as a key intermediate. It is believed that the mechanism of 
the reaction proceeds via initial binding to the amide nitrogen by the osmium(VI) 
centre which reduces nitrogen-oxygen bond to give an imido osmium(VIII) 
intermediate (327) which can then undergo syn-selective [3+2] cycloaddition with an 
olefin. It was hoped that the resulting amide alcohol (328) would then cyclise to give 
the ester (326)217 (Scheme 5.12). 
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It was proposed that the stilbene intermediate (329) could be formed by Lindlar 
reduction of the tolane benzyl ester (330), itself available by sequential Sonogashira 
type coupling of trimethylsilylacetylene (331) with two appropriate aromatic 
fragments (332, 309) (Scheme 5.13). A summary of progress made by Pasfield in 
this approach follows. 
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3,4-(Methylenedioxy)phenylacetic acid (310) was iodinated under literature 
conditions220 with iodine monochloride to afford the corresponding iodide (333) which 
was then protected as the benzyl ester (332). Initial cross coupling of methyl ester 
(309) (previously obtained by McPherson) with trimethylsilylacetylene (331) 
proceeded smoothly to give the alkyne product (334), followed by a facile 
deprotection of the TMS group in potassium carbonate and methanol. The 
subsequent cross coupling between the terminal alkyne (335) and the benzyl ester 
(332) proved to be troublesome and was achieved in moderate yield by resorting to a 
copper free Sonogashira protocol.216 Unfortunately the Lindlar semihydrogenation of 
the tolane (330) proved to be highly challenging, with incomplete removal of the 
benzyl protecting group and competing over reduction of the resulting stilbene, 
preventing isolation of the desired product (329) (Scheme 5.14). 
 
5.4 Results and Discussion 
 
Upon receiving the project it was decided to continue with the proposed 
aminohydroxylation strategy. The benzyl protecting group was identified as being 
unsuitable owing the difficulties in its orthogonal removal during the Lindlar 
semihydrogenation. As such a strategic decision was made to switch to the use of 
the moderately stable trimethylsilyl ethyl group (TMSE) to reach the key mono 
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protected stilbene (329). The advantage of this is that TMSE groups can be 
selectively cleaved in the presence of fluoride via a Grob like fragmentation, driven 
by the formation of ethylene gas.51 This preserves most of the key synthetic 
elements of the progress made by Pasfield, instead going through the corresponding 
TMSE protected intermediates (336) and (337) (Scheme 5.15). 
 
Initial work focused on addressing inefficiencies in obtaining the second coupling 
partner (309); although there was precedence within the group,213, 216 yields were 
inconsistent. As such a quick methodological screen via 1H NMR was conducted 
(see Table 5.1, Scheme 5.16). Using the brominated material (338) it was thereby 
established that LDA and dimethyl carbonate were superior reagents for effecting the 
desired transformation forming bromide (339) in good yield. Despite similar pKa 
values the LiHMDS used did not seem to undergo deprotonation; use of LiTMP 
resulted in similar product distribution to that of LDA but there may have been some 
problems in the purity of the TMP base. When the iodinated starting material (313) 
was used the yield dropped in a fashion that was consistent with the literature.214 In 
this case freshly distilling the TMP allowed formation of the desired product (309) in 
the same yield as that obtained with brominated material. 
 
X Base Electrophile Yield, Comment 
Br LiHMDS MeOCOCl 0%, Starting material fully recovered 
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Br LiHMDS MeOCOOMe 1%, Starting material recovered 
Br LiHMDS MeOCOCN 5%, Starting material recovered 
Br LDA MeOCOCl 62%, multiple side products observed 
Br LDA MeOCOOMe 81%, clean with some starting material 
Br LDA MeOCOCN 70%, starting material recovery, side products 
Br LiTMP MeOCOCl 44%, starting material recovery, side products 
Br LiTMP MeOCOOMe 40%, starting material recovery 
Br LiTMP MeOCOCN 32%, starting material recovery 
I LDA MeOCOOMe 55%, multiple side products 
I LiTMP MeOCOOMe 81%, some side products, distilled TMP used 
Table 5.1. Optimisation of orthometallation chemistry 
Similarly speaking, the first step in the formation of iodo acid (333) was investigated 
to increase yields but also due to the practical undesirability of working with the 
highly reactive and sludge like iodine monochloride (Scheme 5.17, Table 5.2). A 
range of conditions were screened that cover the various ways of activating iodine 
for electrophilic iodination.221  Interesting all of the trialled conditions resulted in the 
formation of some product, however the only viable non ICl alternative seems to be 
base induced disproportionation. This may be worth further investigation as the 
conditions are unoptimised. It is assumed that the carboxy group may be providing 
some anchimeric assistance.170 
 
Iodine source Conditions Yield 
ICl AcOH 68% 
ICl AcOH (anhydrous) 72% 
ICl AcOH, AgOAc, (silver assisted) 65% 
ICl TFA. AcOH had to be added ICl insoluble in TFA 14% 
I2 NaOH, NaI, H2O/THF (basic, disproportionation) 71% 
I2 K2CO3, H2O2, H2O/THF (basic, oxidative) 26% 
NaI Oxone, H2O/THF (Acidic, oxidative) 12% 
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NaI N-chlorosuccinimide, Acetone (NIS in situ) 21% 
Table 5.2. Optimisation of initial iodination 
After encountering some difficulties, a scalable procedure for TMSE protection was 
developed (Table 5.3, Scheme 5.18). Early attempts using acid chlorides were 
inefficient, resulting in a number of side products that were not easily separable by 
standard techniques. TMSCl assisted esterification looked promising222 but was 
ultimately not amenable to scale with 4-chlorobutanol being observed as a major 
side product arising from solvent reactivity. Utilisation of the Steglich esterification 
protocol51 with DCC and DMAP proved most amenable to use and could be directly 
purified without need for chromatography. 
 
Conditions Yield 
i. Oxalyl chloride, DMF, DCM ii. TMSEOH, pyr, DCM.  60% 
i. Oxalyl chloride, DMF, DCM ii. TMSEOH, NEt3, DCM. 86% 
i. SOCl2 reflux neat ii. TMSEOH, NEt3, DCM. 43%  
TMSCl, TMSEOH, THF 94%  
TMSCl, TMSEOH, THF, large scale 30% 
TMSEOH, DCC, DMAP, DCM 89% 
TMSEOH, DCC, DMAP, MeCN - scalable 91% 
Table 5.3. Optimisation of TMSE esterification 
The initial Sonogashira coupling smoothly afforded the cross coupled product (340) 
in good yield using conditions earlier described by Pasfield.216 The use of catalytic 
silver nitrate in aqueous acetone allowed for the selective deprotection of the 
acetylenic TMS group in the presence of the TMSE ether to give the terminal alkyne 
(341). It is believed that the silver salt acts as a π acid, activating the acetylenic TMS 
to nucleophilic attack by water, potentially forming a silver acetylide that is then 
rapidly protonated223 (Scheme 5.19). 
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Owing to the difficulties previously observed by Pasfield,216 efforts continued with the 
optimisation using the initial coupling copper free Sonogashira protocol.224 Although 
initially promising, difficulties were encountered with relatively poor reproducibility, 
particularly on increasing scale. Multiple side products were generated in various 
quantities without recovery of the alkyne, primarily through a Glaser type 
dimerization,225 the product of which (342) could be isolated and characterised. Slow 
addition of the alkyne to minimise homocoupling proved ineffective, and similar 
results were obtained with either the iodinated (309) or brominated (339) starting 
material. Due to the limiting yields and capricious nature of the reaction, other 
conditions were investigated (Scheme 5.20). 
 
One of the known methods of reducing Glaser-type homocoupled products is to use 
the TMS protected alkyne (340) directly in what is known as a sila-Sonogashira 
reaction.226 This has an added advantage of decreasing the overall step count. 
Unfortunately, using a variety of literature based conditions; this methodology was 
 Chapter 5 
  113 
 
ineffective, providing only low yields of the desired product (Scheme 5.21, Table 
5.4). 
 
Conditions Yield Comment 
Pd(PPh3)4, 50% CuCl, DMF, 80° C 0% Recovery of starting materials 
Pd(PPh3)4, Ag2O, TBAB, THF, 65° C 5% Homocoupling, loss of TMS 
Pd(PPh3)4, AgOAc, THF, 65° C 12% Homocoupling, loss of TMS 
Table 5.4. Sila-Sonogashira attempts 
In order to fully explore the potential conditions for the Sonogashira coupling the 
alternative coupling order was also investigated. Using conditions developed by 
Pasfield, methyl ester (309) was coupled with trimethylsilylacetylene (331) directly 
followed by deprotection of the crude material with potassium carbonate in methanol. 
This afforded the alternate coupling partner (343) in good yield over two steps216 
(Scheme 5.22). 
 
After reviewing the original attempts made by Pasfield, it was decided to return to a 
copper promoted methodology. One of the common conditions originally developed 
for the Sonogashira reaction is to use a free amine as a solvent, which helps to 
solubilise and activate the copper catalyst.227 This was originally overlooked due to 
the possibility of amidation; however with diisopropylethylamine, the large steric bulk 
of amine prevents the formation of amide side products. This immediately led to an 
improvement in yield. As the Glaser coupling is oxidative, switching to the preformed 
Pd(0) catalyst Pd(PPh3)4 substantially increased yields (entry 3).227 By altering the 
order of addition and adding the alkyne last, dropwise over one minute, at 60° the 
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reaction proceeds almost instantly with visible precipitation of diisopropylammonium 
iodide and without significant side products (entries 4 and 7). Presumably the higher 
rate of the reaction helps prevent the build-up of larger concentrations of the free 
alkyne, thus helping to minimise homocoupling. Under optimised conditions the order 
of the Sonogashira couplings made minimal difference to the overall yield (entries 4 
and 7) (Table 5.5, Scheme 5.23). 
 
No. X Y Conditions Yield 
1 I C2H DIPA, CuI, P(tBu)3, Pd(MeCN)2Cl2 36% 
2 I C2H DIPA, CuI, PCy3, Pd(MeCN)2Cl2  52% 
3 I C2H DIPA, CuI, Pd(PPh3)4 71% 
4 I C2H DIPA, CuI, Pd(PPh3)4  92% 
5 C2H I DIPA, CuI, P(tBu)3, Pd(MeCN)2Cl2 25% 
6 C2H I DIPA, CuI, PCy3, Pd(MeCN)2Cl2 23% 
7 C2H I DIPA, CuI, Pd(PPh3)4 96% 
Table 5.5. 5% Pd catalyst loading, 10% CuI loading. 
In contrast to the results reported by Pasfield,216 initial investigations with Lindlar 
catalyst228 did not afford any reduction but resulted in the recovery of unchanged 
starting material (336). Likewise, a two-step process of hydroboration with 
dicyclohexylborane, followed by protodeboration with acetic acid229 only resulted in 
the return of starting material and no isolation of the desired stilbene (344) (Scheme 
5.24). 
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A third and ultimately more productive option was explored whereby the triple bond 
undergoes a platinum oxide catalysed hydrosilylation followed by addition of TBAF 
which both fluorodesilylates the double bond and simultaneously removes the TMSE 
protecting group. This was adapted from a reported procedure used in the synthesis 
of the stilbene moiety of combretastatin A-4 (345) where other semihydrogenation 
attempts of the tolane (346) had resulted in modest yields or selectivities230 (Scheme 
5.25). 
 
The precise role of platinum oxide in this particular reaction has not been directly 
evaluated and likely proceeds through reduction by the silane to form platinum black 
as the active catalyst.231 The generally accepted mechanism for hydrosilylation is the 
Chalk-Harrod mechanism, depicted here for a single regioisomeric addition. This 
invokes initial oxidative addition of the silane to a platinum centre followed by 
association of the alkyne. Migratory insertion of the hydride occurs in a cis-selective 
fashion to give an intermediate organoplatinum species (347) which undergoes 
reductive elimination with the silyl group with retention of configuration to give the 
observed cis-silyl stilbene232 (348). The exact speciation of the platinum centre is 
difficult to ascertain given the heterogeneous nature of the reaction (Scheme 5.26). 
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The resulting silyl cis-stilbenes (348) undergo nucleophilic attack by fluoride at the 
silicon centre resulting in a transient ate complex (349) that is protonated by water 
present in the TBAF reagent233 with deprotection of the TMSE group occurring via 
the previously mentioned Grob like fragmentation51 to give the desired product (329) 
(Scheme 5.27). 
 
Initial attempts at this two step protocol resulted in an unoptimised 23% yield of the 
key intermediate (329), which was increased to 54% on flame drying of the catalyst 
under vacuum before use. This was supported by the appearance of two additional 
signals in the 1H NMR at 6.82 and 6.53 ppm with a coupling constant of 12 Hz, 
characteristic of the Z-stilbene234 (Scheme 5.28). 
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In order to better assess the situation the reaction was carried out in two separate 
steps and on a larger scale, with yields of the silylated material (350) estimated by 
1H NMR (see Table 5.6, Scheme 5.29). Recrystallisation of the starting material after 
significant quantities were obtained, identified solubility problems with the neat 
reaction conditions. This was thought to be a limiting factor in conversion, particularly 
on a larger scale. Addition of a small volume of DCM equal to that of the silane 
reagent resulted in observable dissolution of the starting material and a noticeable 
exotherm however a lower yield was obtained, presumably due to the lower reflux 
temperature of the reaction mixture. Switching to chloroform resulted in a better 
conversion but also the observation of additional side products, possibly due to 
acidic impurities. Acetonitrile proved to be immiscible with the silylating agent, 
whereas THF was eventually identified as an ideal solvent, resulting in full 
conversion of starting material. 
 
Additive Yield Comment 
None 42% Solubility problems, SM recovery 
DCM 32% Dissolved, SM recovery, lower reflux temperature 
CHCl3 60% Side products observed, SM recovery 
MeCN 0% Solvent immiscible with silane, SM recovery 
THF 82% Full conversion 
Table 5.6. Silylation optimisation 
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When attempts were made to isolate and characterise the intermediates (350), the 
ethoxy group on the silane was observed to be moderately unstable to 
chromatography. Both regioisomers were observed along with partial hydrolysis of 
the vinylethoxysilane. The 1H NMR of individual fractions indicated that the silylated 
stilbenes were atropisomeric resulting in characteristic diastereotopic splitting in the 
two silyl methyl groups and all three methylenes, which significantly complicated 
analysis. Fortuitously, these isomers converged upon deprotection with TBAF to give 
the desired product (329) in good yield (Scheme 5.30). 
 
By switching to a newer bottle of anhydrous platinum oxide, with dry THF as a 
solvent, the hydrosilylation reaction could be monitored directly by TLC. After full 
conversion to the two regioisomers, TBAF could be added directly in excess to the 
reaction mixture resulting in a 96% yield of the deprotected stilbene acid (329) as a 
single diastereomer in one pot from tolane (336) (Scheme 5.31). 
 
With an established route to the free acid (329), efforts were undertaken to 
synthesise the hydroxamate ester (325) in order to attempt the pivotal osmium 
catalysed intramolecular aminohydroxylation step. Investigation of the various 
literature sources had primarily indicated formation of the corresponding acid 
chloride (351) which is subsequently reacted with hydroxylamine to form the 
hydroxamic acid (352).217-219 Initial reaction with oxalyl chloride or thionyl chloride 
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and catalytic DMF consumed starting material, however multiple products formed. 
This included characteristic 1H NMR peaks for the trans stilbene234 with coupling 
constants of ~16 Hz and additional peaks around 9 ppm, characteristic of an 
aldehyde. A possible explanation for this is that the Vilsmeier like intermediate 
formed by DMF115 is undergoing electrophilic aromatic substitution. Based on this 
information it was presumed that the starting material of this reaction featured 
considerable acid sensitivity (Scheme 5.32). 
 
Given the relatively precious nature of the advanced intermediate, a simple model 
was chosen to identify milder conditions for the formation of the hydroxamic acid and 
to establish the proof of concept. As such phenylacetic acid (353) was treated with 
CDI in an attempt to generate the imidazoloyl system in situ under basic conditions 
which would then be displaced by hydroxylamine235 to give the hydroxamic acid 
(354). Under the initial conditions found in the literature using 1.5 equivalents of CDI 
in refluxing tetrahydrofuran followed by addition of an excess of hydroxylamine 
hydrochloride, only moderate conversions were observed. Investigation of the crude 
1H NMR spectra revealed that a Lossen rearrangement134 had likely taken place to 
generate a number of side products, indicated by additional distinct peaks between 4 
and 4.5 ppm characteristic of benzylic amine derivatives which were not further 
analysed. By altering the order of addition, temperature and stoichiometry this was 
avoided. The side product seemed to arise from the hydroxamic acid reacting with 
remaining CDI reagent, a reaction known in the literature.236 After formation of the 
imidazoloyl system, the reaction was cooled to room temperature and an excess of 
imidazole (ground to a fine powder) was added prior to addition of hydroxylamine 
hydrochloride. This then allowed any excess CDI reagent to be consumed by free 
hydroxylamine, minimising the possibility of side products (Scheme 5.33). 
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Taking heed of the lessons learnt in the model system, the developed methodology 
was applied to the synthesised stilbene acid (329). Treatment with CDI and 
hydroxylamine hydrochloride under optimised conditions cleanly afforded the desired 
hydroxamic acid (352). When subjecting the crude hydroxamic acid to the 
benzoylation conditions, pyridine was used as a weaker base in place of 
triethylamine to help prevent the previously observed Lossen rearrangement. 
Thankfully, the O-benzoylated derivative (325) was obtained in high purity with an 
overall yield of 87% over two steps (Scheme 5.34). 
 
With the critical benzoylated hydroxamate (325) in hand it was finally possible to 
attempt the key late stage amidohydroxylation reaction. Simple treatment of the 
system with 10% potassium osmate in a 1:1:1 mixture of t-BuOH, MeCN and water 
resulted in complete consumption of starting material and the isolation of the desired 
product (326) as a single diastereomer in 35% yield with the majority of the 
remaining mass balance accounted for by the reduced amide (355) which could be 
isolated and characterised (Scheme 5.35). 
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The mechanism for the formation of the reduced amide product is unknown but had 
also been observed in the literature for certain other leaving groups, most notably the 
pivalate ester.237 It is intriguing as cleavage of the N-O bond is an inherently 
reductive process yet only a catalytic quantity of osmate is used without the 
observation of any other oxidised products. In addition to the benzoate (325), the 
mesitoate (356) and 4-chlorobenzoate (357) derivatives were also synthesised in 
comparable yield from their corresponding acid chlorides. These examples were 
selected as they had been the groups of choice in previous literature studies218-219 
(Scheme 5.36). 
 
Optimisation of the aminohydroxylation protocol is summarised in Table 5.7 (Scheme 
5.37). Interestingly, under identical conditions the differing benzoyl leaving groups 
had practically no effect on the isolated yield, with results falling easily within 
experimental error (entries 1-3). As such the remainder of the optimisation work was 
carried out with the 4-chloro derivative (356) as the 1H NMR peaks were the most 
clearly identifiable in the spectrum of the crude reaction mixture, allowing for a direct 
approximation of yield. It was later discovered that the product could be cleanly 
isolated from crude reaction mixtures dissolving the crude mixture in hot 
tetrahydrofuran then adding an equivalent volume of hexane to selectively precipitate 
the product. A quick screen of solvents (entries 4-9) identified THF and dioxane as 
 Chapter 5 
  122 
 
the most suitable, in most cases the mass balance was accounted for by the 
reduced amide side product (355). Changing the catalyst to osmium tetroxide219 
resulted in a modest reduction in yield and additional uncharacterised side products 
presumably due to dihydroxylation (entry 11). Attempts to change the pH of the 
reaction medium (entries 12-15) to see if it was having an effect on yield resulted in a 
modest increase in yield using sodium bicarbonate, but almost complete loss of 
activity in the presence of sodium carbonate or acetic acid. Interestingly the addition 
of triethylamine to the reaction medium seemed to have no deleterious or beneficial 
effect. The best yield of 63% was obtained by reducing the concentration of water in 
the reaction medium (entry 17), however too little water resulted in a decrease in the 
observed yield.  
 
No. R Solvent Ratio Catalyst Additive 
Yield 
(%) 
1* Ph 
tBuOH, MeCN, 
H2O 
1:1:1 K2OsO2(OH)4 10% none 35 
2* 4-ClPh 
tBuOH, MeCN, 
H2O 
1:1:1 K2OsO2(OH)4 10% none 32 
3* Mes 
tBuOH, MeCN, 
H2O 
1:1:1 K2OsO2(OH)4 10% none 31 
4* 4-ClPh MeCN, H2O 4:1 K2OsO2(OH)4 10% none 30 
5* 4-ClPh Dioxane, H2O 4:1 K2OsO2(OH)4 10% none 38 
6 4-ClPh tBuOH, H2O 4:1 K2OsO2(OH)4 10% none 10 
7 4-ClPh nBuOH, H2O 4:1 K2OsO2(OH)4 10% none 5 
8 4-ClPh Acetone, H2O 4:1 K2OsO2(OH)4 10% none 8 
9* 4-ClPh THF, H2O 4:1 K2OsO2(OH)4 10% none 42 
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10 4-ClPh THF, H2O 1:1 K2OsO2(OH)4 10% none 27 
11 4-ClPh THF, H2O 4:1 OsO4 10% none 21 
12 4-ClPh THF, H2O 4:1 K2OsO2(OH)4 10% citric acid 0 
13* 4-ClPh THF, H2O 4:1 K2OsO2(OH)4 10% NaHCO3 51 
14 4-ClPh THF, H2O 4:1 K2OsO2(OH)4 10% NEt3 38 
15 4-ClPh THF, H2O 4:1 K2OsO2(OH)4 2% Na2CO3 6 
16 4-ClPh THF, H2O 4:1 K2OsO2(OH)4 20% NaHCO3 12 
17* 4-ClPh THF, H2O 4:1 K2OsO2(OH)4 10% NaHCO3 53 
18* 4-ClPh THF, H2O 9:1 K2OsO2(OH)4 10% NaHCO3 63 
19* 4-ClPh THF, H2O 40:1 K2OsO2(OH)4 10% NaHCO3 42 % 
Table 5.7 Entries marked with * correspond to isolated yields. 
The water itself is required for the catalytic cycle to maintain higher turnover as the 
cyclic osmium intermediate (358) must be hydrolysed to regenerate active 
osmium(VI) and free the nascent benzylic alcohol to cyclise with the ester.217 
However water may also be problematic in the formation of reduced amide side 
product (355) by hydrolysis of the intermediate imido osmium species (327). The 
initial activation step produces an equivalent of the corresponding benzoic acid 
which will lower the pH as the reaction proceeds, use of NaHCO3 to buffer the 
reaction system may be what resulted in the modest increase in yield if the lower pH 
promotes imido osmium hydrolysis (Scheme 5.38). 
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Formation of the desired product was supported by experimental evidence and could 
be fully characterised. Strong diastereotopic splitting of the amide alpha protons are 
indicative of incorporation into a ring and a clear coupling could be observed 
between the amide NH signal at 8.30 ppm and the aminomethine at 4.95 ppm. A 
correct mass of m/z 390 for the sodium adduct ([M+Na]+), and loss of the methyl 
ester signal by NMR gave additional evidence that lactone formation had also 
occurred. The relative stereochemistry is not easily determined from the 
experimental data but inferred based on the mechanism of the amidohydroxylation217 
and the isolation of a single diastereomer. 
After successful development of the key osmium catalysed transformation, attention 
was turned to methylating and then reducing the amide. Initial efforts focused around 
direct formation of the methylamide (359). Unfortunately, despite attempting a 
number of conditions this was found to be unsuccessful. With kinetic deprotonation 
with LDA in THF, quenched with methyl iodide or dimethyl sulfate a complex mixture 
of seemingly inseparable products was obtained, the use of diisopropylethylamine at 
higher temperatures yielded similar results. This is presumed to be due to the highly 
similar pKa values of the amide nitrogen and the acidic methylene protons alpha to 
the amide which makes both C and O-methylation possible in addition to the desired 
N-alkylated product. Additional singlet peaks were observed in 1H NMR around 3.8, 
3.5, 3.4, 2.4, 1.7 and doublets at 1.2, which along with other signals indicated 
formation of at least 4 different products. Further investigation of this approach was 
therefore determined to be a waste of valuable material. 
 
The primary focus was therefore shifted to chemoselective reduction of the 
secondary amide in the presence of the ester carbonyl. This in turn would produce 
the natural product norbicuculline (360), which can be converted to bicuculline itself 
via an Eschweiler-Clarke reaction under literature conditions.210 If successful this 
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would constitute a total synthesis of norbicuculline and a formal synthesis of 
bicuculline itself (Scheme 5.40). In general, conditions for the selective reduction of 
amides in the presence of esters exploit the higher nucleophilicity of the amide 
carbonyl and require the use of the electrophilic reducing agents.238 
 
When the system was subjected to the most prototypical electrophilic reducing 
agent, borane,238a over reduction was observed spectroscopically but the product 
was not isolated. This was supported by the appearance of an addition AB system in 
the 1H NMR at 5.1 ppm corresponding to the protons of the benzylic alcohol. The 
reaction proceeded via initial formation of a borane adduct accompanied by 
production of hydrogen gas, this was supported by initial 1H NMR of the crudely 
obtained material which featured the same signals as the starting material without 
the amide NH accompanied by a distinct broadening and change in solubility.238a 
Upon heating only over reduction to the amino alcohol was observed, presumably 
facilitated by internal hydride delivery. Attempts to form an amide formaldehyde 
adduct and reduce directly with borane to give bicuculline were likewise 
unsuccessful, with none of the key literature peaks being identifiable in the 1H NMR 
(Scheme 5.41). 
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Two alternative approaches were therefore investigated to selectively activate the 
amide carbonyl to reduction.239 It was thought that this could be achieved by either 
selective transformation with triflic anhydride to the iminoyl triflate (362) followed by 
nucleophilic reduction in situ; or in a two-step process featuring selective formation of 
the thioamide (363) with Lawesson’s reagent,240 the sulphur atom could then be 
reductively removed with an appropriate thiophilic reducing agent241 such as sodium 
mercury amalgam or Raney nickel (Scheme 5.42). 
 
In general, selective activation of the amide carbonyl with triflic anhydride was 
successful, however subsequent addition of sodium triacetoxyborohydride resulted in 
incomplete reduction, forming characteristic peaks identified as the enamine (364) in 
the 1H NMR of the crude reaction product, forming a pair of doublets at 7.6 and 6.3 
ppm with a coupling constant of 12 Hz (Scheme 5.43). When the crude material was 
further exposed to NaCNBH3 and acetic acid in an attempt to isolate the desired 
product, only decomposition was observed. Use of triethylsilane or diludine following 
literature precedence242 resulted only in formation of complex mixtures. 
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Using the thioamide approach with Lawesson’s reagent in refluxing tetrahydrofuran, 
the thioamide product (363) was clearly observable as the major product by TLC with 
a characteristic decrease in polarity. Direct treatment of the crude thioamide (363) 
with Raney Ni resulted in recovery of the starting amide (326), however it is known in 
the literature that this may be due to poor reagent quality.240b Owing to time and 
safety constraints it was not possible to prepare freshly activated reagent (Scheme 
5.44). 
 
5.5 Future work 
 
At this point research was discontinued due to time constraints. Both the thioamide 
and imidoyl triflate approaches warrant further investigation as the final step of the 
synthesis, as each are promising. Another option that was considered but not 
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attempted is to N,O-bis-methylate (365) with Meerwein’s salt243 or methyl triflate then 
reduce; or to alkylate the nitrogen with something that can be subsequently reduced 
to a methyl group for example a formyl substituted imide51 (366) using formic acetic 
anhydride followed by borane reduction (Scheme 5.45). Additional work could then 
be undertaken to establish enantioselective conditions for the pivotal 
amidohydroxylation reaction, for which there is some literature precedence in the 
intermolecular case.219 
 
5.6 Conclusion 
 
Overall the synthetic procedure came tantalisingly close to the synthesis of the 
natural product norbicuculline (360), which should be achievable with further effort. 
The required carbon framework (336) was rapidly accessed utilising a twinned 
Sonogashira coupling of readily accessible starting materials. Following which a key 
stereoselective hydrosilylation /protodesilylation/deprotection transformation was 
effected in high yield, in a one pot reaction (329). This then set the stage for a syn-
selective osmium catalysed intramolecular amidohydroxylation reaction, establishing 
two new rings with the desired relative configuration present in the natural product. 
This key polycyclic framework (326) was synthesised in a completely 
diastereoselective fashion in an impressive 31.5% overall yield in a shortest linear 
sequence of 8 steps (Scheme 5.46). 
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Chapter 6 - Conclusion 
 
The preceding body of work covers a broad range of chemistry featuring diverse 
approaches to access a variety of complex molecular scaffolds. Attempts have been 
made to conduct a systematic investigation of the chemistry therein, grounded in the 
scientific method. Through this approach, guided by results and observations, 
progress was made towards the synthesis of the desired targets. 
In chapter 2 careful analysis of side products revealed a facile 5-exo-tet cyclisation 
that was able to be incorporated into the synthetic scheme. Combined with the 
versatility and mild conditions of the gold(I) catalysed intramolecular hydroarylation 
this ultimately allowed for a protecting group free synthesis of the natural product 
angelmarin (43) in only 7 steps and 22% overall yield (Scheme 6.1). 
 
In comparison to the pre-existing syntheses, this one is particularly versatile, 
allowing for an easy synthesis of analogues. The possibility of an enantioselective 
synthesis was also investigated. In doing so a novel annulation reaction was 
discovered that has the potential to generate either enantiomer via a known 
Sharpless epoxidation procedure (Scheme 6.2). 
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During investigations into the synthesis of ochrosamine B (118) in Chapter 3, an 
ambitious high risk, high reward plan was embarked upon to rapidly access the 
desired framework through novel chemical approaches. Despite exploration of a 
range of intriguing approaches, little progress was achieved. This is part of the reality 
of the research paradigm where the exploration of the unknown often correlates 
poorly with success. It remained, however a worthwhile investigation in the pursuit of 
good synthesis. Research towards the hasubanan framework (204) followed a 
similar pathway with efforts falling short of obtaining the desired α-tertiary amine 
framework that would have enabled the planned intramolecular Alder-ene reaction. 
Finally in Chapter 5, significant progress was made towards a regioselective 
synthesis of bicuculline (288). Key highlights were the developments of a highly 
efficient one pot stereoselective hydrosilylation/protodesilylation/deprotection 
transformation and the successful implementation of an osmium catalysed 
intramolecular amidohydroxylation reaction to simultaneously and 
diastereoselectively, install both of the remaining rings found in the natural product 
(Scheme 6.3). 
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This sets the stage for reduction of the amide and subsequent methylation to form 
the natural product. The major advantage of the synthetic approach is that the 
inherent stereoselectivity of the reactions’ mechanisms completely control the 
relative stereochemistry. Adaptation of existing research, regarding enantioselective 
amidohydroxylations, to the intramolecular version carries the possibility of achieving 
an enantioselective synthesis. 
In terms of the overall goal of striving towards good synthesis, many aspects have 
been achieved. The successful development of a protecting group free synthesis of 
angelmarin is an excellent showcase of the powerful yet mild Au(I) catalysed 
intramolecular hydroarylation bolstered by the invention of a novel annulation 
reaction. This is again demonstrated in the research towards the synthesis of 
bicuculline, with a highly efficient and stereoselective synthesis of the desired 
polycyclic framework featuring one of the first applications of an amidohydroxylation 
towards the synthesis of a natural product. 
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Chapter 7 – Experimental 
 
7.1 General Experimental Procedures 
 
Proton (1H) and carbon (13C) NMR spectra were recorded on a Varian or Bruker 
spectrometer operating at 400 MHz for proton and 100 MHz for carbon nuclei or on a 
Bruker spectrometer operating at 800 MHz for proton and 200 MHz for carbon 
nuclei. Unless otherwise specified, spectra were acquired at 25 °C in 
deuterochloroform (CDCl3) that had been stored over anhydrous K2CO3. Chemical 
shifts are recorded as δ values in parts per million (ppm) downfield shift from 
tetramethylsilane (δTMS = 0), using residual solvent as an internal reference.244 
Infrared spectra (νmax, cm-1) were recorded on a Perkin–Elmer 1800 Series FTIR 
Spectrometer and samples were analysed as thin films on KBr plates. Low and high 
resolution ESI mass spectra were recorded on a Micromass–Waters LC-ZMD single 
quadrupole liquid chromatograph-mass spectrometer while low and high-resolution 
EI mass spectra were recorded on a VG Fisons AUTOSPEC three-sector double 
focussing instrument. Melting points were measured using a Stanford Research 
Systems Optimelt automated melting point system and are uncorrected. Analytical 
thin layer chromatography (TLC) was performed on aluminium-backed 0.2 mm thick 
silica gel 60 F254 plates as supplied by Merck. Eluted plates were visualized using a 
254 nm UV lamp and/or by treatment with a suitable dip followed by heating.245 Flash 
chromatographic separations were carried out following protocols defined by Still et 
al.246 with silica gel 60 (40–63 μm) as the stationary phase and using the AR or 
HPLC-grade solvents indicated. Starting materials and reagents were generally 
available from Sigma–Aldrich, Merck, TCI, Strem or Lancaster chemical companies 
and were used as supplied. Solvents, drying agents and other inorganic salts were 
purchased from the AJAX, BDH or Unilab chemical companies. Solvents including 
THF, DMF, dichloromethane, benzene and toluene were dried using a Glass 
Contour solvent purification system that was based upon a technology originally 
described by Grubbs et al.247 Methanol and ethanol were used as obtained from the 
above mentioned suppliers. Where necessary, reactions were performed under a 
nitrogen atmosphere. All X-Ray crystallographic analysis was performed by Dr. Tony 
Willis of the Australian National University.  
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7.2 Angelmarin and Columbianetin. 
 
1,3-Bis(methoxymethoxy)benzene (71)49 
 
Sodium hydride 60% dispersion in mineral oil (872 mg, 36.3 mmol) was added 
portionwise over 5 minutes to a stirred solution resorcinol (72) (1.00 g, 9.08 mmol) in 
anhydrous N,N-dimethylformamide (25 mL) at 0 °C. After 30 minutes, 
methoxymethylchloride (2.76 mL, 36.3 mmol) was added as a single portion and the 
resulting solution was warmed to room temperature over 12 hours. The reaction was 
cooled to 0 °C, quenched by the addition of saturated aqueous NaHCO3 (20 mL), 
and then extracted with ethyl acetate (3 × 30 mL). The combined organic fractions 
were washed with brine (30 mL), dried over Na2SO4, and concentrated. The residue 
was purified via silica gel chromatography using ethyl acetate : hexane (1:4) to afford 
1,3-bis(methoxymethoxy)benzene (71) as a colourless oil (1.75 g, 97%); 
1H NMR (400 MHz, CDCl3) δ 7.22 (m, 1H), 6.80 (t, J = 2.3 Hz, 1H), 6.75 (dd, J = 8.2, 
2.4 Hz, 2H), 5.20 (s, 4H), 3.51 (s, 6H). Spectral data were in good agreement to that 
reported in the literature.49 
 
1,3-Bis(methoxymethoxy)-2-(3-methylbut-2-en-1-yl)benzene (73)50 
 
Butyllithium 1.6 M solution in hexane (7.50 mL, 12.0 mmol) was added to a stirred 
solution of 1,3-bis(methoxymethoxy)benzene (71) (2.00 g, 10.1 mmol) in dry 
tetrahydrofuran (10 mL) under nitrogen at -78 °C. This was warmed to 0 °C and 
stirred for 1 hour. Prenyl bromide (1.28 mL, 11.1 mmol) (70) was then added 
dropwise and the reaction allowed to warm to room temperature over a 14 hour 
period. The reaction was then diluted with water (25 mL) and the product extracted 
with ethyl acetate (3 x 20 mL). The combined organic layers were washed with brine 
(20 mL), dried over Na2SO4 and concentrated in vacuo. The crude oil was purified by 
silica gel chromatography using ethyl acetate : hexane (1:9) to give 1,3-
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bis(methoxymethoxy)-2-(3-methylbut-2-en-1-yl)benzene (73)  as a colourless oil 
(1.83 g, 68%). 
1H NMR (400 MHz, CDCl3) δ 7.08 (1H, t, J = 8.5 Hz), 6.77 (2H, d, J = 8.5 Hz), 5.23 
(1H, t, J = 7 Hz), 5.20 (4H, s), 3.49 (6H, s), 3.42 (2H, d, J = 7 Hz), 1.81 (3H, s), 1.68 
(3H, s); 13C NMR (100 MHz, CDCl3) δ 155.9, 131.2, 127.0, 123.1, 120.4, 108.2, 94.7, 
56.2, 26.0, 23.0, 18.0. Spectral data identical to that reported in the literature.50 
 
2,2-Dimethylchroman-5-ol (74)52 
 
To a cooled (0 °C), stirred solution of 1,3-Bis(methoxymethoxy)-2-prenylbenzene 
(73) (1.33 g, 5 mmol) in tetrahydrofuran (4 mL), was added aqueous HCl (0.1 M, 1 
mL). The solution was stirred, and monitored by thin layer chromatography. After 2 
hours starting material had been consumed. The acidic solution was neutralised by 
careful addition of saturated aqueous NaHCO3 (10 mL) and extracted with ethyl 
acetate (3 x 15 mL). The combined organic layers were washed with brine (20 mL), 
dried over Na2SO4 and concentrated in vacuo. The resulting residue was subjected 
to silica gel chromatography by gradient elution using ethyl acetate : hexane (1:10 – 
1:0). Concentration of the resulting fractions led to the isolation of 2,2-
dimethylchroman-5-ol as a colourless oil (74) (521 mg, 58%). 
1H NMR (400 MHz, CDCl3) δ 6.97 (m, 1H), 6.43 (dd, J = 7.9, 1.0 Hz, 1H), 6.34 (dd, J 
= 7.9, 1.0 Hz, 1H), 4.7 (s, 1H), 2.68 (t, J = 6.8 Hz, 1H), 1.83 (t, J = 6.8 Hz, 2H), 1.35 
(s, 6H); 13C NMR (100 MHz, CDCl3) δ 155.5, 154.2, 127.5, 110.3, 108.8, 106.3, 74.3, 
32.5, 27.0, 17.2. Spectral data identical to that reported in the literature.52 
 
3-(2,6-Bis(methoxymethoxy)benzyl)-2,2-dimethyloxirane (75) 
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m-chloroperbenzoic acid (925 mg, 77%, 4.13 mmol) was added portionwise to a 
stirred, cooled (0 °C) solution of 1,3-bis(methoxymethoxy)-2-prenylbenzene (73) (1 
g, 3.75 mmol) in dichloromethane (25 mL) over a period of 5 minutes. The reaction 
was stirred for a further 2 hours at 0 °C then quenched by addition of saturated 
aqueous Na2SO3 (20 mL). The ensuing mixture was then extracted with 
dichloromethane (3 x 20 mL) and the combined organic extracts washed with 
saturated aqueous Na2CO3 (2 x 20 mL). After drying over Na2SO4 and removal of 
solvent in vacuo, the resulting residue was purified by silica gel chromatography 
using ethyl acetate : hexane (1:9) to give 3-(2,6-bis(methoxymethoxy)benzyl)-2,2-
dimethyloxirane (75) as a colourless oil (869 mg, 82%). 
Rf = 0.76 (EtOAc:Hex, 1:1); 1H NMR (800 MHz, CDCl3) δ 7.16 (t, J = 8.3 Hz, 1H), 
6.83 (d, J = 8.3 Hz, 2H), 5.23 (m, 4H), 3.51 (s, 6H), 3.15 (dd, J = 13.6, 4.5 Hz, 1H), 
3.01 (dd, J = 7.5, 4.5 Hz, 1H), 2.87 (dd, J = 13.6, 7.5 Hz, 1H); 13C NMR (200 MHz, 
CDCl3) δ 156.3, 127.8, 116.2, 107.8, 94.6, 63.8, 59.1, 56.1, 24.9, 23.3, 19.1; IR νmax 
(neat) 2956, 1594, 1468, 1254, 1152, 1039, 922, 783 cm–1; LRMS (ESI, +ve) m/z 
305.1 [(M + Na)+, 100%], 251 (22), 221 (43); HRMS [Found: (M + Na)+, 305.1368. 
C15H22O5Na requires (M + Na)+, 305.1365]. 
 
2,2-Dimethyl-2H-chromen-5-ol (77)54 
 
To a cooled (0 °C), stirred solution of 3-(2,6-bis(methoxymethoxy)benzyl)-2,2-
dimethyloxirane (75) (421 mg, 1.49 mmol) in tetrahydrofuran (4 mL), was added 
0.1M HCl (1 mL). The solution was stirred and monitored by thin layer 
chromatography. After 2 h starting material had been consumed. The acidic solution 
was neutralised by careful addition of saturated sodium bicarbonate solution (10 mL) 
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and extracted with ethyl acetate (3 x 15 mL). The combined organic layers were 
washed with brine (20 mL), dried over Na2SO4 and concentrated in vacuo. The 
resulting residue was subjected to silica gel chromatography by gradient elution 
using ethyl acetate : hexane (1:10 – 1:0) concentration of the resulting fractions led 
to the isolation of undesired 2,2-dimethyl-2H-chromen-5-ol (77) as a colourless solid 
(85 mg, 32%). 
m.p. 114 °C, (lit 114-116° C); 1H NMR (400 MHz, CDCl3) δ 6.92 (t, J = 7.8 Hz, 1H), 
6.61 (d, J = 10.2 Hz, 1H), 6.40 (d, J= 8.8 Hz, 1H), 6.28 (d, J = 8.3 Hz, 1H), 5.58 (d, J 
= 9.7 Hz, 1H), 4.83 (s, 1H), 1.41 (s, 6H). Spectral data identical to that reported in 
the literature.54 
 
2-Bromoresorcinol (79)248 
 
Bromine (3.83 mL, 74.4 mmol) was slowly added to resorcinol (72) (2.48 g, 22.5 
mmol) in chloroform (40 mL) over 5 minutes at room temperature. After heating at 
reflux for 1 hour the solvent was removed by rotary evaporation and the residue 
dissolved in methanol (55 mL). To this a solution of sodium sulfite (5.67 g, 45.0 mmol 
) and sodium hydroxide (1.80 g, 45.0 mmol) in water (65 mL) was added and stirred 
for 18 hours at room temperature. The reaction was then acidified with 1 M 
hydrochloric acid followed by extraction with diethyl ether (3 x 50 mL). The combined 
organic layers were dried over Na2SO4, concentrated under reduced pressure and 
then purified by silica gel chromatography using ethyl acetate : hexane (3:17) to give 
2-bromoresorcinol (79) as pale orange crystals (3.66 g, 86%). 
Rf = 0.22 (EtOAc:Hex, 3:7); m.p. 83-84 °C (lit 101-102 °C)248; 1H-NMR (400 MHz, 
CDCl3) δ 7.09 (t, J = 8.0 Hz, 1H), 6.60 (d, J = 8.0 Hz, 2H), 5.48 (br s, 2H); 13C-NMR 
(100 MHz, CDCl3) δ 152.9, 129.0, 108.1, 99.3; Spectral data identical to that 
reported in the literature.248 
 
2-Iodoresorcinol (80)56 
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To a cooled (0 °C) suspension of resorcinol (72) (7.27 g, 66.0 mmol) and iodine 
(17.92 g, 70.6 mmol), in water (46 mL) was added sodium bicarbonate (6.16 g, 73.3 
mmol) portionwise over 5 minutes. The mixture was warmed to room temperature 
and stirred for a further 30 minutes. The products were extracted with ethyl acetate 
(3 x 50 mL) and the combined organic extracts successively washed with 10% 
aqueous sodium sulfite (50 mL) and brine (50 mL). After drying over Na2SO4 and 
removal of solvent in vacuo, the solid residue was triturated with cold (-10 °C) 
chloroform (20 mL) then dried under vacuum to give 2-iodoresorcinol (80) as a 
cream-coloured solid (9.43 g, 61%). 
m.p. 98 °C (lit. 99-101 °C)56; 1H NMR (400 MHz, acetone-d6) δ 8.83 (s, 2H), 7.00 (t, 
J = 8.1 Hz, 1H), 6.46 (d, J = 8.1 Hz, 2H); 13C NMR (100 MHz, acetone-d6) δ 158.8, 
130.4, 107.1, 75.4. Spectral data identical to that reported in the literature.56  
 
2-Bromo-3-(methoxymethoxy)phenol (81)57b 
 
A solution of 2-bromoresorcinol (79) (1.00 g, 5.29 mmol) in dry N,N-
dimethylformamide (5 mL) was slowly added to a suspension of sodium hydride (444 
mg, 11.1 mmol, 60% in mineral oil, washed three times with pentane) in dry N,N-
dimethylformamide (10 mL) at 0 °C. After stirring for 1 hour at room temperature, 
methoxymethyl chloride (0.4 mL, 5.27 mmol) was added dropwise at 0 °C and the 
solution stirred for a further 2 hours. The reaction was quenched by addition of 
saturated aqueous ammonium chloride (10 mL) and extracted with ethyl acetate (3 x 
30 mL). The combined organic layers were washed with brine (30 mL) and dried 
over Na2SO4. The solvent was evaporated in vacuo and the crude product was 
purified by silica gel chromatography using ethyl acetate : hexane (1:9) yielding 2-
bromo-3-(methoxymethoxy)phenol (81) (653 mg, 53%). 
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m.p. 55 °C (lit. 55-56 °C)57b. 1H NMR (400 MHz, CDCl3) δ 7.14 (m, 1H), 6.71 (m, 2H), 
5.70 (s, 1H), 5.24 (s, 2H), 3.51 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 154.3 153.5, 
128.7, 109.4, 107.4, 101.3, 95.5, 56.4. Spectral data identical to that reported in the 
literature.57b 
 
2-Iodo-3-(methoxymethoxy)phenol (82)55 
 
A solution of 2-Iodoresorcinol (80) (1.25 g, 5.29 mmol) in dry N,N-dimethylformamide 
(5 mL) was slowly added to a suspension of sodium hydride (444 mg, 11.1 mmol, 
60% in mineral oil, washed three times with pentane) in dry N,N-dimethylformamide 
(10 mL) at 0 °C. After stirring for 1 hour at room temperature, methoxymethyl 
chloride (0.4 mL, 5.27 mmol) was added dropwise at 0 °C and the solution stirred for 
a further 2 hours. The reaction was quenched by addition of saturated aqueous 
ammonium chloride (10 mL) and extracted with ethyl acetate (3 x 30 mL). The 
combined organic layers were washed with brine (30 mL) and dried over Na2SO4. 
The solvent was evaporated in vacuo and the crude product was purified by silica gel 
chromatography using ethyl acetate : hexane (1:9) yielding 2-Iodo-3-
(methoxymethoxy)phenol (82) (723 mg, 49%). 
Rf = 0.24 (EtOAc:Hex, 9:1); 1H NMR (400 MHz, CDCl3) δ 7.16 (dd, J = 8.3, 8.1 Hz, 
1H), 6.69 (dd, J1 = 8.3, 1.2 Hz, 1H), 6.62 (dd, J1 = 8.1, 1.2 Hz, 1H), 5.52 (s, 1H), 
5.24 (s, 2H), 3.51 (s, 3H); Spectral data identical to that reported in the literature.55 
 
(E)-2-(1-Hydroxy-2-methylbut-2-en-1-yl)-3-(methoxymethoxy)phenol (84) 
 
The following serves as a representative example for reactions of 81 or 82 with 70 or 
73. A solution of tBuLi 1.6M in pentane (1.9 mL, 3.0 mmol) was added dropwise to a 
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cooled (-78 °C), stirred solution of 2-Iodo-3-(methoxymethoxy)phenol (82) (280 mg, 
1.0 mmol) in  tetrahydrofuran (3 mL) over a period of 5 minutes, this was warmed to -
40 °C and stirred for 1 h. At this temperature prenyl bromide (70) (0.13 mL, 1.1 
mmol) was added dropwise as a solution in tetrahydrofuran (1 mL). The solution was 
stirred for a further 3 hours then quenched under nitrogen by addition of saturated 
aqueous ammonium chloride (10 mL). The ensuing mixture was then extracted with 
ethyl acetate (3 x 20 mL) and the combined organic extracts washed with brine (20 
mL) then dried over Na2SO4. Following removal of solvent under reduced pressure 
the resulting residue was purified by silica gel chromatography using ethyl 
acetate:hexane (1:1) to give (E)-2-(1-hydroxy-2-methylbut-2-en-1-yl)-3-
(methoxymethoxy)phenol (84) as a colourless solid (115 mg, 48%). The remaining 
mass balance was accounted for by compound 85 which was not further 
characterised. Evaporative crystallisation of the isolated product from ethyl acetate 
yielded crystals that were submitted for crystallographic analysis. Crystallographic 
data is available as supplementary information that accompanies the thesis. 
m.p. = 75–79 °C; Rf = 0.18 (EtOAc:Hex); 1H NMR (800 MHz, CDCl3) δ 8.44 (s, 1H), 
7.02 (t, J = 8.2 Hz, 1H), 6.51 (dd, J = 8.2, 0.7 Hz, 1H), 6.48 (dd, J = 8.1, 0.9 Hz, 1H), 
5.70 (s, 1H), 5.54 (q, J = 6.7 Hz, 1H), 5.03–5.08 (m, 2H), 3.35 (s, 3H), 2.33 (s, 1H), 
1.62 (s, 3H), 1.55 (d, J = 6.7 Hz, 3H); 13C NMR (200 MHz, CDCl3) δ 157.4, 154.6, 
135.7, 129.0, 121.7, 114.2, 111.1, 105.2, 94.4, 75.2, 56.1, 13.3, 12.3; IR νmax (neat) 
3381, 3220, 2914, 1591, 1455, 1150, 1030, 1006, 907, 778 cm–1; LRMS (ESI, +ve) 
m/z 261.1 [(M + Na)+, 100%], 221 (22), 189 (90); HRMS [Found: (M + Na)+, 
261.1104. C13H18O4Na requires (M + Na)+, 261.1103]. 
Prenyl bromide (70)65 
 
To a stirred, cooled (0 °C) solution of 2-methylbut-3-en-2-ol (94) (5 mL, 47.8 mmol) 
in dichloromethane (50 mL) was added acetyl bromide (5.3 mL, 71.7 mmol) dropwise 
over 5 minutes. The mixture was stirred at this temperature for a further 2 hours. 
After addition of water (50 mL), the mixture was extracted with dichloromethane (2 x 
30 mL). The combined organic layers were washed sequentially with saturated 
 Chapter 7 
  141 
 
aqueous NaHCO3 (50 ml) and brine (50 ml), dried over Na2SO4 and concentrated to 
give prenyl bromide (70) (6.59 g, 92%) 
1H NMR (400 MHz, CDCl3) δ 5.51 (tq, J = 2.6, 1.1, 1H), 3.99 (d, J = 8.4, 2H), 1.77 (s, 
3H), 1.72 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 140.3, 121.0, 29.9, 26.0, 17.8. 
Spectral data identical to that reported in the literature.65 
 
Tributyl(3-methyl-2-butenyl)tin (93)249 
 
A suspension of magnesium turnings (305 mg,12.5 mmol) in tetrahydrofuran (10 mL) 
was immersed in an ice filled ultrasound bath and 1,2-dibromoethane (0.10 mL, 1.2 
mmol) added. The mixture was sonicated for 10 minutes then tributyltin chloride (2.7 
mL, 10 mmol) added. To this suspension a solution of prenyl bromide (70) (1.4 mL, 
12 mmol) in 5 mL of THF was added dropwise, over 30 minutes, under sonication at 
0 °C. After the addition was complete, sonication was continued for a further 30 
minutes at 0 °C. The reaction mixture was poured onto ice water (50 mL) and the 
resulting mixture extracted with ethyl acetate (3 x 30 mL). The combined organic 
extracts were washed sequentially with water (30 mL) and brine (30 mL), dried over 
Na2SO4, and the solvent removed in vacuo to give tributyl(3-methyl-2-butenyl)tin (93) 
(2.6 g, 72%). 
1H NMR (400 MHz, CDCl3) δ 5.28 (t, J = 9 Hz, 1H), 1.67 (s, 3H), 1.64 (d, J = 9 Hz), 
1.57 (s, 3H), 1.47 (m, 6H), 1.29 (m, 6H), 0.89 (t, J = 7 Hz, 9H), 0.83 (m, 6H); 13C 
NMR (100 MHz, CDCl3) δ 125.3, 123.0, 29.3, 27.4, 25.5, 17.4, 13.7, 10.7, 9.4. 
Spectral data identical to that reported in the literature.249 
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2-Butylresorcinol (95) 
 
2-Iodoresorcinol (80) (236 mg. 1.0 mmol) was added to a stirred solution of tributyl(3-
methyl-2-butenyl)tin (93) (540 mg, 1.5 mmol), palladium acetate (24 mg, 0.1 mmol), 
caesium fluoride (304 mg, 2.0 mmol), and copper iodide (36 mg, 0.2 mmol) in 
degassed toluene (5 mL). The resultant mixture was heated under reflux for 16 hours 
and the reaction quenched through addition of saturated aqueous NH4Cl (10 mL) 
and extracted with ethyl acetate (3 x 15 mL). The combined organic extracts were 
washed with brine (10 mL), dried over Na2SO4, and concentrated in vacuo. The 
crude mixture was subjected to silica gel chromatography using ethyl acetate : 
hexane (1:1) to yield 2-butylresorcinol (95) (18 mg, 11%) which was identified by 1H 
NMR and discarded without further characterisation. 
1H NMR (400 MHz, CDCl3) 7.01 (t, J = 8.1 Hz, 1H), 6.36 (d, J = 8.1 Hz, 2H), 2.63 (t, 
J = 7.0 Hz, 2H), 1.53 (m, 2H), 1.40 (m, 2H), 0.94 (t, J = 7.0 Hz, 3H). 
 
2-(3-Methylbut-2-en-1-yl)cyclohexane-1,3-dione (97)69 
 
Diisopropylethylamine (14.6 mL) and prenyl bromide (70) (7.7 mL, 9.8 g, 0.07 mol) 
were added simultaneously, and dropwise, to a cooled (0° C) and magnetically 
stirred suspension of cyclohexane-1,3- dione (96) (11.3 g, 0.10 mol) in water (15 
mL). The ensuing mixture was allowed to warm to 18 °C then stirred at this 
temperature for 16 h before being treated with aqueous sodium hydroxide (160 mL,1 
M). The aqueous phase was washed with hexane (3 × 50 mL) then acidified with 
glacial acetic acid. The ensuing precipitate was collected by filtration and dried under 
reduced pressure to give the previously reported 2-(3-methylbut-2-en-1-
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yl)cyclohexane-1,3-dione (97) (9.1 g, 75%) as an amorphous solid. This material was 
used without purification in the following steps. 
2,2-Dimethyl-7,8-dihydro-2H-chromen-5(6H)-one (99)54 
 
A magnetically stirred solution of compound 2-(3-methylbut-2-en-1-yl)cyclohexane-
1,3-dione (97) (450 mg, 2.5 mmol) in dry 1,4-dioxane (30 mL) was treated with 2,3-
dichloro-5,6-dicyanobenzo-1,4-quinone (623 mg, 2.74 mmol) and the resulting 
mixture heated at reflux for 6 hours. The cooled reaction mixture was filtered and the 
filtrate treated with TLC-grade silica (1.5 g) then concentrated to dryness under 
reduced pressure. The resulting free-flowing solid was then purified by silica gel 
chromatography using ethyl acetate : hexane (1:1) to afford 2,2-dimethyl-7,8-
dihydro-2H-chromen-5(6H)-one (99) as a light orange solid (325 mg, 73%). 
m.p. 38 °C (lit 40–41 °C)54; 1H NMR (400 MHz, CDCl3) δ 1.66 (s, 6H),1.85-1.95 (m, 
2H), 2.26-2.36 (m, 4H), 5.17 (d, 1H, J = 9.6 Hz), 6.34 (d, 1H, J = 9.6 Hz). Spectral 
data identical to that reported in the literature.54 
 
2-(2-Iodopropan-2-yl)-2,3,6,7-tetrahydrobenzofuran-4(5H)-one (100) and 3-iodo-2,2-
dimethyl-3,4,7,8-tetrahydro-2H-chromen-5(6H)-one (102). 
Iodine (1.77 g, 7.0 mmol) was added to a solution of 2-(3-methylbut-2-en-1-
yl)cyclohexane-1,3-dione (97) (630 mg, 3.5 mmol) in MeOH (10 mL) and stirred for 
16 hours at room temperature. The solution was quenched by addition of saturated 
aqueous Na2SO3 (10 mL) and diluted with water (10 mL). The excess methanol was 
removed under reduced pressure and the resulting solution extracted with ethyl 
acetate (3 x 20 mL). The combined organic extracts washed with brine (20 mL) then 
dried over Na2SO4. Following removal of solvent under reduced pressure, the 
resulting residue was purified by silica gel chromatography using ethyl acetate : 
hexane (1:1) to give two isolated products. 
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The major product 2-(2-iodopropan-2-yl)-2,3,6,7-tetrahydrobenzofuran-4(5H)-one 
(100) (662 mg, 62%) as a light yellow solid. 
m.p. = 118 °C; Rf = 0.33 (EtOAc:Hex, 1:1); 1H NMR (800 MHz, CDCl3) δ 4.20 (m, 
1H), 2.98 (dd, J = 14.9, 10.2 Hz, 1H), 2.76 (dd, J = 14.9, 7.7 Hz, 1H), 2.48 (m, 2H), 
2.39 (m, 2H), 2.09 (m, J = 7.2, 1.6 Hz, 2H), 1.96 (s, 3H), 1.94 (s, 3H); 13C NMR (200 
MHz, CDCl3) δ 195.3, 176.8, 113.2, 92.9, 49.3, 36.4, 33.0, 32.5, 31.7, 23.8, 21.7; IR 
νmax (neat) 2981, 2888, 1621, 1402, 1113, 952, 600, cm–1; LRMS (ESI, +ve) m/z 
307.0, [(M)+, 100%], 179 (20); HRMS [Found: (M + Na)+, 329.0014. C11H15O2INa 
requires (M + Na)+, 329.0015]. 
 
The minor product 3-iodo-2,2-dimethyl-3,4,7,8-tetrahydro-2H-chromen-5(6H)-one 
(102) (289 mg, 27%) as a light yellow oil. 
Rf = 0.59 (EtOAc:Hex, 1:1); 1H NMR (800 MHz, CDCl3) δ 4.18 (dd, J = 8.9, 5.5 Hz, 
1H), 2.96 (dd, J = 17.3, 5.4 Hz, 1H), 2.77 (dd, J = 17.3, 8.9 Hz, 1H), 2.32 (m, 4H), 
1.93 (m, 2H), 1.47 (s, 3H), 1.41 (s, 3H); 13C NMR (200 MHz, CDCl3) δ 197.0, 169.7, 
109.9, 79.3, 36.4, 30.7, 30.3, 28.8, 27.0, 24.3, 20.8; IR νmax (neat) 2980, 2946, 1617, 
1379, 1274, 1126, cm–1; LRMS (ESI, +ve) m/z 307.1 [(M)+, 100%], 171 (28); HRMS 
[Found: (M)+, 307.0191. C11H15O2I127 requires (M)+, 307.0195]. 
 
2-(2-Hydroxypropan-2-yl)-2,3,6,7-tetrahydrobenzofuran-4(5H)-one (104) 
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A solution of m-chloroperbenzoic acid (1.37 g, 77%, 6.11 mmol) in dichloromethane 
(25 mL) was added dropwise, to a magnetically stirred, cooled (–10 °C) mixture of 2-
(3-methylbut-2-en-1-yl)cyclohexane-1,3-dione (97) (1.00 g, 5.55 mmol) and 
anhydrous K2CO3 (1.15 g, 8.32 mmol) in dichloromethane (25 mL). The ensuing 
mixture was allowed to stir at room temperature for 14 hours then diluted with water 
(30 mL). The separated aqueous layer was extracted with dichloromethane (3 × 30 
mL) and the combined organic phases washed with saturated aqueous Na2CO3 (40 
mL) and brine (20 mL) before being dried over Na2SO4 and concentrated under 
reduced pressure to give 2-(2-hydroxypropan-2-yl)-2,3,6,7-tetrahydrobenzofuran-
4(5H)-one (104) (1.03 g, 95%) as a white, crystalline solid. Evaporative 
crystallisation of the isolated product from ethyl acetate yielded crystals that were 
submitted for crystallographic analysis. Crystallographic data is available in the 
CCDC or as supplementary information that accompanies the thesis. 
m.p. = 120–122 °C; Rf = 0.1 (EtOAc:Hex, 1:1); 1H NMR (400 MHz, CDCl3) δ 4.60 
(m, 1H), 2.76 (m, 1H), 2.67 (m, 1H), 2.43 (m, 2H), 2.33 (m, 2H), 2.04 (m, 2H),1.85 
(broad s, 1H), 1.27 (s, 3H), 1.17 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 195.4, 177.2, 
113.8, 91.7, 71.8, 36.3, 27.1, 25.5, 23.8, 23.7, 21.7; IR νmax (KBr) 3400, 2943, 1619, 
1405, 1233, 1182, 1062, 999, 944 cm–1; LRMS (EI, 70 eV) m/z 196 (M+•, 82%), 181 
(44), 163 (63), 138 (100), 137 (92), 110 (95), 82 (66). HRMS [Found: M+•, 196.1100. 
C11H16O3 requires M+•, 196.1099]. This material was used without purification in the 
next step of the reaction sequence. 
2-(2-Hydroxypropan-2-yl)-6,7-dihydrobenzofuran-4(5H)-one (105) 
 
A solution of 2-(2-hydroxypropan-2-yl)-2,3,6,7-tetrahydrobenzofuran-4(5H)-one (104) 
(101 mg, 0.52 mmol) in dry dichloromethane (30 mL) was treated with freshly 
prepared MnO2 (241 mg, 2.77 mmol) and the ensuing mixture stirred vigorously at 
room temperature for 48 hours. The suspension was then treated with TLC-grade 
silica (1.0 g) and concentrated to dryness under reduced pressure. The resulting 
free-flowing solid was purified by silica gel chromatography using ethyl acetate : 
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hexane (1:1) to give 2-(2-hydroxypropan-2-yl)-6,7-dihydrobenzofuran-4(5H)-one 
(105) (42 mg, 44%) as an unstable, pale-yellow oil. 
 Rf = 0.3 ( EtOAc:Hex, 1:1). 1H NMR (400 MHz, CDCl3) δ 6.46 (s, 1H), 2.87 (t, J = 
6.0 Hz, 2H), 2.48 (m, 2H), 2.17 (p, J = 6.0 Hz, 2H), 1.59 (s, 6H) (signal due to OH 
group proton not observed); 13C NMR (CDCl3, 100 MHz) δ 194.7, 166.5, 160.5, 
121.6, 100.3, 100.2, 68.6, 37.6, 28.5, 23.4, 22.6; IR νmax (KBr) 3403, 2977, 2941, 
1663, 1599, 1455, 1358, 1217, 1181, 1126, 1003 cm–1; LRMS (EI, 70 eV) m/z 194 
(M+•, 100%), 180 (83), 179 (72), 151 (45), 137 (65). HRMS [Found: M+•, 
194.0945.C11H14O3 requires M+•, 194.0943] 
2-(2-Hydroxypropan-2-yl)-2,3-dihydrobenzofuran-4-ol (68) 
 
A magnetically stirred solution of 2-(2-hydroxypropan-2-yl)-2,3,6,7-
tetrahydrobenzofuran-4(5H)-one (104) (402 mg, 2.05 mmol) in dry 1,4-dioxane (30 
mL) was treated with 2,3-dichloro-5,6-dicyanobenzo-1,4-quinone (426 mg, 1.88 
mmol) and the resulting mixture heated at reflux for 6 hours. The cooled reaction 
mixture was filtered and the filtrate treated with TLC-grade silica (1.0 g) then 
concentrated to dryness under reduced pressure. The resulting free-flowing solid 
was purified by silica gel chromatography using ethyl acetate : hexane (1:1) to give 
an orange solid, recrystallisation (from ethyl acetate/hexane) of which afforded 2-(2-
hydroxypropan-2-yl)-2,3-dihydrobenzofuran-4-ol (68) (318 mg, 80%) as pale-yellow 
crystals. 
m.p. = 143–147 °C (lit. 150–152 °C). 1H NMR (400 MHz, CDCl3) δ 6.98 (t, J = 8.4 
Hz, 1H), 6.40 (d, J = 8.4 Hz, 1H), 6.31 (d, J = 8.4 Hz, 1H), 4.80 (br s, 1H), 4.65 (t, J = 
8.8 Hz, 1H), 3.10 (d, J = 8.8 Hz, 2H),1.92 (br s, 1H), 1.35 (s, 3H), 1.23 (s, 3H); 13C 
NMR (100 MHz, CDCl3) δ 161.2, 152.9, 128.9, 112.7,107.9, 101.7, 89.7, 71.9, 27.9, 
26.1, 23.8; IR νmax (KBr) 3302, 2977, 1608, 1465, 1376, 1326, 1281, 1235,1152, 
1041, 1003 cm–1; LRMS (EI, 70 eV) m/z 194 (M+•, 76%), 161 (37), 136 (100), 135 
(82), 107 (62). HRMS [Found: M+•, 194.0945 C11H14O3 requires M+•, 194.0943] 
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2-(2-Hydroxypropan-2-yl)-2,3-dihydrobenzofuran-4-yl propiolate (67) 
 
A chilled (0 °C) suspension of 2-(2-hydroxypropan-2-yl)-2,3-dihydrobenzofuran-4-ol 
(68) (100 mg, 0.52 mmol) and propiolic acid (108 mg, 1.54 mmol) in acetonitrile (3 
mL) was added, dropwise, to a magnetically stirred solution of DCC (160 mg, 0.78 
mmol) in acetonitrile (3 mL). The resulting solution was stirred at room temperature 
for 4 hours then filtered to remove the precipitated dicyclohexylurea. The filtrate was 
concentrated under reduced pressure and the residue thus obtained subjected to 
silica gel column chromatography using ethyl acetate : hexane gradient elution (1:4–
1:1) to yield 2-(2-hydroxypropan-2-yl)-2,3-dihydrobenzofuran-4-yl propiolate (67) (89 
mg, 70%) as a pale-yellow oil. 
Rf = 0.6 (EtOAc:Hex, 1:1); 1H NMR (400 MHz, CDCl3) δ 7.13 (t, J = 8.4 Hz, 1H), 6.70 
(d, J = 8.4 Hz, 1H), 6.64 (d, J = 8.4 Hz, 1H), 4.65 (t, J = 8.8 Hz, 1H), 3.08 (d, J = 8.8 
Hz, 2H), 3.08 (d, J =8.8 Hz, 2H), 3.08 (s, 1H), 1.90 (broad s, 1H), 1.32 (s, 3H), 1.21 
(s, 3H); 13C NMR (100 MHz, CDCl3) δ 161.3, 149.9, 146.3, 129.1, 119.6, 113.2, 
107.6, 89.9, 76.9, 74.0, 71.7, 28.7, 25.9, 24.0; IR νmax (KBr) 3441, 3268, 2977, 2934, 
2123, 1732, 1622, 1600, 1481, 1464, 1246, 1201, 1003, 777 cm–1; LRMS (ESI, +ve) 
m/z 269 [(M + Na)+, 100%]. HRMS [Found: (M + Na)+, 269.0789 C14H14O4 requires 
(M + Na)+, 269.0790] 
(±)-Columbianetin (44)42 
 
A magnetically stirred solution of 2-(2-hydroxypropan-2-yl)-2,3-dihydrobenzofuran-4-
yl propiolate (67) (89 mg, 0.36 mmol) in dichloromethane (3 mL) was treated with 
acetonitrile[(2-biphenyl)di-tert-butylphosphine]gold(I)-hexafluoroantimonate 
(Echavarren's catalyst (106), 5.5 mg, 2 mol %) and the resulting solution heated at 
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reflux for 16 hours. The cooled reaction mixture was concentrated under reduced 
pressure and the residue thus obtained subjected to silica gel chromatography using 
ethyl acetate : hexane (1:1) to yield (±)-columbianetin (44) (66.5 mg, 75%) as a pale-
yellow solid. Evaporative crystallisation of the isolated product from ethyl acetate 
yielded crystals that were submitted for crystallographic analysis. Crystallographic 
data is available in the CCDC or as supplementary information that accompanies the 
thesis. 
m.p. 164–168 °C (lit.42 161–162 °C); Rf = 0.4 (EtOAc:Hex, 1:1); 1H NMR (400 MHz, 
CDCl3) δ 7.62 (d, J = 9.6 Hz, 1H), 7.26 (d, J = 8.4 Hz, 1H), 6.75 (d, J = 8.4 Hz, 1H), 
6.21 (d, J = 9.6 Hz, 1H), 4.80 (t, J = 8.8 Hz, 1H), 3.32 (m, 2H), 1.80 (br s, 1H), 1.37 
(s, 3H), 1.24 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 163.7, 161.0,151.3, 144.0, 128.7, 
114.0, 113.1, 112.2, 106.7, 91.3, 71.8, 27.6, 26.0, 24.0; IR νmax (KBr) 3444, 2975, 
1732,1716, 1615, 1461, 1262, 1115, 1066, 964, 833 cm–1; LRMS (EI, 70 eV) m/z 
246 (M+•, 42%), 188 (80), 187 (100), 160 (35), 136 (33). HRMS [Found: M+•, 
246.0900. C14H14O4 requires M+•, 246.0892]. 
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(±)-Angelmarin (43)32 
 
A magnetically stirred solution of (±)-columbianetin (44) (82 mg, 0.33 mmol) in 
toluene (4 mL) was treated with Meldrum’s acid (56) (53 mg, 0.37 mmol). The 
resulting solution was heated at reflux for 6 hours then cooled and concentrated 
under reduced pressure. The ensuing yellow oil was dissolved in pyridine (4 mL) and 
the solution so-formed treated with piperidine (3 drops) and p-hydroxybenzaldehyde 
(58) (45 mg, 0.37 mmol) then heated at 70 °C for 16 hours. The cooled reaction 
mixture was diluted with ethyl acetate (10 mL) then washed with aqueous HCl (5 mL, 
5% w/v), water (5 mL) and brine (5 mL) before being dried (MgSO4), filtered and 
concentrated under reduced pressure. The light-yellow oil thus obtained was 
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subjected to silica gel column chromatography using hexane : ethyl acetate (1:1) to 
yield (±)-angelmarin (43) (99 mg, 76%) as a white, amorphous solid. 
Rf = 0.3 (EtOAc:Hex, 1:1), 1H NMR (400 MHz, CDCl3) δ 7.66 (d, J = 9.6 Hz, 1H), 
7.36 (d, J = 15.6 Hz, 1H), 7.29 (d, J = 8.4 Hz, 1H), 7.26 (d, J = 8.4 Hz, 2H), 6.82 (d, J 
= 8.5 Hz, 2H), 6.78 (d, J = 8.5 Hz, 1H), 6.23 (d, J = 9.6 Hz, 1H), 6.15 (d, J = 15.6 Hz, 
1H), 5.20 (m, 1H), 3.37 (m, 2H), 1.65 (s, 3H), 1.60 (s, 3H) (signal due to phenolic 
group proton not observed); 13C NMR (100 MHz, CDCl3) δ 166.4, 164.1, 161.3, 
157.9, 151.2, 144.4, 144.2, 130.0, 128.9, 127.0, 116.4, 115.9, 113.6, 113.1, 112.1, 
106.9, 89.2, 82.2, 27.6, 22.2, 21.2; IR νmax (KBr) 3338, 2926, 1732, 1705, 1616, 
1605, 1514, 1457, 1329, 1263,1168, 1134, 831 cm–1; LRMS (EI, 70 eV) m/z 392 
(M+•, 23%), 228 (73), 213 (100), 147 (95). HRMS [Found: M+•, 392.1261 C23H20O6 
requires M+•, 392.1260]. 
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Shi epoxidation protocol for compound 104 
A solution of aqueous Oxone (1M, 10 mL) was added dropwise simultaneously with 
a solution of aqueous potassium hydroxide (2M, 10 mL) over 1 hour, to a 
magnetically stirred, cooled (0 °C) mixture of 2-(3-methylbut-2-en-1-yl)cyclohexane-
1,3-dione (97) (1.00 g, 5.55 mmol) in acetonitrile (25 mL). The ensuing mixture was 
allowed to stir at room temperature for 6 hours then diluted with water (30 mL). The 
resultant solution was extracted with dichloromethane (3 × 50 mL) and the combined 
organic phases washed with saturated aqueous Na2CO3 (40 mL) and brine (50 mL) 
before being dried over Na2SO4. Concentration under reduced pressure yielded a 
light-yellow solid that was subjected to silica gel chromatography using hexane : 
ethyl acetate (1:1) to give 2-(2-hydroxypropan-2-yl)-2,3,6,7-tetrahydrobenzofuran-
4(5H)-one (104) (195 mg, 18%) as a white, crystalline solid. Chiral HPLC analysis 
was performed with the use of a DAICEL chiralcel OJ-H column which features a tris 
p-toluate cellulose stationary phase; with a flow rate of 0.5 mL/min using a 5% 
solution of isopropanol and hexane. The enantiomeric excess was determined to be 
15%. 
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1-Bromomethyl-2,2-dimethyloxirane (113)82  
 
To a stirred solution of aqueous KOH (29 g, in 100 mL) was slowly added bromine 
(28 g, 17.4 mmol) at 0 °C. The mixture was stirred for 15 minutes at the same 
temperature, then to this solution was added 2-methyl-3-buten-2-ol (94) (10 g, 11.61 
mmol) at 0 °C and stirred for 20 hours. The mixture was diluted with hexane (50 mL) 
and the organic layer separated and evaporated under reduced pressure. Distillation 
of the resulting oil under reduced pressure afforded 1-Bromomethyl-2,2-
dimethyloxirane (113) (16 g, 82.0%) as a colourless oil. 
b.p. 53 °C (25 mmHg); 1H NMR (400 MHz, CDCl3) δ 3.48 (dd, J = 10.4, 6.0, 1H), 
3.23 (dd, J = 10.4, 7.0, 1H), 3.05 (dd, J = 7.5, 6.0, 1H), 1.33 (s, 3H), 1.29 (s, 3H); 13C 
NMR (100 MHz, CDCl3): δ 62.1, 60.5, 29.8, 24.3, 18.1. Spectral data identical to that 
reported in the literature.82 
 
3-((3,3-Dimethyloxiran-2-yl)methoxy)cyclohex-2-enone (114) 
 
1-Bromomethyl-2,2-dimethyloxirane (113) (485 mg, 2.94 mmol) was added to a 
magnetically stirred solution of cyclohexane-1,3-dione (96) (302 mg, 2.70 mmol), 
lithium iodide (40 mg, 0.29 mmol) and lithium carbonate (260 mg, 2.53 mmol) in 
acetonitrile (10 mL). The resulting suspension was heated to reflux and after 14 
hours the reaction mixture was cooled to room temperature then treated with water 
(10 mL) and saturated aqueous Na2CO3 (5 mL) The ensuing solution was extracted 
with ethyl acetate (3 × 10 mL) and the combined organic layers were then washed 
with brine (20 mL) and dried over Na2SO4. Concentration under reduced pressure 
yielded a light-yellow solid that was subjected to silica gel chromatography using 
hexane : ethyl acetate (1:1) affording two fractions, A and B. Concentration of 
fraction A afforded 3-((3,3-dimethyloxiran-2-yl)methoxy)cyclohex-2-enone (114) (360 
mg, 62%) as a white, crystalline solid. Evaporative crystallisation of the isolated 
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product from dichloromethane yielded crystals that were submitted for 
crystallographic analysis. Crystallographic data is available in the CCDC or as 
supplementary information that accompanies the thesis. 
m.p. 59–63 °C, Rf = 0.3 (EtOAc:Hex, 1:1). 1H NMR (400 MHz, CDCl3) δ 5.33 (s, 1H), 
4.04 (dd, J = 10.8, 4.0 Hz, 1H), 3.83 (dd, J = 10.8, 4.0 Hz, 1H), 3.06 (dd, J = 6.4, 4.0 
Hz, 1H), 2.44 (m, 2H), 2.35 (t, J = 6.4 Hz, 2H), 1.98 (p, J = 6.4 Hz, 2H), 1.36 (s, 3H), 
1.31 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 199.5, 177.4, 103.1, 67.5, 60.2, 58.1, 
36.7, 28.8, 24.5, 21.2, 19.0; IR νmax (KBr) 3059, 2945, 1648, 1599, 1391, 1240, 
1226, 1184, 1132, 998, 961, 877, 811 cm–1; LRMS (EI, 70 eV) m/z 196 (M+•, 11%), 
126 (70), 85 (100). HRMS (Found: M+•, 196.1096. C11H16O3 requires M+•, 
196.1099) 
Concentration of fraction B afforded 2-(2-hydroxypropan-2-yl)-2,3,6,7-
tetrahydrobenzofuran-4(5H)-one (104) (180 mg, 31% yield) that was identical, in all 
respects, with the material obtained earlier. 
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7.3 Ochrosamines 
 
2-Iodocyclohex-2-enone (161)101 
 
To a magnetically stirred solution of cyclohex-2-enone (160) (500 mg, 5.2 mmol) and 
pyridine (10 mL) in chloroform (10 mL) was slowly added a solution containing I2 
(5.23 g, 20.6 mmol) and pyridine (10 mL) in chloroform (10 mL). The reaction was 
stirred at room temperature for 30 minutes, before being diluted with diethyl ether 
and washed sequentially with 1 M aqueous HCl (30 mL), water (20 mL), saturated 
aqueous Na2SO3 (2 × 10 mL) and brine (10 mL). The organic phases were dried 
over MgSO4, and concentrated in vacuo to afford 2-iodocyclohex-2-enone (161) 
(1.01 g, 90 %) as a yellow oil which was used without further purification 
Rf = 0.5 (EtOAc:Hex, 1:3); 1H NMR (300 MHz, CDCl3) δ 7.78 (t, J = 4.4 Hz, 1H), 2.67 
(t, J = 6.6 Hz, 2H), 2.47 (dt, J = 4.5, 6 Hz, 2H), 2.09 (m, 2H); 13C NMR (100 MHz, 
CDCl3) δ 192.2, 159.5, 103.9, 37.3, 30.0, 22.9. Spectral data identical to that 
reported in the literature.101 
 
2'-Nitro-4,5-dihydro-[1,1'-biphenyl]-2(3H)-one (147)98 
 
A magnetically stirred mixture of 2-iodonitrobenzene (134) (2.49 g, 10 mmol), 2-
iodocyclohex-2-enone (161) (1.11 g,  5 mmol), copper powder (1.59 g, 25 mmol) and 
tris(dibenzylideneacetone)dipalladium (260 mg, 0.25 mmol) in DMSO (15 mL) was 
heated at 70 °C for 1 hour under a nitrogen atmosphere then cooled and diluted with 
diethyl ether (150 mL). The resulting mixture was then filtered through a pad of Celite 
which was then washed with ether (50 mL). The combined filtrates were washed with 
water (150 mL) and brine (150 mL) then dried over MgSO4. The resulting solution 
was concentrated under reduced pressure to give a brown oil which was purified by 
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silica gel chromatography using ethyl acetate : hexane (3:7) to afford 2'-nitro-4,5-
dihydro-[1,1'-biphenyl]-2(3H)-one (147) (712 mg, 65%) as a yellow solid. 
m.p. = 92–95 °C (lit. 96–98 °C)98; 1H NMR (400 MHz, CDCl3) δ 7.99 (dd, J= 8.1, 1.5 
Hz, 1H), 7.58 (td, J= 7.5, 1.5Hz, 1H), 7.45 (td, J= 8.1, 1.5 Hz, 1H), 7.24 (dd, J= 7.5 
and 1.5 Hz, 1H), 7.01 (t, J=4.2 Hz, 1H), 2.60–2.54 (m, 4H), 2.13 (p, J= 6.9 Hz, 2H); 
13C NMR (100MHz, CDCl3) δ 196.4, 148.4, 146.8, 139.2, 133.2, 131.9, 131.5, 128.6, 
123.9, 38.1, 26.1, 22.4. Spectral data identical to that reported in the literature.98 
 
Aziridine (150)107 
 
To a cooled (0 °C), stirred solution of ethanolamine (162) (6.10 g, 0.1 mol) in diethyl 
ether (1000 mL); chlorosulfonic acid (11.6 g, 10 mmol) was added dropwise over 20 
minutes. The solution was stirred for a further 2 hours during which a precipitate 
forms. This was collected by filtration, washed with diethyl ether (3 x 100 mL) and 
dried under vacuum. To the resulting solid zwitterion (163) was added 6 M aqueous 
NaOH (80 mL) and the solution heated at 50 °C for 2 hours. The solution was then 
distilled at slightly reduced pressure until 10 mL of distillate had been collected. The 
cooled distillate was mixed with sodium hydroxide (10 g), and distilled at atmospheric 
pressure to give aziridine (150) as an unstable volatile liquid (450 mg, 10%), b.p. 55 
°C (lit.107 56-57 °C). Owing to the toxicity and volatility it was used directly without 
further characterisation. 
 
2-(2,6-Dioxocyclohexyl)acetonitrile (167) 
 
Chloroacetonitrile (164) (0.62 mL, 9.8 mmol) was added to a magnetically stirred 
solution of cyclohexane-1,3-dione (96) (1 g, 8.9 mmol), sodium iodide (130 mg, 0.9 
mmol) and sodium carbonate (1.04 g, 9.8 mmol) in acetone (50 mL). The resulting 
suspension was heated to reflux and after 5 hours the solvent volume was reduced 
 Chapter 7 
  156 
 
to 10 mL in vacuo. The suspension was then diluted with saturated aqueous Na2CO3 
(50 mL) and water (30 mL). The ensuing solution was extracted with ethyl acetate (2 
x 30 mL) at the organic fractions set aside. The aqueous phase was then acidified 
with 2M aqueous HCl to pH 3 then extracted with ethyl acetate (3 x 50 mL). The 
combined extracts from the acidified solution were then washed with brine (30 mL) 
and dried over Na2SO4. Concentration under reduced pressure gives a complex 
orange solid assigned as 2-(2,6-dioxocyclohexyl)acetonitrile (167) that was used 
without further purification. 
 
Concentration of the combined organic extracts from the basified solution yields 
essentially pure 2-((3-oxocyclohex-1-en-1-yl)oxy)acetonitrile (166) (230 mg, 17%) as 
a colourless solid. 
m.p. = 58–62 °C; Rf = 0.24 (EtOAc:Hex, 1:1); 1H NMR (400 MHz, CDCl3) δ 5.40 (s, 
1H), 4.63 (s, 2H), 2.46 (t, J = 6.4 Hz, 2H), 2.36 (t, J = 6.4 Hz, 2H), 2.01 (p, J = 6.4 
Hz, 2H). 13C NMR (100 MHz, CDCl3) δ 199.3, 175.5, 113.9, 103.8, 52.8, 36.5, 28.2, 
20.8; IR νmax (neat) 2980, 2889, 1655, 1610, 1383, 1175, 1137, 1012 cm–1; LRMS 
(ESI, +ve) m/z 152.0 [(M)+, 100%]; HRMS [Found: (M + Na)+, 174.0530. C8H9NO2Na 
requires (M + Na)+, 174.0531]. 
6-Hydroxy-2'-nitro-4,5-dihydro-[1,1'-biphenyl]-2(3H)-one (174)117 
 
A mixture of 1,3-cyclohexanedione (96) (18 g, 160.6 mmol), anhydrous potassium 
carbonate (33.3 g, 241 mmol), and o-iodonitrobenzene (134) (20 g, 80.3 mmol) in 
dimethyl sulfoxide (250 mL) was heated to 90 °C for 4 h. After cooling the mixture 
was poured into water (1 L), the resulting solution was acidified with concentrated 
hydrochloric acid and extracted with dichloromethane (3 x 400 mL). The combined 
organic extracts were washed with brine (250 mL), dried over Na2SO4 and 
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evaporated to give a brown foam, which was recrystallised from dichloromethane to 
give 6-hydroxy-2'-nitro-4,5-dihydro-[1,1'-biphenyl]-2(3H)-one (174) (15.1 g, 81%) as 
a tan powder. 
m.p. = 204-208 °C (lit. 208-209 °C)117 1H NMR (400 MHz, CDCl3) δ 8.96 (s, enol 
OH), 7.87 (d, J = 7.9 Hz, 1H), 7.49 (dd, J = 8.0, 7.1 Hz, 1H),7.33 (t, J = 8.1 Hz, 1H), 
7.18 (d, J = 7.2 Hz, 1H), 2.35-2.5 (m, 4H), 1.9-2.1 (m, 2H). Spectral data in good 
agreement with that reported in the literature117.  
2'-Nitro-6-oxo-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-carbonitrile (176) 
 
chloroacetonitrile (0.4 mL, 6.4 mmol) was added to a magnetically stirred solution of 
6-hydroxy-2'-nitro-4,5-dihydro-[1,1'-biphenyl]-2(3H)-one (174) (1 g , 4.3 mmol), 
lithium iodide (1.26 g, 9.43 mmol) and lithium carbonate (475 mg, 6.4 mmol) in 
acetone (10 mL). The resulting suspension was heated to reflux and after 16 hours 
the solution was diluted with saturated aqueous Na2CO3 (50 mL) and water (30 mL). 
The ensuing solution was extracted with ethyl acetate (3 x 30 mL) and the combined 
organic extracts were then washed with brine (30 mL) and dried over Na2SO4. 
Concentration under reduced pressure gave a crude brown solid that was purified by 
silica gel chromatography using gradient elution (EtOAc : Hexanes 4:1–1:1) to give 
2'-nitro-6-oxo-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-carbonitrile (176) as a tan solid 
(602 mg, 58%). A sample was crystallised from ethyl acetate and diethyl ether, and 
submitted to X-ray crystallographic analysis. Crystallographic data is available as 
supplementary information that accompanies the thesis. 
m.p. = 96–101 °C; Rf = 0.57 (EtOAc:Hex, 1:1); 1H NMR (800 MHz, CDCl3) δ 8.17 
(dd, J = 8.2, 0.9 Hz, 1H), 7.67 (td, J = 7.5, 1.1 Hz, 1H), 7.57 (ddd, J = 7.5, 8.2, 1.3 
Hz, 1H), 7.34 (dd, J = 7.6, 1.3 Hz, 1H), 2.76 (ddd, J = 18.4, 8.1, 5.0 Hz, 1H), 2.68 (m, 
2H), 2.57 (ddd, J = 16.5, 7.8, 4.3 Hz, 1H), 2.26 (m, 1H), 2.12 (m, 1H); 13C NMR (200 
MHz, CDCl3) δ 194.3, 148.6, 147.6, 134.2, 131.8, 130.8, 128.9, 125.1, 124.7, 116.5, 
37.7, 28.7, 21.9. IR νmax (neat) 2980, 2219, 1689, 1522, 1345, 1182, 747, 728 cm–1; 
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LRMS (ESI, +ve) m/z 265.0 [(M + Na)+, 100%], 185 (19); HRMS [Found: (M + Na)+, 
265.0589. C13H10N2O3Na requires (M + Na)+, 269.0589]. 
The O-alkylated product could also be identified by NMR from the same reaction 
mixture but not cleanly isolated. 2-((2'-nitro-6-oxo-3,4,5,6-tetrahydro-[1,1'-biphenyl]-
2-yl)oxy)acetonitrile (175) 
 
1H NMR (400 MHz, CDCl3) δ 8.04 (dd, J = 8.2, 0.7 Hz, 1H), 7.62 (tdd, J = 7.6, 1.3, 
0.6 Hz, 1H), 7.48 (tdd, J = 7.5, 1.4, 0.6 Hz, 1H), 7.25 (m, 1H), 4.64 (d, J = 16.3 Hz, 
1H), 4.56 (d, J = 16.3 Hz, 1H), 2.79 (m, 2H), 2.54 (t, J = 6.8 Hz, 2H), 2.21 (m, 2H). 
Conversion of (175) to (176) 
A crude mixture of (176) and (175) (212 mg, 3:7 ratio, see table Table 3.2. Entry 3.) 
was dissolved in acetone (5 mL), to this solution lithium iodide (630 mg, 4.71 mmol) 
and lithium carbonate (237 mg, 3.2 mmol) were added. The resulting suspension 
was heated to reflux and after 72 hours the solution was diluted with saturated 
aqueous Na2CO3 (30 mL) and water (15 mL). The ensuing solution was extracted 
with ethyl acetate (3 x 30 mL) and the combined organic extracts were then washed 
with brine (30 mL) and dried over Na2SO4. Concentration under reduced pressure 
gave a crude brown solid that was purified by silica gel chromatography using 
gradient elution (EtOAc : Hexanes 4:1–1:1) to give 2'-nitro-6-oxo-3,4,5,6-tetrahydro-
[1,1'-biphenyl]-2-carbonitrile (176) as a tan solid (171 mg, 88%) identical in all 
respects to that obtained earlier. 
6-Iodo-2'-nitro-4,5-dihydro-[1,1'-biphenyl]-2(3H)-one (178) 
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Iodine (278 mg, 1.1 mmol) was added in small portions to a solution of 
triphenylphosphine (314 mg, 1.2 mmol) and imidazole (82 mg, 1.2 mmol) in a 
mixture of acetonitrile (3mL) and diethyl ether (1mL) then stirred for 1 hour at room 
temperature. To the resulting suspension was added 6-hydroxy-2'-nitro-4,5-dihydro-
[1,1'-biphenyl]-2(3H)-one (174) (233 mg, 1 mmol) as a solution in acetonitrile (1mL). 
The flask was wrapped in tin foil and allowed to stir for a further 16 hours. The 
resulting suspension was filtered and then diluted with water (10 mL). The solution 
was then extracted with diethyl ether (3 x 10 mL) and the combined organic extracts 
washed with brine and dried over Na2SO4. The solvent was removed in vacuo and 
the resulting residue purified by silica gel chromatography using ethyl acetate : 
hexane with gradient elution  (1:4–1:1) to afford 6-iodo-2'-nitro-4,5-dihydro-[1,1'-
biphenyl]-2(3H)-one (178) as a brown solid. 
m.p. = 103 °C (decomposes); Rf = 0.70 (EtOAc:Hex, 1:1); 1H NMR (800 MHz, 
CDCl3) δ 8.10 (dd, J = 8.3, 1.1 Hz, 1H), 7.60 (td, J = 7.5, 1.2 Hz, 1H), 7.47 (ddd, J = 
8.3, 7.5, 1.4 Hz, 1H), 7.17 (dd, J = 7.6, 1.4 Hz, 1H), 3.12 (m, 2H), 2.64 (ddd, J = 
16.4, 10.4, 5.0 Hz, 1H), 2.56 (ddd, J = 16.4, 7.1, 4.5 Hz, 1H), 2.09 (m, 2H); 13C NMR 
(200 MHz, CDCl3) δ 191.9, 146.4, 135.8, 133.7, 132.3, 129.4, 126.3, 124.8, 115.8, 
42.3, 37.7, 24.2. IR νmax (neat) 2980, 1666, 1595, 1518, 1342, 1285, 1128, 980, 733, 
566 cm–1; LRMS (ESI, +ve) m/z 366.0 [(M + Na)+, 100%], 217 (28), 161 (46); HRMS 
[Found: (M + Na)+, 365.9604. C12H10NIO3Na requires (M + Na)+, 365.9603]. 
2-(2-Hydroxyphenyl)acetonitrile (184)126 
 
Aqueous potassium hydroxide (1.68 g, 30 mmol, in water 1.2 mL) was rapidly added 
to a solution of salicylaldehyde (190) (1.22 g, 10 mmol) in methanol (2 mL), and 
formalin (1 mL, 13 mmol). The reaction mixture was then heated to reflux for 2 hours. 
The reaction mixture was cooled to room temperature, diluted with water (20 mL) 
and extracted with ethyl acetate (3 x 15 mL). The combined organic phases were 
washed sequentially with water (10 mL) and brine (10 mL). The ensuing solution was 
dried over Na2SO4, and the solvent removed in vacuo to give the alcohol (191) as a 
white solid (1.08 g, 87%) used directly in the next step. 
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The previously obtained crude 2-hydroxybenzyl alcohol (191) (1.08 g, 8.7 mmol) and 
sodium cyanide (511 mg, 10.4 mmol) in N,N-dimethylformamide (10 mL) was stirred 
under nitrogen at 120 °C for 16 hours. The solution was cooled to room temperature, 
and water added (50 mL). The mixture was extracted with dichloromethane (3 x 40 
mL), and the combined organic extracts were washed with water (10 mL), dried over 
Na2SO4, and evaporated under reduced pressure. The residual orange oil was 
subjected to silica gel chromatrography by gradient elution using ethyl acetate : 
hexane (1:2–1:0) to afford 2-(2-hydroxyphenyl)acetonitrile (184) (810 mg, 67%) as 
an off white solid. 
 m.p. 115 °C (lit. 116–118 °C)126; 1H NMR (400 MHz, CDCl3) δ 7.21 (m, 2H), 6.82 
(m, 2H), 3.58 (s, 2H). Spectral data identical to that reported in the literature.126 
 
tert-Butyl methyl(phenyl)carbamate (189)129 
 
To magnetically stirred molten t-butyldicarbonate (2.4 g, 11 mmol), N-methylaniline 
(188) (1.07 g, 10 mmol) was added portonwise over 10 minutes and stirred for 16 
hours. The product was was then kept under vacuum (1 mmHg) at 40 °C to yield the 
essentially pure tert-butyl methyl(phenyl)carbamate (189) as a colourless oil (2.07 g, 
~100%). 
1H NMR (400 MHz, CDCl3) δ 7.12-7.31 (m, 5H), 3.21 (s, 3H), 1.43 (s, 9H); 13C NMR 
(100 MHz, CDCl3) δ 154.8, 143.8, 128.6. 125.6, 125.5, 80.2, 37.4, 28.3. Spectral 
data identical to that reported in the literature129.  
 
Tributyl(2-nitrophenyl)stannane (185)127 
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A stirred solution of hexabutylditin (8.7 g, 15 mmol), 2-iodonitrobenzene (134) (2.49 
g, 10 mmol), and tetrakis(triphenylphosphine)palladium (115 mg, 0.1 mmol) in 
toluene (20 mL) was heated at 60 °C for 72 h under nitrogen. After removal of 
solvent in vacuo, the residue was dissolved in ethyl acetate (20 mL) and washed 
with aqueous potassium fluoride (10% w/w, 10 mL) then brine (10 mL). After drying 
over Na2SO4 and concentration under redued pressure, the resulting residue was 
purified by silica gel chromatography using hexane to yield tributyl(2-
nitrophenyl)stannane (185) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ 8.31 (dd, J = 8.2, 0.8 Hz, 1H), 7.68 (dd, J = 7.2, 1.5 Hz, 
1H), 7.61 (td, J = 7.2, 1.1 Hz, 1H), 7.49 (ddd, J = 8.7, 7.2, 1.6 Hz, 1H), 1.49 (m, 6H), 
1.31 (hx, J = 7.3, 7.3 Hz, 6H), 1.12 (m, 6H), 0.87 (t, J = 7.3 Hz, 9H). Spectral data in 
good agreement with that reported in the literature.127 
 
N-(2-Bromoethyl)phthalimide (200)141 
 
Potassium phthalimide (199) (9.26 g., 50 mmol) was added in four equal portions 
over a 4 hour period to a refluxing solution of 1,2-dibromoethane (18.8 g, 100 mmol) 
in acetone (50 mL). The resulting mixture was heated at reflux for 24 hours, cooled 
to room temperature, and filtered. The filtrate was concentrated in vacuo and the 
crude residue was taken up in ethyl acetate (50 mL). This solution was washed with 
cold 2M sodium hydroxide (30 mL), and brine (30 mL) then dried over Na2SO4. 
Solvent was removed in vacuo and the crude solid thus obtained was recrystallised 
from ethanol to give N-(2-Bromoethyl)phthalimide (200) (11.0 g, 87%) as a 
colourless solid. 
m.p. 80 °C (lit. 81 °C)141; 1H NMR (400 MHz, CDCl3) 7.88-7.83 (m, 2H), 7.76-7.70 
(m, 2H), 4.09 (t, J = 6.9 Hz, 2H), 3.60 (t, J = 6.9 Hz, 2H); 13C NMR (100 MHz, CDCl3) 
167.8, 134.2, 131.7, 123.4, 39.2, 28.1. Spectral data identical to that reported in the 
literature.141 
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N-(2-(2,6-Dioxocyclohexyl)ethyl)phthalimide (198) 
 
N-(2-Bromoethyl)phthalimide (200) (750 mg, 2.95 mmol) was added to a 
magnetically stirred solution of cyclohexane-1,3-dione (96) (800 mg , 7.13 mmol), 
lithium iodide (80 mg, 0.59 mmol) and lithium carbonate (436 mg, 5.9 mmol) in 
acetone (15 mL). The resulting suspension was heated to reflux and after 16 hours 
the solvent volume was reduced to ~5 mL in vacuo and diluted with saturated 
aqueous Na2CO3 (20 mL) and water (15 mL). The ensuing solution was extracted 
with ethyl acetate (2 × 30 mL) and the organic extracts set aside. The aqueous 
phase was then acidified with 2M aqueous HCl to pH 3 then extracted with ethyl 
acetate (3 x 20 mL). The combined extracts from the acidified solution were then 
washed with brine (30 mL) and dried over Na2SO4. Concentration under reduced 
pressure gives an impure crude orange solid (198) (521 mg, ~27% desired 
compound by NMR ) used directly in the following steps. 
Rf = 0.32 (EtOAc:Hex, 1:1); 1H NMR (800 MHz, CDCl3) δ 7.79 (dd, J = 5.4, 3.0 Hz, 
2H), 7.68 (dd, J = 5.5, 3.0 Hz, 2H), 4.02 (m, 2H), 3.34 (m, 2H), 2.58-1.88 (m, 6H). 
13C NMR not resolvable. IR νmax (neat) 3199, 2951, 1729, 1588, 1377, 1353, 715, 
cm–1; LRMS (ESI, +ve) m/z 308.1 [(M + Na)+, 100%].HRMS [Found: (M + Na)+, 
308.0897. C16H15NO4Na requires (M + Na)+, 308.0899]. 
Concentration of the combined organic extracts from the basified solution yields 
essentially pure N-(2-((3-oxocyclohex-1-en-1-yl)oxy)ethyl)phthalimide (201) (361 mg, 
43%) as a colourless solid. 
 
m.p. = 171 °C; Rf = 0.18 (EtOAc:Hex, 1:1); 1H NMR (800 MHz, CDCl3) δ 7.91 (dd, J 
= 5.4, 3.0 Hz, 2H), 7.78 (dd, J = 5.5, 3.0 Hz, 2H), 5.37 (s, 1H), 4.12 (t, J = 5.3 Hz, 
2H), 4.09 (t, J = 5.3 Hz, 2H), 2.39 (t, J = 6.3 Hz, 2H), 2.35 (t, J = 6.4 Hz, 2H), 1.98 (p, 
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J = 6.5 Hz, 2H); 13C NMR (200 MHz, CDCl3) δ 199.5, 177.1, 168.0, 134.2, 131.9, 
123.5, 103.1, 65.0, 36.7, 36.6, 28.9, 21.1; IR νmax (neat) 2950, 1774, 1712, 1650, 
1604, 1393, 1184, 721 cm–1; LRMS (ESI, +ve) m/z 308.1 [(M + Na)+, 100%], 174 
(20); HRMS [Found: (M + Na)+, 308.0902 C16H15NO4Na requires (M + Na)+, 
308.0899]. 
 
1,2-Dihydrocarbazol-4(3H)-one (196)139 
 
A solution of phenylhydrazine (600 mg, 5.5 mmol) in 10% aqueous acetic acid (25 
ml) was added to a solution of cyclohexane-1,3-dione (96) (600 mg, 5.3 mmol) in 
10% aqueous acetic acid (25 mL). The mixture was warmed to 60 °C for 20 minutes 
and then allowed to cool to room temperature when a yellow- brown solid 
precipitated. This was filtered off and used directly in the next step. The crude brown 
solid was dispersed in aqueous sulphuric acid (20% v/v, 20 mL), and the mixture 
was heated to 110 °C for 3 hours. The resulting solution was poured into ice water 
(50 mL) to give a yellow solid which was filtered off and recrystallized from aqueous 
ethanol to afford 1,2-Dihydrocarbazol-4(3H)-one (196) as an orange solid (53%) 
m.p. 218 °C (lit. 221-223 °C)139; 1H NMR (400 MHz, CDCl3) δ 8.55 (br s, 1H), 8.22 
(m, 1H), 7.30 (m, 3H), 2.98 (t, J  = 6.2 Hz, 2H), 2.60 (t, J = 6.4 Hz, 2H), 2.25 (m, 2H). 
Spectral data identical to that reported in the literature.139 
 
  
 Chapter 7 
  164 
 
7.4 Hasubanans Framework 
 
2-Bromo-3-methoxycyclohex-2-enone (247)173 
 
Bromine (0.52 mL, 10 mmol) was added dropwise over 5 minutes to a stirred, cooled 
(-40 °C) solution of cyclohexane-1,3-dione (96) (1.12 g, 10 mmol) and pyridine (0.89 
mL, 11 mmol) in methanol (25 mL). After addition was complete, trimethyl 
orthoformate (1.32 mL, 12 mmol) was added. The solution was stirred for 2 hours at 
-40 °C then slowly allowed to warm to room temperature and stirred for a further 16 
h. The solution was then diluted with water (200 mL) and saturated aqueous Na2SO3 
(10 mL) with vigorous stirring upon which a crystalline solid precipitated. This was 
collected by filtration and recrystallised from ethyl acetate and hexane to afford 2-
bromo-3-methoxycyclohex-2-enone (247) (1.78 g, 87%) as colourless crystals. 
m.p. 92-94 °C (lit. 94-95 °C)173; 1H NMR (400 MHz, CDCl3) δ 3.68 (s, 3H), 2.40 (t, J 
= 6.3 Hz, 2H), 2.34 (t, J = 6.3 Hz, 2H), 1.97 (p, J = 6.4 Hz, 2H). Spectral data in good 
agreement to that reported in the literature.173 
2-(Benzo[d][1,3]dioxol-5-yl)-3-methoxycyclohex-2-enone (246) 
 
2-bromo-3-methoxycyclohex-2-enone (247) (3.08 g. 15.0 mmol) was added to a 
stirred solution of 3,4-(methylenedioxy)phenylboronic acid (224) (3.49 g, 21.0 mmol), 
tetrakis(triphenylphosphine)palladium (694 mg, 0.6 mmol) and triethylamine (10 mL) 
in degassed benzene/H2O (200 mL of an 4:1 v/v mixture). The resultant mixture was 
heated under reflux for 6 hours and the reaction quenched through addition of 
saturated aqueous NH4Cl (100 mL) and extracted with ethyl acetate (3 x 150 mL). 
The combined organic extracts were washed with brine (100 mL), dried over 
Na2SO4, and concentrated in vacuo. The crude product was purified by silica gel 
 Chapter 7 
  165 
 
chromatography using ethyl acetate : hexane (2:1) to yield 2-(benzo[d][1,3]dioxol-5-
yl)-3-methoxycyclohex-2-enone (246) (2.35 g, 64%) as a brown oil. 
Rf = 0.66 (EtOAc:Hex, 1:1); 1H NMR (400 MHz, CDCl3) δ 6.79 (d, J = 7.9 Hz, 1H), 
6.64 (s, 1H), 6.61 (d, J = 8.1 Hz, 3H), 5.92 (s, 2H), 3.72 (s, 3H), 2.69 (t, J = 6.2 Hz, 
2H), 2.47 (t, J = 6.3 Hz, 2H), 2.08 (p, J = 6.4 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 
196.6, 171.1, 145.9, 145.1, 125.9, 123.0, 119.3, 110.3, 106.8, 99.7, 55.8, 36.0, 25.6, 
19.7; IR vmax (neat) 2946, 2892, 1721, 1646, 1588, 1487 cm-1; LRMS (ESI, +ve) m/z 
269.1 [(M + Na)+, 100%]; HRMS [Found: (M + Na)+∙, 269.0793. C14H14O4Na requires 
(M + Na)+∙, 269.0784]. 
 
2-(2-(Benzo[d][1,3]dioxol-5-yl)-3-oxocyclohex-1-en-1-yl)acetonitrile (243)169 
 
A magnetically stirred solution of diisopropylamine (0.78 mL, 5.5 mmol) in 
tetrahydrofuran (10 ml) was cooled to -78 °C under an atmosphere of nitrogen, to 
this n-BuLi (3.6 mL, 1.6M in pentane, 5.76 mmol) was added and the mixture 
warmed to 0 °C for 5 minutes. It was then cooled to -40 °C and to this solution 
acetonitrile (0.37 mL, 7 mmol) was then added and stirred for a further 1 hour. A 
solution of 2-(benzo[d][1,3]dioxol-5-yl)-3-methoxycyclohex-2-enone (246) (468 mg, 
1.9 mmol) in THF (5 mL) was added over 2 minutes and the resultant mixture was 
stirred at -40 °C for 2 hours, then slowly warmed to room temperature and stirred for 
a further 16 hours. The reaction was quenched through addition of aqueous citric 
acid (10% w/w, 50 ml) and extracted with EtOAc (3 x 30 mL). The combined organic 
phases were washed with brine (30 mL), dried over Na2SO4, and concentrated in 
vacuo to give a brown oil that was purified by silica gel chromatography using ethyl 
acetate : hexane (1:2) to give 2-(2-(benzo[d][1,3]dioxol-5-yl)-3-oxocyclohex-1-en-1-
yl)acetonitrile (243) as a brown oil (60 %). 
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Rf = 0.63 (EtOAc:Hex, 1:1) 1H NMR (400 MHz, CDCl3) δ 6.82 (d, J = 7.5 Hz, 1H), 
6.51 (m, 2H), 5.98 (s, 2H), 3.22 (s, 2H), 2.67 (t, 6.0 Hz, 2H), 2.58 (t, 6.6 Hz, 2H), 
2.15 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 197.1, 147.9, 147.6, 146.9, 140.4, 127.2, 
122.9, 116.2, 109.9, 108.6, 101.3, 55.6, 29.7, 24.2, 21.8; Spectral data identical to 
that reported by Nugent.169 
 
2-(2-(Benzo[d][1,3]dioxol-5-yl)-3-hydroxycyclohex-1-en-1-yl)acetonitrile (244)169 
 
A magnetically stirred solution of 2-(2-(benzo[d][1,3]dioxol-5-yl)-3-oxocyclohex-1-en-
1-yl)acetonitrile (243) (913 mg, 3.57 mmol) and CeCl3.7H2O (1.48 g, 4.00 mmol) in 
MeOH (50 mL) was cooled to 0 °C, to this NaBH4 (192.5 mg, 5.25 mmol) was added 
batchwise over 10 minutes. The solution was maintained at this temperature for 1 
hour, at which point the reaction was quenched through addition of saturated 
aqueous NH4Cl (50 mL). The reaction was diluted with ethyl acetate (150 ml) and 
washed with brine (50 mL), before being dried over Na2SO4. Concentration in vacuo 
gave a yellow oil which was purified by silica gel chromatography using ethyl acetate 
: hexane (1:1) to give 2-(2-(benzo[d][1,3]dioxol-5-yl)-3-hydroxycyclohex-1-en-1-
yl)acetonitrile (244) (667 mg, 73%) as a yellow crystalline solid 
m.p. = 87.2 – 88.5 °C; Rf = 0.63 (EtOAc:Hex, 1:1); 1H NMR (400 MHz, CDCl3) δ 6.83 
(d, J = 8.4 Hz, 1H), 6.65 (m, 2H), 5.99 (s, 2H), 4.35 (m, 1H), 2.98 (m, 2H), 2.23 (m, 
4H), 1.78 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 148.0, 147.2, 140.1, 132.4, 127.1, 
122.1, 117.8, 108.9, 108.6, 101.2, 68.4, 31.0, 29.0, 23.0, 17.8; Spectral data 
identical to that reported by Nugent.169 
 
(E)-2-(2-(Benzo[d][1,3]dioxol-5-yl)cyclohex-2-en-1-ylidene)acetonitrile (254) 
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2-(2-(benzo[d][1,3]dioxol-5-yl)-3-hydroxycyclohex-1-en-1-yl)acetonitrile (244) (257 
mg, 1 mmol) was added to a stirred solution of 1,8-bis(dimethylamino)naphthalene 
(253) (43 mg, 0.2 mmol), in freshly distilled trichloroacetonitrile (2 mL). The solution 
was then stirred at room temperature and monitored by TLC for consumption of 
starting material. After 4 hours the reaction was quenched by addition of saturated 
aqueous ammonium chloride (10 mL) and extracted with dichloromethane (3 x 10 
mL). Concentration in vacuo of the combined organic fractions yielded a black tar 
which was subjected to silica gel chromatography eluting with ethyl acetate : hexane 
(1:3). Concentration of the appropriate fractions led to the isolation of (E)-2-(2-
(benzo[d][1,3]dioxol-5-yl)cyclohex-2-en-1-ylidene)acetonitrile (254) (76 mg, 32%) as 
a brown residue. 
Rf = 0.83 (EtOAc:Hex, 1:1); 1H NMR (800 MHz, DMSO) δ 6.90 (d, J = 7.9 Hz, 1H), 
6.75 (d, J = 1.2 Hz, 1H), 6.66 (dd, J = 7.9, 1.5 Hz, 1H), f 6.03 (s, 2H), 5.09 (s, 1H), 
2.71 (t, J = 6 Hz, 2H), 2.37 (td, J = 5.7, 4.3 Hz, 2H), 1.79 (m, 2H). 13C NMR (200 
MHz, DMSO) δ 159.0, 147.7, 147.2, 138.6, 138.2, 133.0, 122.7, 118.3, 109.7, 108.7, 
101.5, 94.1, 29.9, 26.4, 22.0; IR νmax (neat) 2924, 2210, 1718, 1607, 1485, 1232, 
1035, 931,812 cm–1; LRMS (ESI, +ve) m/z 240.1 [(M + H)+, 100%], 227 (78); HRMS 
[Found: (M + H)+, 240.1016 C15H14NO2 requires (M + H)+, 240.1025]. 
 
2-(Benzo[d][1,3]dioxol-5-yl)-3-vinylcyclohex-2-enone (258) 
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To a stirred solution of 2-(Benzo[d][1,3]dioxol-5-yl)-3-methoxycyclohex-2-enone 
(246) (246 mg, 1 mmol) in tetrahydrofuran (5 mL), cooled to -40 °C, was added 
vinylmagnesium bromide (4 mL, 1M in tetrahydrofuran, 4 mmol) dropwise. The 
solution was stirred at this temperature for 2 hours then slowly warmed to room 
temperature and stirred for a further 14 hours. The reaction was quenched through 
addition of 10% w/w citric acid (20 ml), stirred for a further 1 hour and extracted with 
EtOAc (3 x 30 mL). The combined organic phases were washed with brine (30 mL), 
dried over Na2SO4, and concentrated in vacuo to give a brown oil that was purified 
by silica gel chromatography using ethyl acetate : hexane (1:4) to give 2-
(benzo[d][1,3]dioxol-5-yl)-3-vinylcyclohex-2-enone (258) (198 mg, 82%) as a 
colourless oil. 
Rf = 0.9 (EtOAc:Hex, 1:1); 1H NMR (800 MHz, CDCl3) δ 6.80 (d, J = 7.9 Hz, 1H), 
6.56 (d, J = 1.5 Hz, 1H), 6.51 (m, 2H), 5.96 (s, 2H), 5.65 (d, J = 17.6 Hz, 1H), 5.35 
(d, J = 11.0 Hz, 1H), 2.64 (t, J = 6.1 Hz, 2H), 2.57 (t, J = 6.3 Hz, 2H), 2.11 (p, J = 6.3 
Hz, 2H); 13C NMR (200 MHz, CDCl3) δ 199.0, 151.4, 147.3, 147.0, 138.1, 136.4, 
128.6, 124.0, 120.4, 111.0, 108.0, 101.0, 38.4, 25.4, 21.8; IR νmax (neat) 2937, 1716, 
1663, 1485, 1239, 1037, 932 cm–1; LRMS (ESI, +ve) m/z 265.2 [(M +Na)+, 100%]; 
HRMS [Found: (M + Na)+, 265.0837. C15H14O3Na requires (M + Na)+, 265.0841]. 
 
3',4'-Dimethoxy-6-vinyl-4,5-dihydro-[1,1'-biphenyl]-2(3H)-one (261)178 
 
2-bromo-3-methoxycyclohex-2-enone (247) (3.08 g. 15.0 mmol) was added to a 
stirred solution of 3,4-(methylenedioxy)phenylboronic acid (260) (3.82 g, 21.0 mmol), 
tetrakis(triphenylphosphine)palladium (694 mg, 0.6 mmol) and triethylamine (10 mL) 
in degassed dioxane/water (200 mL of an 4:1 v/v mixture). The resultant mixture was 
heated under reflux for 6 hours and the reaction quenched through addition of 
saturated aqueous NH4Cl (100 mL) and extracted with ethyl acetate (3 x 150 mL). 
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The combined organic extracts were washed with brine (100 mL), dried over 
Na2SO4, and concentrated in vacuo. The resulting crude orange solid was dissolved 
in tetrahydrofuran (50 mL) and cooled to -40 °C, then vinylmagnesium bromide (45 
mL, 1M in tetrahydrofuran, 45 mmol) was added over 10 minutes. The solution was 
stirred at this temperature for 2 hours then slowly warmed to room temperature and 
stirred for a further 14 hours. Water (10 mL) was added and the reaction volume was 
then reduced to ~10 mL in vacuo. This was then diluted with 10% w/w citric acid (100 
ml), stirred for a further 1 hour and extracted with EtOAc (3 x 50 mL). The combined 
organic phases were washed with brine (50 mL), dried over Na2SO4, and 
concentrated in vacuo to give a brown oil that was purified by silica gel 
chromatography using ethyl acetate : hexane (1:4) to give 3',4'-dimethoxy-6-vinyl-
4,5-dihydro-[1,1'-biphenyl]-2(3H)-one (261) (1.43 g, 37%) as a colourless oil in 37% 
yield over two steps. 
Rf = 0.37 (EtOAc:Hex, 1:2) 1H NMR (400 MHz, CDCl3) δ 6.85 (d, J = 7.9 Hz, 1H) 
6.58-6.66 (m, 2H) 6.49 (dd, J = 17.5 Hz, 11.0 Hz, 1H) 5.64 (d, J = 17.5 Hz, 1H), 5.32 
(d, J  = 11.0 Hz, 1H), 3.85 (s, 3H), 3.82 (s, 3H), 2.64 (t, J = 6.0 Hz, 2H), 2.56 (t, J = 
7.0 Hz, 2H), 2.11 (p, J = 6.3 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 199.0, 151.2, 
148.2, 138.1, 136.3, 127.5, 124.0, 122.9, 120.3, 113.6, 110.6, 55.7, 55.6, 38.3, 25.3, 
21.7. Spectral data were in good agreement to that reported in the literature.178 
 
6,7-Dimethoxy-2,3,9,10-tetrahydrophenanthren-4(1H)-one (262)178 
 
A solution of 3',4'-dimethoxy-6-vinyl-4,5-dihydro-[1,1'-biphenyl]-2(3H)-one (261) (242 
mg, 1 mmol) and boron trifluoride diethyl etherate (1.2 mL, 10 mmol) in carbon 
tetrachloride (10 mL) was refluxed for 16 hours. The reaction mixture was diluted 
with ether (50 mL) and neutralized with saturated aqueous NaHCO3 (10 mL). The 
aqueous phase was extracted with diethyl ether (2 x 20 mL) and the combined 
organic extracts were washed with brine (30 mL) and dried over Na2SO4. Removal of 
solvent in vacuo resulted in a colourless oil which was purified by silica gel 
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chromatography with ethyl acetate : hexane (1:2), to give 6,7-dimethoxy-2,3,9,10-
tetrahydrophenanthren-4(1H)-one (262) (90 mg, 35%) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ 7.82 (s, 1H), 6.66 (s, 1H), 3.90 (s, 3H), 3.87 (s, 3H), 
2.68 (t, J = 7.7 Hz, 2H), 2.56 (m, 4H), 2.40 (t, J = 7.7 Hz, 2H), 2.04 (p, J = 7.7 Hz, 
2H); 13C NMR (100 MHz, CDCl3) 197.6, 158.6, 147.4, 147.1, 146.7, 128.1, 123.5, 
110.9,110.4, 55.8, 55.7, 39.4, 32.1, 30.9, 26.9, 21.8. Spectral data in good 
agreement to that reported in the literature.178 
 
6,7-Dimethoxy-1,2,3,4,9,10-hexahydrophenanthren-4-ol (263) 
 
A magnetically stirred solution of 6,7-dimethoxy-2,3,9,10-tetrahydrophenanthren-
4(1H)-one (262) (258 mg, 1 mmol) and CeCl3.7H2O (409 mg, 1.1 mmol) in MeOH (5 
mL) was cooled to 0 °C, to this NaBH4 (57 mg, 1.5 mmol) was added batchwise over 
2 minutes. The solution was maintained at this temperature for 1 h, at which point 
the reaction was quenched through addition of saturated aqueous NH4Cl (5 mL). The 
reaction was diluted with ethyl acetate (30 mL) and washed with brine (10 mL), 
before being dried over Na2SO4. Concentration in vacuo gave an oily residue that 
was purified by silica gel chromatography using ethyl acetate : hexane (1:1) to give 
6,7-dimethoxy-1,2,3,4,9,10-hexahydrophenanthren-4-ol (263) (260 mg, ~100%) as a 
colourless oil. 
Rf = 0.48 (EtOAc:Hex 1:1); 1H NMR (800 MHz, CDCl3) δ 6.77 (s, 1H), 6.53 (s, 1H), 
4.58 (m, 1H), 3.79 (s, 3H), 3.78 (s, 3H), 2.76 (m, 2H), 2.61 (m, 2H), 1.35-1.80 (m, 
6H) (OH not observed); 13C NMR (200 MHz, CDCl3) δ 147.5, 147.4, 136.5, 131.3, 
128.1, 127.4, 112.6, 107.9, 67.0, 56.1, 55.8, 33.9, 32.6, 30.6, 29.6, 20.2; IR νmax 
(neat) 3498, 2925, 2850, 1607, 1512, 1451, 1253, 1212, 1118, 728 cm–1; LRMS 
(ESI, +ve) m/z 283.2 [(M +Na)+, 100%], 245 (27); HRMS [Found: (M + Na)+, 
283.1314. C16H20O3Na requires (M + Na)+, 283.1310]. 
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2-(Benzo[d][1,3]dioxol-5-yl)cyclohex-2-enone (270)250 
 
A magnetically stirred solution of 2-iodocyclohex-2-enone (161) (3.33 g, 15 mmol) 
and 3,4-(methylenedioxy)phenylboronic acid (224) (3.48 g, 21 mmol) was treated 
with a degassed solution of benzene/2M Na2CO3 (200 mL 4:1), 
tetrakis(triphenylphosphine)palladium (693 mg, 0.6 mmol) was added and the 
resultant mixture was heated under reflux for 16 h. The reaction was quenched 
through addition of saturated aqueous NH4Cl (100 mL) and extracted with EtOAc (3 
x 150 mL). The combined organic extracts were washed with brine (100 mL), dried 
over MgSO4, and concentrated in vacuo. The crude product was purified by silica 
gel chromatography using ethyl acetate : hexane (1:1) to give 2-(benzo[d][1,3]dioxol-
5-yl)cyclohex-2-enone (270) (2.66 g, 82%) as a colourless crystalline solid. 
m.p. = 103 °C (lit. 98-100 °C)250, Rf = 0.47 (EtOAc:Hex, 1:3); 1H NMR (400 MHz, 
CDCl3) δ 6.98 (t, J = 4.4 Hz, 1H), 6.68 (m, 3H), 5.95 (s, 2H), 2.55 (m, 4H), 2.09 (m, 
2H); 13C NMR (100 MHz, CDCl3) δ 198.1, 147.3, 147.2, 147.1, 139.9, 130.5, 122.1, 
109.4, 108.0, 101.0, 39.1, 26.6, 22.9; Spectral data identical to that reported in the 
literature.250 
(Z)-N-(2-(benzo[d][1,3]dioxol-5-yl)cyclohex-2-en-1-ylidene)-1-(4-
methoxyphenyl)methanamine oxide (274) 
 
A magnetically stirred solution of 2-(benzo[d][1,3]dioxol-5-yl)cyclohex-2-enone (270) 
(216 mg, 1 mmol) and N-(4-methoxybenzyl)hydroxylamine (182 mg, 1.2 mmol) in 
tetrahydrofuran (5 mL) was treated with titanium(IV) ethoxide (556 mg, 2 mmol). The 
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mixture was heated at reflux for 16 hours. The reaction mixture was filtered through 
a plug of wet silica (prepared by evaporating a suspension of silica gel and 10 mL of 
a 9:1 tetrahydrofuran/water solution). The resulting filtrate was concentrated in vacuo 
to give crude product as a dark oil (351 mg) that was analysed directly by NMR. The 
key identifiable signals for (274) are given below in addition to the identification of the 
M+H signal by LCMS at 352 m/z. Signals in the aromatic portion of the NMR spectra 
could not be confidently assigned due to overlap with other impurities. 
1H NMR (400 MHz, CDCl3) δ 6.16 (t, J = 5.3 Hz, 1H), 5.97 (s, 2H), 4.64 (s, 2H), 3.77 
(s, 3H), 2.93 (t, J = 6.4 Hz, 2H), 2.21 (td, J = 6,2 Hz, 5.3 Hz, 2H), 1.83 – 1.74 (tt, J = 
6.4 Hz, 6.2 Hz, 2H). LRMS (ESI, +ve) m/z 352.0 [(M + H)+, 72%] 
(Z)-Ethyl 2-(2-(benzo[d][1,3]dioxol-5-yl)cyclohex-2-en-1-ylidene)acetate (281) 
 
To a solution of ethyl trimethylsilylacetate (0.38 mL, 2.1 mmol) in tetrahydrofuran (2 
mL), cooled to -78 °C, was added lithium bis(trimethylsilyl)amide (2.2 mL, 1M in 
tetrahydrofuran, 2.2 mmol). This was stirred for 1 hour at -78 °C, followed by the 
addition of 2-(benzo[d][1,3]dioxol-5-yl)cyclohex-2-enone (170) (432mg, 2 mmol) as a 
solution in THF (2 mL) this was warmed slowly to room temperature then stirred for a 
further 16 hours. The reaction mixture was diluted with water (20 mL) and extracted 
with ethyl acetate (3 x 20 mL). The combined organic phases were washed with 
brine (20 mL) and dried over Na2SO4. Removal of solvent in vacuo yielded a light 
yellow oil that was subjected to silica gel chromatography using ethyl acetate : 
hexane (1:3) to yield (Z)-ethyl 2-(2-(benzo[d][1,3]dioxol-5-yl)cyclohex-2-en-1-
ylidene)acetate (281) (474 mg, 83%) as a light yellow oil. 
Rf = 0.73 (EtOAc:Hex, 1:1); 1H NMR (800 MHz, CDCl3) δ 6.73 (d, J = 1.5 Hz, 1H), 
6.69 (m, 2H), 5.94 (td, J = 4.0, 1.3 Hz, 1H), 5.90 (s, 2H), 5.69 (s, 1H), 3.61 (q, J = 7.1 
Hz, 2H), 2.43 (m, 2H), 2.39 (td, J = 6.2, 4.2 Hz, 2H), 1.91 (m, 2H), 1.02 (t, J = 7.1 Hz, 
3H); 13C NMR (200 MHz, CDCl3) δ 170.6, 166.9, 148.6, 147.4, 134.3, 129.8, 121.2, 
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120.0, 116.7, 107.9, 107.7, 100.8, 60.1, 34.9, 26.7, 23.0, 13.9; IR νmax (neat) 2940, 
1744, 1711, 1486, 1240, 1192, 1035, 933, 912, 727 cm–1; LRMS (ESI, +ve) m/z 
309.2 [(M + Na)+, 100%]; HRMS [Found: (M + Na)+, 309.1102. C17H18O4Na requires 
(M + Na)+, 309.1103]. 
 
2-Bromo-2-cyclohexen-1-one (282)194 
 
To a stirred solution of 2-cyclohexen-1-one (160) (0.6 mL, 6.2 mmol) in 
dichloromethane (16 mL) at 0 °C was added a solution of bromine (0.32 mL, 6.3 
mmol) in dichloromethane (16 mL) over 1 hour. Triethylamine (1.44 mL, 10.3 mmol) 
was then added and the resulting mixture was allowed to warm at room temperature 
then stirred for 2 hours before it was quenched with 1M aqueous HCl (10 mL). The 
layers were separated and the organic layer was washed with brine (100 mL), dried 
over Na2SO4) and concentrated in vacuo to afford 2-bromo-2-cyclohexen-1-one 
(282) (1.06 g, 98%) which was stored in the dark at 0 °C and used without further 
purification. 
 
(Z)-Ethyl 2-(2-bromocyclohex-2-en-1-ylidene)acetate (283) 
 
To a solution of ethyl trimethylsilylacetate (0.38 mL, 2.1 mmol) in tetrahydrofuran (2 
mL), cooled to -78 °C, was added lithium bis(trimethylsilyl)amide (2.2 mL, 1M in 
tetrahydrofuran, 2.2 mmol). This was stirred for 1 hour at -78 °C, followed by the 
addition of 2-bromo-2-cyclohexen-1-one (282) (432mg, 2 mmol) as a solution in THF 
(2 mL) this was warmed slowly to room temperature then stirred for a further 16 
hours. The reaction mixture was diluted with water (20 mL) and extracted with ethyl 
acetate (3 x 20 mL). The combined organic phases were washed with brine (20 mL) 
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and dried over Na2SO4. Removal of solvent in vacuo yielded a light yellow oil that 
was subjected to silica gel chromatography using ethyl acetate : hexane (1:3) to yield 
(Z)-ethyl 2-(2-bromocyclohex-2-en-1-ylidene)acetate (283) (480 mg, 87%) as a light 
yellow oil. 
Rf = 0.85 (EtOAc:Hex, 1:1); 1H NMR (800 MHz, CDCl3) δ 6.68 (t, J = 4.6 Hz, 1H), 
6.23 (s, 1H), 4.18 (q, J = 7.1 Hz, 2H), 3.10 (m, 2H), 2.30 (q, J = 5.7 Hz, 2H), 1.77 (p, 
J = 6.1 Hz, 2H), 1.30 (t, J = 7.2 Hz, 3H); 13C NMR (200 MHz, CDCl3) δ 166.8, 150.0, 
140.9, 122.6, 118.5, 60.0, 28.5, 27.7, 21.6, 14.3; IR νmax (neat) 2980, 2935, 1709, 
1617, 1369, 1301, 1232, 1174,1033, 870 cm–1; LRMS (ESI, +ve) m/z 245.1 [(M)+, 
100%], 219 (65), 217 (69), 137 (53); HRMS [Found: (M + Na)+, 268.9975. 
C10H13O2BrNa requires (M + Na)+, 268.9976]. 
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7.5 Bicuculline 
 
Methyl 5-bromobenzo[d][1,3]dioxole-4-carboxylate (339)216 
 
Butyllithium (1.31 M in pentane, 7.02 mL, 9.13 mM) was dropwise over 5 minutes to 
a cooled (-78 °C) solution of diisopropylamine (1.40 mL, 9.95 mmol) in 
tetrahydrofuran (20 mL) under nitrogen. The mixture was warmed to 0 °C for 5 
minutes then returned to -78 °C. 5-bromobenzo[d][1,3]dioxole (338) (1.00 mL, 8.30 
mmol) was then added dropwise over 2 minutes at this temperature. After stirring for 
45 minutes dimethyl carbonate (2.1 mL, 25 mmol) was added and the reaction then 
slowly warmed to room temperature over 2 hours. The solution was diluted with 
water (30 mL) and extracted with ethyl acetate (3 x 30 mL). The combined organic 
layers were washed sequentially with 1M aqueous HCl (30 mL), saturated aqueous 
sodium carbonate (40 mL) and brine (40 mL). After drying over Na2SO4 the solution 
was concentrated under reduced pressure and the resulting oil purified by silica gel 
chromatography using ethyl acetate : hexane (1:9) to afford methyl 5-
bromobenzo[d][1,3]dioxole-4-carboxylate (339) (1.78 g, 81%) as a pale yellow solid 
Rf = 0.09 (Ether:Hex, 1:9); m.p. 58-59 °C; 1H-NMR (400 MHz, CDCl3) δ 7.05 (d, J = 
8.0 Hz, 1H), 6.72 (d, J = 8.4 Hz, 1H), 6.05 (s, 2H), 3.94 (s, 3H); 13C-NMR (100 MHz, 
CDCl3) δ 164.0, 147.6, 147.4, 126.0, 115.9, 111.2, 110.9, 102.3, 52.4; IR vmax (neat) 
2953, 2905, 1733, 1626, 1451, 1342, 1276, 1137 cm-1; LRMS (ESI+) m/z = 281 
([79BrM+Na]+, 100%), 283 ([81BrM+Na]+, 98%); HRMS [Found 280.9425. 
C9H7O479BrNa requires (M+Na)+ 280.9425], [Found 282.9409. C9H7O481BrNa 
(M+Na)+ requires 282.9405]. Data identical to that obtained by Pasfield.216 
 
Methyl 5-iodobenzo[d][1,3]dioxole-4-carboxylate (309)216 
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Butyllithium (1.3M in pentane, 28.2 mL, 42.4 mmol) was added dropwise over 5 min 
to a cooled (-78 °C) solution of 2,2,6,6-tetramethylpiperidine (7.86 mL, 46.2 mmol) in 
tetrahydrofuran under nitrogen and the reaction warmed to 0°C. After stirring for 10 
minutes the reaction was returned to -78°C followed by the dropwise addition of 5-
iodobenzo[d][1,3]dioxole (313) (5.00 mL, 38.5 mmol) over 5 minutes. The solution 
was stirred for a further 45 minutes at -78 °C and dimethyl carbonate (12 mL, 142 
mmol) was then added dropwise over 5 minutes. The reaction was then slowly 
warmed to room temperature over 2 hours, then quenched with water (100 mL) and 
extracted with ethyl acetate (3 x 50 mL). The combined organic layers were washed 
sequentially with 1M aqueous HCl (30 mL), saturated aqueous sodium carbonate (40 
mL) and brine (40 mL). After drying over Na2SO4 the solution was concentrated 
under reduced pressure and the resulting oil purified by silica gel chromatography 
using ethyl acetate : hexane (1:9) to afford methyl 5-iodobenzo[d][1,3]dioxole-4-
carboxylate (309) (1.78 g, 81%) as a yellow oil. 
Rf = 0.19 (Ether:Hex, 1:9); 1H-NMR (400 MHz, CDCl3) δ 7.36 (d, J = 8.4 Hz, 1H), 
6.62 (d, J = 8.0 Hz, 1H), 6.04 (s, 2H) 3.94 (s, 3H); 13C-NMR (100 MHz, CDCl3) δ 
165.0, 148.5, 147.4, 133.3, 119.0, 112.0, 102.2, 81.4, 52.6; IR vmax (neat) 2951, 
2903, 1729, 1619, 1448, 1273, 1239, 1041 cm-1; LRMS (EI+) m/z = 306 (M+•, 100%); 
HRMS (Found 305.9393.C9H7O4I (M+•) requires 305.9389). Data identical to that 
obtained by Pasfield.216 
 
2-(6-Iodobenzo[d][1,3]dioxol-5-yl)acetic acid (333)251 
 
Iodine (7.9 g, 31.1 mmol) was added in small portions over 1 hour to a vigorously 
stirred solution of 2-(benzo[d][1,3]dioxol-5-yl)acetic acid (310) (4.00 g, 22.2 mmol), 
NaOH (2.66 g, 66.6 mmol) and NaI (3.33 g, 22.2 mmol) in tetrahydrofuran (15 mL) 
and water (30 mL). After addition was complete the reaction was then allowed to stir 
for 16 hours at room temperature and the reaction quenched by addition of a 
saturated aqueous Na2SO3 (20 mL). The resulting solution was poured into water 
(100 mL) and the reaction stirred under a stream of nitrogen for 3 hours, resulting in 
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the formation of a precipitate. The solids were collected by filtration and washed with 
water (3 x 30 mL) and dried under vacuum to afford 2-(6-iodobenzo[d][1,3]dioxol-5-
yl)acetic (333) as a white solid (6.11 g, 71%). 
Rf (EtOAc:Hex ; 1:1) 0.05; m.p. 179-186 °C (lit 180-181 °C)251;  1H-NMR (400 MHz, 
CD3OD) δ 7.26 (s, 1H), 6.87 (s, 1H), 5.97 (s, 2H), 3.71 (s, 2H); 13C-NMR (100 MHz, 
CD3OD) δ 174.5, 150.0, 149.0, 132.9, 119.3, 111.7, 103.2, 89.5, 46.6; IR vmax (neat) 
3317, 3012, 2910, 1697, 1484, 1407, 1226, 1034 cm-1; LRMS (ESI+) m/z = 329 
([M+Na]+, 100%); HRMS (ESI+) calc. for C9H7O4Na  ([M+H]+) 328.9287, found 
328.9286. Data in good agreement with the literature.251 
 
2-(Trimethylsilyl)ethyl 2-(6-iodobenzo[d][1,3]dioxol-5-yl)acetate (337) 
 
A solution of 2-(trimethylsilyl)ethanol (2.87 mL, 20 mmol) and  2-(6-
iodobenzo[d][1,3]dioxol-5-yl)acetic (333) (6.00 g, 19.6 mmol) in acetonitrile (30 mL) 
was added over 5 minutes to a stirred, cooled (0 °C) mixture of N,N’-
dicyclohexylcarbodiimide (4.25 g, 20.58 mmol) and 4-(dimethylamino)pyridine (240 
mg, 1.96 mmol) in acetonitrile (30 mL). The resulting solution was stirred at room 
temperature for a further 16 hours, cooled to 0 °C then filtered. The filtrate was 
concentrated under reduced pressure and the residue treated with hexane and 
sonicated. The resulting solution was cooled to 0 °C and filtered a second time. 
Concentration in vacuo afforded the essentially pure 2-(trimethylsilyl)ethyl 2-(6-
iodobenzo[d][1,3]dioxol-5-yl)acetate (337) (7.25 g, 91%) as a colourless oil. 
Rf = 0.72 (EtOAc:Hex, 1:4); 1H NMR (800 MHz, CDCl3) δ 7.24 (s, 1H), 6.80 (s, 1H), 
5.96 (s, 2H), 4.21 (m, 2H), 3.69 (s, 2H), 1.01 (m, 2H), 0.03 (s, 9H); 13C NMR (200 
MHz, CDCl3) δ 170.8, 148.5, 147.6, 131.0, 118.6, 110.5, 101.7, 88.9, 63.4, 46.2, 
17.3, -1.5; IR νmax (neat) 2890, 1728, 1478, 1227, 1150, 1036, 831, 694 cm–1; LRMS 
(ESI, +ve) m/z 429.0 [(M +Na)+, 100%], 379 (20), 252 (38); HRMS [Found: (M + 
Na)+, 428.9993. C14H19IO4Si2Na requires (M + Na)+, 428.9995]. 
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2-(Trimethylsilyl)ethyl 2-(6-((trimethylsilyl)ethynyl)benzo[d][1,3]dioxol-5-yl)acetate 
(340) 
 
To a stirred solution of 2-(trimethylsilyl)ethyl 2-(6-iodobenzo[d][1,3]dioxol-5-yl)acetate 
(337) (3.12 g, 7.68 mmol), tetrakis(triphenylphosphine)palladium (443 mg, 0.38 
mmol) and copper iodide (146 mg, 0.77 mmol) in tetrahydrofuran (50 mL) was added 
triethylamine (3.12 mL, 22.4 mmol) followed by ethynyltrimethylsilane (331) (1.59 
mL, 11.1 mmol). The reaction was stirred for 16 hours at room temperature and then 
quenched with saturated aqueous NH4Cl (75 mL). The resulting solution was 
extracted with ethyl acetate (3 x 30 mL), the combined organic layers washed with 
brine (30 mL), dried over Na2SO4 and concentrated in vacuo. The residual orange oil 
was purified by silica gel chromatography using ethyl acetate : hexane (1:9) to give 
2-(trimethylsilyl)ethyl 2-(6-((trimethylsilyl)ethynyl)benzo[d][1,3]dioxol-5-yl)acetate 
(340)  (2.63 g, 91%) as a tan solid. 
m.p. = 72 °C; Rf = 0.75 (EtOAc:Hex, 1:4); 1H NMR (800 MHz, CDCl3) δ 6.90 (s, 1H), 
6.74 (s, 1H), 5.95 (s, 2H), 4.19 (m, 2H), 3.73 (s, 2H), 0.99 (m, 2H), 0.23 (s, 9H), 0.02 
(s, 9H); 13C NMR (200 MHz, CDCl3) δ 171.3, 148.2, 146.4, 131.8, 116.5, 111.7, 
110.1, 103.2, 101.4, 97.3, 63.1, 39.8, 17.4, 0.0, -1.5; IR νmax (neat) 2890, 2152, 
1728, 1483, 1247, 1156, 830, 758 cm–1; LRMS (ESI, +ve) m/z 399.2 [(M +Na)+, 
100%], 349 (55); HRMS [Found: (M + Na)+, 399.1425. C19H28O4Si2Na requires (M + 
Na)+, 399.1424] 
 
2-(Trimethylsilyl)ethyl 2-(6-ethynylbenzo[d][1,3]dioxol-5-yl)acetate (341) 
 
Aqueous silver nitrate (90 mg, 0.53 mmol, 5 mL water) was added to a solution of  2-
(trimethylsilyl)ethyl 2-(6-((trimethylsilyl)ethynyl)benzo[d][1,3]dioxol-5-yl)acetate (340) 
(2.00 g, 5.31 mmol) in acetone (15 mL) and stirred for 16 hours at room temperature 
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under nitrogen. Brine (20 mL) was added and the solution filtered. The filtrate was 
extracted with ethyl acetate (3 x 20 mL) and the combined organic extracts washed 
with brine (30 mL) and dried over Na2SO4. Removal of solvent in vacuo gave a 
colourless oil that was purified by silica gel chromatography using ethyl acetate : 
hexane (1:9) to give 2-(trimethylsilyl)ethyl 2-(6-ethynylbenzo[d][1,3]dioxol-5-
yl)acetate (341) (1.47g, 91%) as a colourless oil. 
Rf = 0.67 (EtOAc:Hex, 1:4); 1H NMR (800 MHz, CDCl3) δ 6.90 (s, 1H), 6.74 (s, 1H), 
5.94 (s, 2H), 4.18 (m, 2H), 3.73 (s, 2H), 3.15 (s, 1H), 0.97 (m, 2H), 0.00 (s, 9H); 13C 
NMR (200 MHz, CDCl3) δ 171.3, 148.4, 146.5, 131.9, 115.3, 112.4, 110.1, 101.5, 
81.8, 80.1, 63.2, 39.7, 17.3, -1.5; IR νmax (neat) 3290, 2972, 2103, 1728, 1482, 1380, 
1248, 1152, 1036, 939, 833 cm–1; LRMS (ESI, +ve) m/z 327.1.4 [(M +Na)+, 100%], 
277 (33); HRMS [Found: (M + Na)+, 327.1030. C16H20O4SiNa requires (M + Na)+, 
327.1029] 
 
Methyl 5-ethynylbenzo[d][1,3]dioxole-4-carboxylate (343) 
 
To a solution of methyl 5-iodobenzo[d][1,3]dioxole-4-carboxylate (309) (2.27 g, 7.42 
mmol), tetrakis(triphenylphosphine)palladium (428 mg, 0.37 mmol), and copper 
iodide (140 mg, 0.74 mmol) in tetrahydrofuran (50 mL) was added triethylamine 
(3.12 mL, 22.4 mM) followed by ethynyltrimethylsilane (331) (1.6 mL, 11.1 mmol) 
and the reaction stirred for 16 hours at room temperature. The reaction was then 
quenched by addition of saturated aqueous NH4Cl (75 mL) followed by extraction 
with ethyl acetate (3 x 30 mL). The combined organic layers were washed with brine 
(30 mL) and dried over Na2SO4. Concentration under reduced pressure gave an 
orange oil that was used directly in the next step. 
The previously obtained oil was dissolved in methanol (50 mL) and anhydrous 
potassium carbonate (102 mg, 0.74 mmol) added. The resulting suspension was 
then stirred at room temperature for 3 hours. The reaction was then diluted with 
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water (50 mL) followed by extraction with dichloromethane (3 x 40 mL) and washing 
with brine (50 mL). The combined organic layers were evaporated on to TLC grade 
silica (3 g) and evaporated to dryness. The compound was then purified by silica gel 
chromatography using ethyl acetate : hexane (1:4) to afford methyl 5-
ethynylbenzo[d][1,3]dioxole-4-carboxylate (343) (775 mg, 95%) as a tan solid. 
Rf (Ether:Hex ; 3:7) 0.18; m.p. 96 °C (decomp); 1H-NMR (400 MHz, CDCl3) δ 7.13 
(d, J = 8.0 Hz, 1H), 6.85 (d, J = 8.4 Hz, 1H), 6.09 (s, 2H), 3.94 (s, 3H), 3.20 (s, 1H); 
13C-NMR (100 MHz, CDCl3) δ 164.3, 148.7, 147.8, 129.1, 115.6, 114.9, 110.7, 
102.3, 81.5, 79.7, 52.2; IR vmax (neat) 3248, 2956, 2919, 1713, 1449, 1243, 1054, 
921 cm-1; LRMS (EI+) m/z =  204 (M+•, 100%); HRMS [Found  204.0426. C11H8O4 
requires (M+•) 204.0423]  
 
Methyl 5-((6-(2-oxo-2-(2-(trimethylsilyl)ethoxy)ethyl)benzo[d][1,3]dioxol-5-
yl)ethynyl)benzo[d][1,3]dioxole-4-carboxylate (336) 
 
To a stirred, heated (60 °C) solution of 2-(trimethylsilyl)ethyl 2-(6-
iodobenzo[d][1,3]dioxol-5-yl)acetate (337) (5.2 g, 12.8 mmol), copper iodide (230 
mg, 1.26 mmol), and tetrakis(triphenylphosphine)palladium (700 mg, 0.61 mmol) in 
diisopropylamine (40 mL) was added methyl 5-ethynylbenzo[d][1,3]dioxole-4-
carboxylate (343) (2.61 g, 12.8 mmol) as a solution in DIPA (10 mL) over a period of 
one minute. The solution was stirred for a further 30 minutes resulting in a 
voluminous precipitate. The reaction mixture was diluted with water (100 mL) and 
acidified to pH 4 with 2M aqueous HCl. The resulting solution was then extracted 
with ethyl acetate (3 x 70 mL) and the combined organic extracts washed with brine 
then dried over Na2SO4. Removal of solvent in vacuo yields a crude orange solid that 
was purified by silica gel chromatrography using ethyl acetate : hexane (1:4) to 
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afford methyl 5-((6-(2-oxo-2-(2-(trimethylsilyl)ethoxy)ethyl)benzo[d][1,3]dioxol-5-
yl)ethynyl)benzo[d][1,3]dioxole-4-carboxylate (336) (5.68 g, 92%) as a beige solid. 
m.p. = 126 °C; Rf = 0.31 (EtOAc:Hex, 1:4); 1H NMR (800 MHz, CDCl3) δ 7.14 (d, J = 
8.1 Hz, 1H), 6.96 (s, 1H), 6.88 (d, J = 8.0 Hz, 1H), 6.79 (s, 1H), 6.10 (s, 2H), 5.98 (s, 
2H), 4.18 (m, 2H), 3.96 (s, 3H), 3.85 (s, 2H), 0.95 (m, 2H), -0.01 (s, 9H); 13C NMR 
(200 MHz, CDCl3) δ 171.5, 164.4, 148.2, 148.1, 147.9, 146.5, 131.3, 128.1, 116.7, 
116.4, 114.9, 111.5, 110.8, 110.1, 102.3, 101.5, 90.6, 90.3, 63.1, 52.3, 39.8, 17.3, -
1.6; IR νmax (neat) 2890, 2201, 1715, 1611, 1467, 1450, 1375, 1234, 1035, 840, 488 
cm–1; LRMS (ESI, +ve) m/z 505.2 [(M +Na)+, 100%], 455 (24); HRMS [Found: (M + 
Na)+, 505.1286. C25H26O8SiNa requires (M + Na)+, 505.1295]. 
 
Bis(2-(trimethylsilyl)ethyl) 2,2'-(6,6'-(buta-1,3-diyne-1,4-diyl)bis(benzo[d][1,3]dioxole-
6,5-diyl))diacetate (342) 
 
After pooling of unsuccessful Sonogashira reactions and purification of the resulting 
residue by column chromatography with gradient elution using ethyl acetate : hexane 
(1:9 – 1:0) it was possible to isolate the homocoupled side product for 
characterisation. 
m.p. = 120-130 °C, Rf = 0.5 (EtOAc:Hex, 1:4); 1H NMR (800 MHz, CDCl3) δ 6.94 (s, 
2H), 6.78 (s, 2H), 5.98 (s, 4H), 4.22 (m, 4H), 3.76 (s, 4H), 1.02 (m, 4H), 0.02 (s, 
18H); 13C NMR (200 MHz, CDCl3) δ 171.1, 148.9, 146.6, 133.1, 115.1, 112.2, 110.2, 
101.7, 80.4, 76.8, 63.3, 39.7, 17.4, -1.5; IR νmax (neat) 2889, 2144, 1727, 1613, 
1482, 1270, 1250, 1153, 1033, 831, 694, 519 cm–1; LRMS (ESI, +ve) m/z 629.4 [(M 
+Na)+, 100%], HRMS [Found: (M + Na)+, 629.2003. C32H38O8Si2Na requires (M + 
Na)+, 629.2003]. 
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(Z)-2-(6-(2-(4-(Methoxycarbonyl)benzo[d][1,3]dioxol-5-yl)vinyl)benzo[d][1,3]dioxol-5-
yl)acetic acid (329) 
 
Ethoxydimethylsilane (1 mL, 7.2 mmol) was added under nitrogen to a solution of 
Methyl 5-((6-(2-oxo-2-(2-(trimethylsilyl)ethoxy)ethyl)benzo[d][1,3]dioxol-5-
yl)ethynyl)benzo[d][1,3]dioxole-4-carboxylate (336) (1.01 g, 2.07 mmol) dissolved in 
tetrahydrofuran (1 mL), to this solution was added anhydrous platinum oxide (50 mg, 
0.22 mmol). The resulting suspension was heated to 60 °C for 6 hours then the 
solvent removed in vacuo. The oily black residue was resuspended in 
tetrahydrofuran (3 mL) and cooled to -10 °C, followed by addition of a solution of 
tetrabutylammonium fluoride (10 mL of a 1M solution in THF, 10 mmol) over a period 
of 2 minutes, during which gas was evolved. The solution was slowly warmed to 
room temperature and stirred for a further 14 hours. The reaction was quenched by 
addition of 10% CaCl2 solution (10 mL) and stirred for a further 1 hour. The resulting 
grey suspension is then filtered through Celite and the solids washed with diethyl 
ether (3 x 5 mL) and water (2 x 5 mL). The collected filtrates were extracted with 
diethyl ether (3 x 10 mL) and the combined organic extracts washed with brine (20 
mL) then dried over Na2SO4. Solvent was removed in vacuo and the resulting grey 
solid was purified by silica gel chromatography using ethyl acetate : hexane : acetic 
acid (24:75:1) to give (Z)-2-(6-(2-(4-(methoxycarbonyl)benzo[d][1,3]dioxol-5-
yl)vinyl)benzo[d][1,3]dioxol-5-yl)acetic acid (329) (771 mg, 96%) as a light orange 
solid. 
m.p. = 153 °C; Rf = 0.34 (EtOAc:Hex, 3:2); 1H NMR (800 MHz, CDCl3) δ 6.82 (d, J = 
11.8 Hz, 1H), 6.68 (s, 1H), 6.64 (d, J = 8.1 Hz, 1H), 6.53 (d, J = 8.0 Hz, 1H), 6.53 (d, 
J = 12.0 Hz, 1H), 6.48 (s, 1H), 6.03 (s, 2H), 5.87 (s, 2H), 3.90 (s, 3H), 3.60 (s, 2H), 
COOH not observed; 13C NMR (200 MHz, CDCl3) δ 177.5, 165.4, 148.0, 147.3, 
146.8, 146.7, 131.0, 130.6, 130.6, 127.3, 125.2, 124.3, 113.0, 111.0, 110.3, 110.0, 
101.9, 101.1, 52.1, 38.4; IR νmax (neat) 3658, 2889, 1711, 1497, 1459, 1266, 1230, 
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1035, 872 cm–1; LRMS (ESI, +ve) m/z 407.2 [(M +Na)+, 100%], 335 (16); HRMS 
[Found: (M + Na)+, 407.0743. C20H16O8Na requires (M + Na)+, 407.0743]. 
 
General procedure for formation of hydroxamate esters: 
To a stirred solution of (Z)-2-(6-(2-(4-(methoxycarbonyl)benzo[d][1,3]dioxol-5-
yl)vinyl)benzo[d][1,3]dioxol-5-yl)acetic acid (329) (1.01 g, 2.65 mmol) in THF (25 mL) 
was added freshly powdered imidazole (1.02 g, 15 mmol) and carbonyl dimidazole 
(670 mg, 4.13 mmol). The resulting solution was heated to reflux for 16 hours then 
cooled to room temperature. At this temperature powdered hydroxylamine 
hydrochloride (1.01 g, 14.5 mmol) was added in a single portion at room 
temperature. The solution was stirred for a further 16 hours, then diluted with water 
(100 mL) and acidified to pH 3 with 2M HCl. The resulting solution was extracted 
with ethyl acetate (3 x 70 mL) and the combined organic fractions washed with brine 
(50 mL) and dried over Na2SO4. Removal of solvent in vacuo yielded a beige solid 
(1.01 g) that was used without further purification. 
The crude hydroxamic acid (1.01 g, 2.5 mmol) was dissolved in THF (25 mL) and 
cooled to 0 °C, Pyridine (0.25 mL, 3.1 mmol) was added, followed by dropwise 
addition of the corresponding acid chloride (2.7 mmol). The reaction mixture was 
slowly warmed to room temperature and stirred for a further 16 hours. The reaction 
mixture was quenched by addition of 10% aqueous citric acid (20 mL) and extracted 
with ethyl acetate (3 x 50 mL). The combined organic phases were washed with 
brine (50 mL), dried over Na2SO4, and the solvent removed in vacuo to give a beige 
solid that was purified by silica gel chromatography using ethyl acetate : hexane 
(1:1) to give the corresponding hydroxamate ester. 
(Z)-Methyl 5-(2-(6-(2-(((4-chlorobenzoyl)oxy)amino)-2-oxoethyl)benzo[d][1,3]dioxol-
5-yl)vinyl)benzo[d][1,3]dioxole-4-carboxylate (356) 
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89% yield, m.p. 119 (decomp); Rf = 0.73 (EtOAc:Hex, 3:2); 1H NMR (800 MHz, 
CDCl3) δ 9.70 (s, 1H), 8.02 (d, J = 8.6 Hz, 2H), 7.44 (d, J = 8.6 Hz, 2H), 6.79 (d, J = 
11.8 Hz, 1H), 6.76 (s, 1H), 6.68 (d, J = 8.1 Hz, 1H), 6.63 (m, 2H), 6.57 (d, J = 8.1 Hz, 
1H), 6.03 (s, 2H), 5.92 (s, 2H), 3.93 (s, 3H), 3.41 (s, 2H); 13C NMR (200 MHz, CDCl3) 
δ 166.1, 165.4, 163.9, 148.0, 147.5, 147.1, 147.0, 140.7, 131.4, 131.0, 130.8, 130.3, 
129.1, 127.9, 125.3, 124.5, 124.3, 112.6, 111.1, 111.1, 109.8, 102.0, 101.2, 52.6, 
38.0; IR νmax (neat) 2917, 1766, 1715, 1683, 1483, 1465, 1228, 1038, 1009, 908, 
728 cm–1; LRMS (ESI, +ve) m/z 560.1 [(M +Na)+, 100%], 404 (12), 350 (11), 335 
(11); HRMS [Found: (M + Na)+, 560.0723. C27H2035ClNO9Na requires (M + Na)+, 
560.0724]. 
 
(Z)-Methyl 5-(2-(6-(2-((benzoyloxy)amino)-2-oxoethyl)benzo[d][1,3]dioxol-5-
yl)vinyl)benzo[d][1,3]dioxole-4-carboxylate (325) 
 
87% yield; m.p. 121 (decomp); Rf = 0.69 (EtOAc:Hex, 3:2); 1H NMR (800 MHz, 
CDCl3) δ 9.58 (s, 1H), 8.01 (m, 2H), 7.54 (m, 1H), 7.39 (m, 2H), 6.73 (d, J = 11.8 Hz, 
1H), 6.71 (s, 1H), 6.61 (d, J = 8.1 Hz, 1H), 6.59 (d, J = 12.0 Hz, 1H), 6.54 (s, 1H), 
6.51 (d, J = 8.1 Hz, 1H), 5.96 (s, 2H), 5.85 (s, 2H), 3.86 (s, 3H), 3.38 (s, 2H); 13C 
NMR (200 MHz, CDCl3) δ 165.8, 165.4, 164.7, 148.0, 147.4, 147.1, 147.0, 134.1, 
131.9, 131.4, 131.0, 130.8, 130.4, 130.0, 128.7, 124.6, 124.3, 112.6, 111.1, 111.0, 
109.8, 101.9, 101.2, 52.3, 38.7; IR νmax (neat) 3195, 2924, 1768, 1714, 1667, 1450, 
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1229, 1039, 907, 728, 728 cm–1; LRMS (ESI, +ve) m/z 526.1 [(M +Na)+, 100%], 404 
(12), 350 (17), 335 (16); HRMS [Found: (M + Na)+, 526.1115. C27H21NO9Na requires 
(M + Na)+, 526.1141]. 
 
(Z)-Methyl 5-(2-(6-(2-oxo-2-(((2,4,6-
trimethylbenzoyl)oxy)amino)ethyl)benzo[d][1,3]dioxol-5-yl)vinyl)benzo[d][1,3]dioxole-
4-carboxylate (357) 
 
79% yield; m.p. 121 (decomp); Rf = 0.71 (EtOAc:Hex, 3:2); 1H NMR (800 MHz, 
CDCl3) δ 9.58 (s, 1H), 6.79 (s, 2H), 6.70 (s, 1H), 6.69 (d, J = 11.9 Hz, 1H), 6.59 (d, J 
= 8.1 Hz, 1H), 6.57 (d, J = 12 Hz, 1H), 6.55 (s, 1H), 6.50 (d, J = 8.1 Hz, 1H), 5.92 (s, 
2H), 5.86 (s, 2H), 3.86 (s, 3H), 3.34 (s, 2H), 2.30 (s, 6H), 2.21 (s, 3H). 13C NMR (200 
MHz, CDCl3) δ 168.8, 167.8, 166.3, 147.9, 147.4, 147.1, 147.0, 140.5, 136.6, 130.8, 
130.51, 130.3, 128.6, 128.5, 128.0, 124.6, 124.2, 112.6, 111.2, 111.1, 109.7, 101.9, 
101.2, 52.5, 38.1, 21.2, 19.8; IR νmax (neat) 3182, 2920, 1769, 1716, 1668, 1611, 
1481, 1448,1227, 1036 cm–1; LRMS (ESI, +ve) m/z 568.2 [(M +Na)+, 100%], 147 
(35); HRMS [Found: (M + Na)+, 568.1586. C30H27NO9Na requires (M + Na)+, 
568.1584]. 
 
(±)-(R)-5-((S)-8-Oxo-6,8-dihydro-[1,3]dioxolo[4,5-e]isobenzofuran-6-yl)-5,6-dihydro-
[1,3]dioxolo[4,5-g]isoquinolin-7(8H)-one (326) 
 Chapter 7 
  186 
 
 
Potassium osmate(VI) dihydrate (30 mg, 0.09 mmol) was sonicated into a 
suspension in degassed milliQ water (0.5 mL) which was then added to a mixture of 
(Z)-methyl 5-(2-(6-(2-(((4-chlorobenzoyl)oxy)amino)-2-oxoethyl)benzo[d][1,3]dioxol-
5-yl)vinyl)benzo[d][1,3]dioxole-4-carboxylate (356) (500 mg, 0.93 mmol) and ground 
NaHCO3 (120 mg, 1.43 mmol) in degassed tetrahydrofuran (4.5mL) under nitrogen. 
The mixture slowly darkened and was stirred for 16 hours at room temperature. The 
reaction was quenched by addition of saturated aquoues Na2SO3 (5 mL) and filtered 
through Celite. The solids were washed with tetrahydrofuran (3 x 2 mL) and the 
combined filtrates extracted with EtOAc (3 x 10 mL). The combined organic extracts 
were washed with brine (15 mL) and dried over Na2SO4. Removal of the solvent in 
vacuo gives a dark grey residue which was dissolved in hot tetrahydrofuran (10 mL), 
then diluted with hexane (10 mL). The resulting precipitate was filtered and washed 
with hexane to give (±)-(R)-5-((S)-8-oxo-6,8-dihydro-[1,3]dioxolo[4,5-
e]isobenzofuran-6-yl)-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolin-7(8H)-one (326) (214 
mg, 63%) as an off white solid. 
m.p. = 243 °C; Rf = 0.07 (EtOAc:Hex, 3:2); 1H NMR (800 MHz, DMSO) δ 8.30 (d, J = 
3.4 Hz, 1H), 7.23 (d, J = 7.9 Hz, 1H), 6.73 (s, 1H), 6.67 (s, 1H), 6.54 (d, J = 8.1 Hz, 
1H), 6.21 (m, 2H), 5.97 (s, 2H), 5.76 (d, J = 3.4 Hz Hz, 1H), 4.95 (t, J = 3.4 Hz, 1H), 
3.14 (d, J = 20.3 Hz, 1H), 3.08 (d, J = 19.6 Hz, 1H); 13C NMR (200 MHz, DMSO) δ 
170.5, 166.4, 149.5, 147.6, 146.1, 144.7, 138.5, 127.6, 122.2, 116.20, 114.3, 109.2, 
108.0, 107.6, 104.0, 101.6, 84.8, 57.7, 36.1; IR νmax (neat) 2980, 2914, 1762, 1716, 
1666, 1475, 1239, 1037,732 cm–1; LRMS (ESI, +ve) m/z 390.1 [(M +Na)+, 100%], 
280 (14), 228 (13), 206 (14), 164 (24); HRMS [Found: (M + Na)+, 390.0587. 
C19H13NO7Na requires (M + Na)+, 390.0590]. 
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Purification by column chromatography using gradient elution with ethyl acetate : 
hexane : methanol (4:1:0 – 1:0:0 – 19:0:1) allows for isolation of the other major side 
product, (Z)-methyl 5-(2-(6-(2-amino-2-oxoethyl)benzo[d][1,3]dioxol-5-
yl)vinyl)benzo[d][1,3]dioxole-4-carboxylate (355) as a light orange solid. 
 
m.p. = 172 °C; Rf = 0.16 (EtOAc:Hex, 3:2); 1H NMR (800 MHz, CDCl3) δ 6.73 (d, J = 
11.9 Hz, 1H), 6.64 (s, 1H), 6.60 (d, J = 8.1 Hz, 1H), 6.47 (m, 3H), 5.99 (s, 2H), 5.83 
(s, 2H), 5.67 (s, 1H), 5.39 (s, 1H), 3.84 (s, 3H), 3.36 (s, 2H). 13C NMR (200 MHz, 
CDCl3) δ 173.22, 165.62, 148.05, 147.40, 147.07, 146.82, 131.02, 130.65, 130.24, 
127.33, 126.54, 124.11, 112.90, 111.00, 110.60, 110.03, 101.94, 101.14, 52.28, 
41.17; IR νmax (neat) 3438, 3314, 3199, 2919, 2855, 1711, 1660, 1595, 1466, 1448, 
1255, 1037, 1010, 923, 570 cm–1; LRMS (ESI, +ve) m/z 406.1 [(M + Na)+, 100%]; 
HRMS [Found: (M + Na)+, 406.0902. C20H17NO7Na requires (M + Na)+, 406.0903]. 
 
(±)- (S)-6-((R)-5H-[1,3]dioxolo[4,5-g]isochromen-5-yl)-[1,3]dioxolo[4,5-
e]isobenzofuran-8(6H)-one (364) 
 
To a cooled (-40 °C), stirred suspension of (±)-(R)-5-((S)-8-oxo-6,8-dihydro-
[1,3]dioxolo[4,5-e]isobenzofuran-6-yl)-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolin-
7(8H)-one (326) (100 mg, 0.27 mmol) in dicloromethane (2 mL) was added 
trifluoromethanesulfonic anhydride (92 mg, 0.32 mmol). The solution was stirred for 
2 hours at the same temperature then tetrahydrofuran added (2 mL), followed by 
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sodium triacetoxyborohydride (86 mg, 0.40 mmol). The solution was allowed to warm 
to room temperature over 2 hours then quenched by addition of a saturated solution 
of ammonium chloride (5 mL). The resulting solution was extracted with ethyl acetate 
(3 x 5 mL). The combined organic phases were washed with brine (5 mL), dried over 
Na2SO4, and the solvent removed in vacuo to give a beige oil that was analysed 
directly by 1H NMR and LCMS. 
1H NMR (400 MHz, CDCl3) δ 7.57 (d, J = 12.2 Hz, 1H), 6.27 (d, J = 12.2 Hz, 1H). 
LRMS (ESI, +ve) m/z 406.1 [(M + H)+, 100%] 
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